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Abstract 
This dissertation is related to the studies of functionalized nanoparticles for 
self-assembly and as controlled drug delivery system. The whole topic is composed of 
two parts. In the first part, the research was conducted to design and synthesize a new 
type of ionic peptide-functionalized copolymer conjugates for self-assembly into 
nanoparticle fibers and 3D scaffolds with the ability of multi-drug loading and governing 
the release rate of each drug for tissue engineering. The self-assembly study confirmed 
that such peptide-functionalized amphiphilic copolymers underwent different 
self-assembly behavior. The bigger nanoparticles were more easily assembled into 
nanoparticle fibers and 3D scaffolds with larger pore size, while the smaller nanoparticle 
underwent faster self-assembly to form more compact 3D scaffolds with smaller porosity 
but more stable structure. Controlled release studies confirmed the ability of governing 
simultaneous release of different model drugs with independent release rate from a same 
scaffold. Cytotoxicity tests showed that all synthesized peptides, copolymers and 
peptide-copolymer conjugates were biocompatible with SW-620 cell lines and NIH3T3 
cell lines. This new type of self-assembled scaffolds combined the advantages of peptide 
nanofibers and versatile controlled release of polymeric nanoparticles to achieve 
simultaneous multi-drug loading and controlled release of each drug, uniform distribution 
and flexibility of hydrogel scaffolds. 
 The investigations in second part were first to design and synthesize organic 
biocide-loaded nanoparticles for low-leaching wood preservation using a cost-effective 
one-pot method to synthesize amphiphilic chitosan-g-PMMA nanoparticles loading with 
~25-28 wt.% of the fungicide tebuconazole with particle size of ~100 nm diameter by 
FESEM. FESEM analysis confirmed efficient penetration of nanoparticles throughout the 
treated wooden stake with dimension of 1919455 mm. Leaching studies showed that 
biocide introduced into sapwood via nanoparticles leached only ~9% compared with the 
xvi 
 
amount leached from tebuconazole solution-treated control, while soil jar tests showed 
that the nanoparticle-treated wood blocks were effectively protected from biological 
decay tested against G. trabeum, a brown rot fungus. 
 Copper oxide nanoparticles with and without polymer stabilizers were also 
investigated to use as inorganic wood preservatives to clarify the factor affecting copper 
leaching from treated wood. Copper oxide nanoparticles with uniform diameters of ~10 
nm and ~50 nm were prepared, and the leachates from southern pine sapwood treated 
with these nanoparticles were analyzed. It was found by TEM and EDS analysis that 
significant numbers of nanoparticles leached from the treated wood. The 50 nm 
nanoparticles leached slightly less than a soluble copper salt control, but 10 nm 
nanoparticles leached substantially more than the control. The effect of polymer 
stabilizers on nanoparticle leaching was also investigated.  Results showed that polymer 
stabilizers increased leaching. The trends showed that nanoparticle size was a major 
factor in copper leaching. 
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Chapter 1 Introduction 
1.1 General Introduction 
 This dissertation is a collection of already-published articles or articles that are being 
prepared for submission. It is comprised of two parts, with both parts being related to 
design and synthesis of functionalized nanoparticle for self-assembly and for controlled 
drug delivery systems. The first part describes the synthesis and fabrication of a new type 
of ionic complementary peptide-functionalized amphiphilic copolymer designed to 
self-assemble into sophisticated polymeric nanoparticle fibers and 3D scaffolds that have 
the ability to simultaneously load multiple drugs and to separately govern the release rate 
of each drug for appropriate release levels. The methodology could be applied for various 
applications but here the intended application was for tissue engineering. The second part 
of this dissertation describes the synthesis and testing of biocide-loaded nanoparticles for 
use in low leaching wood preservation. Each dissertation part has its own features and 
considerations for design and application, but also has common features with respect to 
nanoparticles as controlled drug delivery system. This chapter will introduce the 
background information, rationale, and perceived advantages of the materials 
investigated in this dissertation.  
1.2 Introduction for Part A 
 The objective of Part A is to fabricate an advanced self-assembled nanoparticle fiber 
scaffolding system with the following advantages: (1) versatility so that different drugs 
can be introduced into nanoparticle matrices that are appropriate to each drug so release 
rates can be appropriately governed; (2) to control assembly of the individual 
nanoparticles into a fiber scaffold; (3) to control the sequence and spatial arrangement of 
the drug-loaded nanoparticles in the scaffold; (4) study further self-assembly into a 3D 
scaffolding system; and (5) demonstrate the ability to combine the advantages of 
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controlled release of multiple drugs with biocompatible tissue scaffolds, and retain these 
abilities in an injectable hydrogel scaffold system. 
 Such a polymeric nanoparticle fiber has substantial advantages over 
electrospunnanofibers, traditional hydrogels, and nanofiber/hydrogel blends. To the best 
of our knowledge, such polymeric nanoparticle fibers and 3D scaffolds are a 
fundamentally new approach to self-assembly systems, and are reported here for thefirst 
time. 
1.2.1 Background on Polymeric Hydrogel Scaffolds and Their Limitation 
 Artificial scaffolds, such as hydrogels and nanofibers, have been under extensive 
investigations for biological mimic of extracellular matrix to increase cell survival and also 
guide cell activities to improve tissue regeneration (1-3). Many studies have shown that 
effective tissue regeneration is usually dependent on delivery of multiple drugs and other 
active ingredients, such as growth factors, to the cells within the damaged tissue region (4). 
For example,effective skin regeneration usually requires a complex set of growth factors 
and cytokines, such as fibroblast growth factor, keratinocyte growth factor, vascular 
endothelial growth factor and interleukin 1α, to be delivered to and release within the 
damaged region to promote cell proliferation and migration to achieve wound healing  
(5,6). Another example is regeneration of neural tissue of the retina, which is a light 
sensitive layer of tissue lying in the inner surface of the eye. The retina itself consists of 
multiple cellular layers across a depth of 100-130 µm (7). Studies show that successful 
retina tissue regeneration requires a scaffold having the ability to simultaneously localize 
multiple growth factors (i.e. amino-terminal sonic hedgehog for rod photoreceptor cells 
and ciliaryneurotrophic factor for bipolar cells) to promote the differentiation of the retinal 
precursor cells to mature cells (8). Therefore, it is clear that the tissue regeneration 
significantly benefits from scaffolding systems with advanced drug delivery abilities for 
multiple drugs.  
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Conventional polymeric hydrogels, whether from synthetic or natural polymers, have 
been widely studied as scaffold systems, with and without incorporated drugs, for tissue 
regeneration. For example, bioactive ingredients have been physically or chemically 
incorporated in synthetic hydrogels such as poly(ethylene glycol) (PEG) hydrogels (9, 
10),poly(lactide)-b-poly(ethylene oxide)-b-poly(lactide) (PLA-b-PEO-b-PLA) or 
poly(lactic-co-glycol acid) (PLGA) (11,12), and natural polymer hydrogels, e.g. alginate, 
collagen, chitosan, gelatin (13-19). But most of these traditional scaffolds can 
accommodate only a single drug and have limited ability to control the drug release rate. 
Multi-drug loading in polymeric hydrogels has been reported, but as drug delivery 
systems and not a tissue scaffold (20-22). For example, Salmaso et al. (21) 
simultaneously loaded different model drugs in cyclodextrin-PEG hydrogels by swell 
embedding. The maximal incorporation by this method for lysozyme, β-estradiol, and 
quinine was 2, 0.6 and 2.4 wt.% respectively, but there was little ability to governing the 
release of each drug, which had different physical properties. Lysozyme was quickly 
released, while β-estradiol and quinine release was inversely proportional to the 
cyclodextrin/PEG ratio. The release profiles were significantly affected by interaction of 
the drugs with hexamethylated β-cyclodextrins in the hydrogel matrices. Such release 
profiles imply the non-effective distribution of the loaded drugs in hydrogels. If such a 
material is used as a multi-drug loaded hydrogel for tissue regeneration, the non-uniform 
drug distribution and poor drug release profiles will not be able to guide cell activity and 
could be detrimental. 
Scaffolding with controlled delivery of multiple growth factors (GFs) for tissue 
engineering, including hydrogels, microsphere gels, and polymeric micro/nanoparticle 
encapsulations, have also been studied and reviewed (23). Typical methods for 
incorporation of multiple GFs include: combining multi-layer hydrogels with each layer 
loaded with one type of growth factor, or hydrogel loading coupled with microsphere 
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loading, or hydrogel loading with micro/nanoparticle loading (23). These techniques each 
have their own advantages with respect to their ability to load different GFs, and also 
showed some control over the release rate of the loaded GFs, but these methods do not 
allow control over the placement and distribution of each micro/nanoparticle.  
1.2.2 Self-Assembling Peptide Scaffolds and Their Limitation 
Self-assembled peptide nanofiber scaffolds have increased in popularity for tissue 
engineering due to non-toxicity, biodegradability, and because the micro-environment it 
provides may be similar to the extracellular matrix for cell attachment and in situ 
formation of a hydrogel under physiological conditions (24). A typical ionic 
complementary β-sheet peptide AEAK16-II (AEAEAKAKAEAEAKAK) was first 
discovered in a yeast protein, zuotin (25). This type of ionic complementary peptide 
shows a spontaneous self-assembly into stable β-sheets in aqueous conditions, across a 
broad range of temperature, and a wide pH range, and the scaffold can maintain integrity 
in the presence of high concentrations of the denaturing agents of urea and guanidium 
hydrochloride (26,27). 
The driving forces for self-assembly of the peptides are the hydrophobic interactions 
of alanine (A) domains and the ion-pair interactions between negatively charged glutamic 
acid (E) side chains and positively charged lysine (K) side chains. The strong ion-pair 
interactions contribute to stable β-sheet formation, which was further supported on 
studying another pair of designer peptides, i.e. self-repulsive but mutually attractive 
peptide sequences that possessed positive charges (Ac-WKVKVKVKVK-amide) and 
negative charges (Ac-EWEVEVEVEV-amide) (28). On mixing this pair of ionic 
complementary peptides, a rapid assembly into a viscoelastic hydrogel occurred at a 
concentration as low as 0.25 wt.%. This hydrogel retained mechanical strength, even after 
repeated shear-induced breakdowns, due to the electrostatic interactions. The strong 
electrostatic and selective interactions between the opposite charges proved to be one of 
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the key merits of using ion-complementary β-sheet peptides. 
Self-assembling peptide nanofibers using designed (i.e. not naturally occurring) 
peptides (e.g. EAK16-II, RADA16-I or II) have been widely used as both controlled drug 
delivery systems and 3D scaffolds (29,30). This is typically done by physically 
incorporating a desired drug into the peptide scaffold during gel formation (31,32), or by 
chemically bonding it onto the C-terminal or N-terminal of the peptide (33). Sometimes a 
combination of both methods is used to load multiple active agents (34,35). However, 
these methods still have significant limitations with respect to the quantity of drug(s) to 
be incorporated, and the properties of drug(s) may have an impact on the subsequent 
self-assembly process or the mechanical stability of the formed hydrogel. Therefore, this 
approach is very limited in its ability to control the release of drugs with different 
properties within a same scaffold (36,37). Moreover, effective distribution of multiple 
drugs in scaffolds is not always easy to achieve, so the peptide hydrogel itself must be 
designed in conjunction with the specific drug(s) that will be incorporated. Because of 
these limitations the self-assembling peptide scaffolds are either unsophisticated to satisfy 
the current requirements for tissue engineering applications. 
1.2.3 Nanocomposite Hydrogel Scaffolds and Their Limitation 
 Because of the limitations of the scaffoldsystemsmentionedabove, researchers sought 
a more powerful and versatile technique to allow multiple drug incorporation within 
scaffolding systems so that the release rate of each drug could be controlled appropriately 
(23,38). There are many ways to deliver drugs, such asmicelles, colloids, capsules, and 
solid polymeric nanoparticles, including self-assembled core-shell nanoparticles (39,40). 
Solid polymeric nanoparticles have been used for oral drug delivery (41), epidermal 
injection (42), targeted delivery of anticancer drugs to cancer cells (43), and delivery of 
bioactive drugs for central nervous system regeneration (44,45). Core-shell polymeric 
nanoparticles are particularly attractive for use in tissue scaffolding because the core can be 
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designed to be suitable for a desired hydrophilic or hydrophobic drug while the shell can be 
designed to be suitable for the use environment. Also, core-shell nanoparticles are 
relatively easy to prepare with a controlled particle size, and various biocompatible 
hydrophilic and hydrophobic monomers are commercially available to make block 
copolymers that self-assemble into core-shell nanostructures (46).  
Even though polymeric nanoparticles have been used as versatile controlled delivery 
system for various drugs, the nanoparticle itself lacks scaffolding property to guide cell 
activities for tissue regeneration. 
 In recent years, nanocomposite hydrogels have been studied. In these hydrogels 
drug-containing nanoparticles have been blended into hydrogels to form a new generation 
of scaffolds for tissue engineering (47). Nanocomposite hydrogels are generally produced 
by chemically or physically cross-linking a polymer network to surface functional groups 
of the incorporated nanoparticles. Inorganic nanoparticles, such as silicate nanoparticles, 
magnetic nanoparticles and calcium phosphate nanocrystals (48-51), have been widely 
used to fabricate this type of hydrogel due to the abundance of surface functional groups 
that can interact with a polymeric network by covalent bonding, ionic interaction or 
hydrogen-bonding. 
 Studies of composite nanoparticle hydrogels have included specimens loaded with 
individual drugs and multiple drugs (23,52,53). For example, encapsulation of 
DNA/cationic polymer nanoparticles in hydrogel formed efficient surface-mediated 
delivery of genesinto cells (52). Lynch et al. (53) also fabricated a multiple drug loaded 
composite hydrogel by separately incorporating two different model drugs within 
hydrophobic microgels and anionic microgels and then embedding these within the host 
gel. Both model drugs showed simultaneous and independent release at different rates 
from the composite hydrogel. Most recently, Caicco et al. (54) developed a physically 
blended composite hydrogel of hyaluronan-methylcellulose (HAMC) for the localized 
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delivery and sustainable release of CyclosporinA (CsA), a promising neuroprotective and 
neuroregenerative agent for neural stem/progenitor cells for treatment of stroke. The 
author incorporated CsA in HAMC gel by three different methods and compared their 
release rate from the gel. These incorporation types include a solubilized type 
(CsA/acetonitrile solution mixed with HAMC gel), a particulate type (CsA solid 
particulate dispersed in methyl cellulose solution and then embedded in HAMC gel) and 
poly(lactic-co-glycolic acid) (PLGA) microsphere-encapsulated CsA type (CsA loaded in 
PLGA microspheres and then embedded in HAMC gel).Interestingly, the in-vitro 
controlled release tests showed that solubilized CsA type directly released from HAMC 
gel only for 2 days, while the particulate type gave a controlled release over 7-10 days, 
but PLGA microsphere encapsulated CsA type showed sustainable release over 21 to 28 
days. Most importantly, the CsA released from PLGA microspheres retained the same 
biological activity as fresh CsAwhen compared in aneurosphere assay (54).  
 Unfortunately, most of the investigations of polymeric nanoparticle composite 
hydrogel are still confined to use as drug delivery system. Due to the lack of effective 
surface functional groups or ligands, the polymeric nanoparticles themselves cannot 
self-assemble into well-organized arrays, leading to ineffective distribution within host 
polymer network via limited bond interaction, such as ionic interaction, or hydrogen 
bonding, or even just van der waals force. Although multiple drug loading and releasing 
in a hydrogel have been tried (23,52), the nanoparticles tend to randomly aggregate 
leading to a non-uniform distribution of the drug and an uncontrolled concentration 
gradient of the drug within the scaffold if such techniques are used to fabricate composite 
hydrogel scaffolds for tissue regeneration. Thus the self-assembly of polymeric 
nanoparticles to form well-organized array with effective interaction with the host 
hydrogel scaffold are necessary to fabricate more sophisticated composite scaffold 
systems for tissue engineering. 
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1.2.4 Self-Assembled Peptide-Nanoparticle Precedents 
 The key merit of using ion-complementary peptides to fabricate sophisticated 
assembly systems is their spontaneous self-assembly into stable β-sheets in aqueous 
solution, which occurs because of the strong electrostatic and selective interaction 
between opposite charges. Using peptide directed assembly of nanoparticles has received 
limited attention, and prior to this work was limited to inorganic nanoparticles (i.e. gold 
nanoparticles, nanotubes) arraysusing self-assembled peptide structures as templates or as 
assembly ligands (55-58). For example, Nikhil et al.(56) reported a well-organized 
one-dimensional gold nanoparticle line formed on a self-assembled polypeptide template, 
and the formation of the nanoparticle array was directed by positive charges on peptide 
fiber surface. Another recent report showed a simple method to fabricate a 
two-dimensional gold nanoparticle line pattern on mica surface from a designed β-sheet 
peptide (LELC16)-functionalized gold nanoparticles. Here the formation of gold 
nanoparticle alignment was directed by β-sheet self-assembly (57).  Peptide amphiphiles 
with alkyl tails or polymer-peptide conjugates have also been studied, but still limited to 
nanofiber hydrogels for biological applications (59,60). No precedent has been found for 
using peptide self-assembly to fabricate polymeric nanoparticle arrays or 3D scaffolds for 
biological application. 
1.2.5 Rationale and Advantages of Research Performed in Part A 
 To address the limitations of the current scaffolding systems described above, it can be 
seen that a more advanced tissue scaffolding system can be achieved by using 
peptide-directed assembly of individual controlled-release devices (here core-shell 
nanoparticles) to give a new type of scaffold that combines the advantages of easy delivery 
of multiple drugs in matrices that give appropriate control of the release rate of each 
desired drug and can simultaneously serve as the scaffold device. We propose to fabricate a 
novel self-assembled polymeric nanoparticle fibers and 3D scaffolds using the attributes of 
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ionic complementary β-sheet peptides, by functionalizing sets of nanoparticles with 
oppositely charged peptides, and then combining them so they self-assemble into fibers 
that are comprised of sequences of individual nanoparticles which can, if desired, carry 
active agents and control their release. The general mechanism is shown in Figure 1.1.  
 
 
Figure 1.1. General procedure shows fabrication of polymeric nanoparticle fibers with 
multi-drug loading abilities. 
 
As Figure 1.1 shows, the ends of two batches of amphiphilic copolymer are 
separately functionalized with the newly designed peptides (P1: 
H2N-TTTT-AEAEAEAE-amide and P2: H2N-TTTT-AKAKAKAK-amide) to form 
peptide-copolymer conjugates, one carrying negative charges from P1, and the other 
carrying positive charges from P2. These two peptide-copolymer conjugates are then 
undergone two-level self-assembly in aqueous solution. The amphiphilic copolymer 
self-assembles into core-shell nanoparticles as drug carriers with charged peptide arms. 
The two batches of nanoparticles are coupled and further self-assembled into nanoparticle 
fibers directed by ionic complementary assembly between P1 and P2, and finally lead to 
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form 3D nanoparticle scaffolds. Such self-assembled nanoparticle scaffolds possess 
several new features: (1) Simultaneously loading of different drugs; (2) Uniform 
distribution of different drugs in scaffolds; (3) Ability to give appropriate controlled 
release of each loaded drug from its own nanoparticle; (4) Flexibility and “injectability” 
of the self-assembled scaffolds; and (5) Further assembly with host peptide to form 
nanoparticle composite peptide hydrogel. Collectively these features allow both temporal 
and spatial control of the drug release and the surface properties of the scaffold, so the 
polymer nanoparticle surface can also be used as platform to further be modified or 
immobilized with functional groups or signals for specific tissue engineering application. 
Here we use reversible addition fragmentation chain transfer (RAFT) polymerization 
to synthesize amphiphilic copolymer with reactive carboxylic end groups 
(HOOC-ABA-COOH) using S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) 
as the chain transfer agent (CTA) (61). RAFT is a controlled radical polymerization, 
which allows the synthesis of block copolymers with controlled block length and block 
sequence, and therefore, control over the size of both core and shell. The carboxylic acid 
end groups at both chain ends are required for the subsequent peptide coupling. The 
hydrophilic block for the nanoparticle shell is 1-vinyl-2-pyrrolidinone (VP), 
2-hydroxyethyl methacrylate (HEMA) or 2-hydroxyethyl acrylate (HEA), while methyl 
methacrylate (MMA) is used for the hydrophobic core. These monomers were selected 
because VP, HEMA, HEA and MMA they have been widely used to synthesize 
biocompatible homopolymers or copolymers for biological applications (62-65), and 
because they are efficiently incorporated into polymer chains produced by RAFT 
polymerization (66). 
Two ionic complementary peptides, P1and P2, are synthesized by semi-automatic 
solid phase peptide synthesis strategy, using Fmoc chemistry, on rink amide resin. These 
detailed synthesis procedures are reported in Chapter 2and Chapter 3. 
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 In Chapter 2 we will prove the hypothesis (Figure 1.1) that ionic complementary 
peptide-functionalized tri-block copolymer will self-assemble into nanoparticle fibers and 
further lead to 3D scaffolds, by functionalizing sets of amphiphilic copolymers 
synthesized by RAFT polymerization to form peptide-copolymer conjugates 
(P1-ABA-P1 and P2-ABA-P2, ABA: triblock copolymer) and perform self-assembly 
study in aqueous solution. Controlled release of a model drug (insulin) and a 
biocompatibility study of the synthesized materials using SW-620 cell lines will also be 
shown in this chapter. 
 In Chapter 3 we will continue to study the self-assembly behavior of the designed 
peptide-functionalized copolymer conjugates with different particle size and 
self-assembly with additional peptides (P1 and P2) to adjust the scaffold porosity and 
mechanical stability. Multiple drug loading capability and the ability of controlling the 
drug release rate from different nanoparticle compositions are also studied in this chapter, 
using several small molecules as model drugs: a hydrophobic model drug 
(4’,5’-dibromofluorecein), a moderately hydrophobic model drug (nitrofurazone) and 
slightly water soluble hydrophilic model drug (amoxicillin). The biocompatibility test 
with fibroblast cells (NIH3T3 cell line) is also conducted by incubating the 
self-assembled 2D scaffold membrane with in a humidified incubator at 37 °C for 2 
weeks, showing non-toxic and non-inhibition to the cell proliferation and migration. 
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1.3 Introduction for Part B 
 The objective in Part B is to design and synthesize organic and inorganic 
biocide-loaded nanoparticles as controlled release systems for wood preservation. Using 
biocide-loaded nanoparticles as controlled release systems for wood preservation affords 
several advantages: (1) Environmentally friendly polymers can be used as biocide 
carriers; (2) Nanoparticles can effectively penetrate the wood interior to protect the wood 
interior as well as its exterior; (3) Nanoparticles can serve as a protective reservoir for the 
biocide and control the release rate of biocide to protect the treated wood from biological 
decay; (4) They can be prepared using simple and cost-effective routes. This section will 
introduce the background information, the rationale for the investigation, and the value of 
the work. 
1.3.1 Background of Wood Preservation 
 Wood is an environmentally friendly and renewable material possessing unique 
physical and mechanical properties, including high strength, low thermal conductivity, 
the ability of damp sound or other vibrations, and has a pleasant appearance. Wood 
products have a long history of use as construction materials, but must be protected from 
biological attack by insects, fungi, mildew, etc. (67). 
One of the most important wood preservatives, chromated copper arsenate (CCA) has 
been widely used in wood treatment for decades, but its use is being phased out due to 
environmental concerns over the arsenic. Two key advantages of CCA are that it “fixes” to 
wood, reducing its leaching from the wood into the environment, and CCA can be 
introduced into wood by pressure-treatment in aqueous solution. Any alternative to CCA 
must also be able to be introduced into wood in an aqueous medium so the wood surfaces 
are not oily, odor-free, and not toxic to non-target species.  
Ideally CCA alternatives should not leach out of the wood, because this is inherently 
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an inefficient use of expensive biocide, but also is toxic to species not attacking the wood 
that are not targets. The main alternatives to CCA are organic biocides, such as azoles, and 
arsenic-free cooper biocides. Organic biocides are not water-soluble and so may be 
introduced in aqueous emulsions. Copper-based preservatives are typically introduced as 
water-soluble salts, or in recent years as water-insoluble nanoparticulate copper salts 
(carbonates or oxides). The organic biocides and the water-soluble copper salts are known 
to leach from treated wood, especially in damp conditions such as when it rains or in 
sensitive wetland areas (68,69). Prior to this work there were no published studies on 
leaching of copper oxide/carbonate nanoparticles from treated wood.  
 The research described in Part B of this dissertation investigated leaching of the 
organic biocide, tebuconazole, a commercial and widely used azole biocide, and copper 
oxide nanoparticles as a representative of the solid copper salt wood preservatives now in 
commercial use (70,71). 
 Tebuconazole is a water insoluble organic biocide, is susceptible to leaching, reducing 
the service life of the treated wood, and adding cost since more tebuconazole is used to 
compensate for that lost to leaching, as well as detrimental environmental effects to 
sensitive environments such as wetlands (72). Prior research in Dr. Heiden’s lab showed 
wood treated with tebuconazole contained within controlled-release nanoparticles afforded 
protection to the treated wood, but did not study differences in leaching, and also the 
method used released the biocide more quickly than was desired (73-75). In Part B of this 
work the objective was to look at different matrix formulations, to allow a slower release 
rate to be obtained from the nanoparticles than was exhibited in the prior research, and to 
determine how effective the nanoparticle method was at reducing leaching when compared 
to wood treated with tebuconazole via a liquid-in-liquid emulsion. 
 Solid copper carbonate and oxide nanoparticles are also commercially employed for 
wood preservation, but leaching studies have not been published concerning these 
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nanoparticles. The objective of the study using solid copper oxide nanoparticles was to 
determine if they leach as nanoparticles (a potential environmental concern), how their 
leaching compares with the soluble copper salts they compete against, and to determine if 
the size of the nanoparticle affects the leaching. Commercial copper salt nanoparticles are 
sold as “micronized” particles (76), but they contain a mixture of various sizes, most of 
which are sub-micron. Prior to this research no leaching studies on such particles-treated 
wood were in the literature. 
1.3.2 Rationale for Controlled Release of Organic Wood Preservatives 
 In our earliest work on nanoparticle-treated wood preservation we used a precipitation 
route to prepare nanoparticles from pre-made random copolymers of 
poly(vinylpyridine-co-styrene) (73-75). The work was novel at that time, and showed 
effective penetration of the wood interior and protected the treated wood from decay. The 
method also had two major drawbacks: the release rate was controlled but faster than it 
needed to be, and the nanoparticle preparation method, while simple, required dilute (≤ 1 
wt%) conditions. To address these drawbacks we then studied a preparation method that 
allowed us to synthesize core-shell nanoparticles in a one-pot/one-step nanoparticle. The 
critical advantages of this method are that the core, serving as a reservoir for the biocide, 
could be made as hydrophilic or hydrophobic as needed to give significant control over the 
rate to biocide release, while the shell could be made hydrophilic to stabilize the resulting 
nanoparticles in water. Furthermore, this method allows the polymer synthesis and the 
nanoparticle preparation to be made at ≥ 10 wt% solids in water. In that work gelatin was 
used to form the shell, and methyl methacrylate (non-polar) and hydroxyethyl methacrylate 
(polar) were grafted from the amine groups of the gelatin to prepare the amphiphilic 
copolymers that self-assembled into core-shell nanoparticles. When the polymerization 
was done in the presence of tebuconazole, the core-shell nanoparticles contained 
tebuconazole (77). However, while the gelatin is inexpensive and biologically safe, it is 
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itself prone to fungal decay, and un-grafted gelatin complicated leaching tests. For that 
reason, in this work a similar study was done using chitosan, the second most abundant 
polysaccharide, which is also non-toxic, biodegradable, and bears numerous amine 
functional groups to be grafted with hydrophobic monomers to self-assemble into 
core-shell nanoparticle (78,79). So we use chitosan as a starting material and grafted with 
methacrylate monomers such as methyl methacrylate (MMA) and hydroxyethyl 
methacrylate (HEMA) to form amphiphilic copolymers that self-assembled into solid 
tebuconazole-containing core-shell nanoparticles and treated wood with these 
nanoparticles to test and compare tebuconazole leaching. The reaction mechanism is 
outlined in Figure 1.2.  
 
 
Figure 1.2. Mechanism of preparing self-assembled chitosan-g-PMMA nanoparticles 
loading with tebuconazole by one-pot method. 
 In Chapter 4, the synthesis and characterization of biocide-loaded 
chitosan-g-PMMA nanoparticles are shown, and the synthesis conditions and formulation 
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are studied to determine how they affect nanoparticle size and biocide release rate. The 
nanoparticle size can be adjusted to < 150 nm by setting reaction concentration and 
chitosan to MMA ratio. The release rate of tebuconazole from nanoparticle can be 
manipulated by adjusting the monomer ratio of MMA:HEMA comprising the core during 
polymerization. Effective nanoparticle penetration throughout the treated wood, low 
leaching of biocide, and wood protection when tested for fungi decay are demonstrated in 
this chapter. 
 The biocide-loaded nanoparticle suspension prepared by such one-pot synthesis route 
is cost-effective and can be directly used to pressure treat wood products without post 
process. The reduced leaching of biocide will increase wood preservation period and 
eliminate toxic impact on neighboring environment, and low cost preparation method 
also matches the market requirement using nanotechnology for wood preservation. 
1.3.3 Rationale for Study of Copper Oxide Nanoparticle Leaching 
 Since copper oxide nanoparticle treated wood products are already commercially 
available, but no research in the public domain has been conducted to determine if the 
nanoparticles are leached or factors affecting leaching behavior of copper from the treated 
wood including the size of nanoparticles. To answer these questions copper oxide 
nanoparticles were prepared at different diameters, with and without a polymer shell, and 
used to treat wood and test leaching. The reaction mechanism is shown in Figure 1.3. 
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Figure 1.3. Synthesis of CuO nanoparticles with or without polymer-stabilizer by 
aqueous thermal hydrolysis using deionized water as the solvent and heating at reflux. 
  
 Chapter 5 describes how the copper oxide diameter was controlled so the leaching of 
nanoparticles with a uniform sized of ~10 nm and ~50 nm, with and without a polymer 
shell. The questions this study asked and answered are: (1) Does nanoparticle size 
influence copper leaching; (2) Is any leached copper leached as nanoparticles; (3) Do 
copper oxide nanoparticles leach more or less than copper from to soluble copper salt 
(ACQ) used as a commercial wood preservative; (4) Do smaller nanoparticles show higher 
bioactivity compared to ACQ; and (5) Does a polymer shell on the copper oxide 
nanoparticles affect copper leaching? 
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Abstract 
A novel self-assembled 3D nanoparticle fiber scaffold was designed and synthesized 
with the ability to govern the controlled release of multiple drugs, by preparing ionic 
complementary peptide-functionalized amphiphilic block copolymers that self-assemble 
into polymeric nanoparticles, and then into fibers, leading to 3D fiber scaffolds. Two 
complementary peptide sequences were prepared that can assemble into β-sheets in 
aqueous solution (neutral water or PBS solution at pH 7.4). The terminal amines of the 
peptides were coupled to amphiphilic triblock copolymers, synthesized by RAFT 
polymerization, with carboxylic acid terminals (HOOC-A-B-A-COOH), to give the 
desired peptide-copolymer conjugates. The peptides, copolymers, and peptide-copolymer 
conjugates were characterized by 1H-NMR, matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry and FTIR. Optical microscopy confirmed the assembly 
of the peptide-copolymer conjugate nanoparticles into fibers and scaffolds. The assembly 
was not hindered when a protein (insulin) was included within the nanoparticles as an 
active ingredient. The release rate of insulin was measured over three weeks. MTS 
cytotoxicity tests on SW-620 cell lines showed that the peptides, copolymers and 
peptide-functionalized copolymers were biocompatible. The methodology of 
self-assembled nanoparticle fibers and 3D scaffolds combines the advantages of a flexible 
hydrogel scaffold and the versatility of controlled release systems. 
 
Key words: β-sheet peptide, self-assembly, nanoparticle fiber, scaffold, RAFT 
polymerization, drug delivery, amphiphilic copolymer, core-shell 
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2.1 Introduction 
The self-assembly of β-sheet peptides is a well-established and versatile technique to 
fabricate 3-dimensional (3D) scaffolds for biological applications, with or without 
encapsulation of some bioactive agent (1). A typical β-sheet peptide motif is (AEAK)16-II 
(AEAEAKAKAEAEAKAK). This motif, composed of periodic repeats of ionic 
hydrophilic and hydrophobic amino acids, was first discovered in a yeast protein (2). This 
type of ionic complementary peptide shows a spontaneous self-assembly into stable 
β-sheets in aqueous conditions. The driving forces are the hydrophobic interactions of 
alanine (A) side chains and ion-pair interaction between negatively charged glutamic acid 
(E) side chains with positively charged lysine (K) side chains. The strong ion-pair 
interaction leading to β-sheet formation was further illustrated using a pair of 
self-repulsing, but mutually attracting, peptide sequences that possessed positive charges 
(Ac-WKVKVKVKVK-amide) and negative charges (Ac-EWEVEVEVEV-amide) (3). 
On mixing this pair of oppositely charged peptides, a rapid assembly into a viscoelastic 
hydrogel occurred, even though the total peptide concentration was only 0.25 wt.%. This 
hydrogel retained mechanical strength, even after repeated shear-induced breakdowns, 
due to the electrostatic interactions. The strong electrostatic and selective interaction 
between opposite charges demonstrated one of the key merits of using 
ion-complementary β-sheet motifs. 
Those attributes are used in this work to provide a novel method to fabricate ordered 
nanoparticle arrays or fibers, by functionalizing sets of nanoparticles with oppositely 
charged peptides, and then combining them so they self-assemble into fibers that are 
themselves comprised of sequences of individual nanoparticles which can, if desired, be 
used to carry active agents and control their release. This is the hypothesis we are going 
to prove in the present work, in its simplest form, by assembling the fibers and scaffolds 
with no more than two nanoparticles and a single active agent.   
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The use of a single drug at this early stage of the research is to minimize the number 
of variable that might affect the assembly. However, it is also important to prove the 
ability to control the release of an active agent, because in many biological applications, 
it is desirable for the scaffold to contain and potentially release various “active agents” 
(e.g. low molecular weight drugs or various proteins), to direct cell activities or improve 
therapeutic efficacy. Here, for the sake of simplicity we will use the term drug to refer to 
any active agent.  
Peptide hydrogels have been a popular device for use as both a controlled drug 
delivery system and 3D scaffold, this is typically done by simply physically entrapping a 
drug into the peptide scaffold during mixing before gel formation (4,5), or chemically 
bonded onto the C-terminal or N-terminal (6), or some combination of both methods to 
load multiple active agents (7,8). However, these methods have significant limitations 
with respect to the quantity of drug(s) that can be “loaded”, and the drug(s) may have an 
impact on the subsequent self-assembly process or the mechanical stability of the formed 
hydrogel, and there is very limited ability to control the release of the drug(s). Therefore, 
the hydrogel itself must be designed in conjunction with the specific drug(s) that will be 
used. Moreover, effective distribution of drugs in scaffolds is not always easy to achieve. 
Controlled release nanoparticles can potentially be distributed within hydrogels, but these 
also are sometimes difficult to distribute uniformly or effectively, and also might interfere 
with assembly. 
Because of these limitations, a more powerful and versatile technique is needed that 
can allow multiple drugs to be incorporated within scaffolding and also allows the release 
rate of each drug to be controlled appropriately.  There are many ways to deliver drugs, 
such asmicelles, colloids, capsules, and solid nanoparticles, including self-assembled 
core-shell nanoparticles (9). Solid nanoparticles have been used for oral drug delivery (10), 
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epidermal injection (11), targeted delivery of anticancer drugs to cancer cells (12), and to 
deliver drugs for central nervous system regeneration (13).  
Core-shell polymeric nanoparticles are particularly attractive for use in tissue 
scaffolding because the core can potentially be designed to be suitable for a desired 
hydrophilic or hydrophobic drug while the shell can be designed to be suitable for the use 
environment. Also, core-shell nanoparticles are relatively easy to prepare with a controlled 
particle size and various bio-compatible hydrophilic and hydrophobic monomers are 
commrecially available to make self-assembling block copolymers that give core-shell 
nanostructures (14).  
Thus, we propose a new and highly versatile type of self-assembly scaffolding 
system that combines controlled release technology with core-shell self-assembly 
techniques and peptide self-assembling techniques, to form “particle fibers”. The 
particles themselves can potentially be of any size or composition, and synthesized by 
any technique, but in this work we opted for amphiphilic tri-block copolymers 
(HOOC-ABA-COOH) synthesized by RAFT polymerization, using BDAT as the CTA 
(15). RAFT is a controlled radical polymerization, which allows the synthesis of block 
copolymers with controlled block length and block sequence, and therefore, control over 
the size of both core and shell, and we used BDAT as the CTA to give carboxylic acid end 
groups at both chain ends, which are required for the subsequent peptide coupling. The 
hydrophilic block for the nanoparticle shell was 1-vinyl-2-pyrrolidinone (VP), 
2-hydroxyethyl methacrylate (HEMA) or 2-hydroxyethyl acrylate (HEA), while methyl 
methacrylate (MMA) was used for the hydrophobic core. These monomers were selected 
because VP, HEMA, HEA and MMA they have been widely used to synthesize 
biocompatible homopolymers or copolymers for biological applications (16-19), and 
because they are efficiently incorporated into polymer chains produced by RAFT 
polymerization (20).  
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The polymeric micro- or nanoparticles (or combination of both), that may or may not 
contain drugs, as desired, are functionalized with oppositely charged β-sheet peptides. 
Peptide directed assembly of nanoparticles has received some attention, but so far it has 
been limited to inorganic nanoparticle arrays using self-assembled peptide structures as 
templates (21-23). For example, Nikhil et al. reported a well-organized one-dimensional 
gold nanoparticle line formed on self-assembled polypeptide template, and the formation 
of the nanoparticle array was directed by regulatory-presented positive charges on peptide 
fiber surface (22). Another recent report showed a simple method to fabricate a 
two-dimensional gold nanoparticle line pattern on mica surface from a designed β-sheet 
peptide (LELC16)-functionalized gold nanoparticles. Here the formation of gold 
nanoparticle alignment was directed by β-sheet self-assembly (23).  Peptide amphiphiles 
with alkyl tails or polymer-peptide conjugates have also been widely studied, but still 
limited to nanofiber hydrogels for biological applications (24,25).  
This research appears to be the first to report the self-assembly of polymeric 
nanoparticles into fiber and scaffolds. This is accomplished by using β-sheet peptides to 
direct the assembly process, by designing and synthesized two mutually attractive peptide 
sequences, peptide1 (P1: H2N-TTTT-AEAEAEAE-amide) and peptide2 (P2: 
H2N-TTTT-AKAKAKAK-amide). These complementary peptides carry opposite charges, 
and by coupling them to the carboxylic acid terminals of these amphiphilic tri-block 
copolymers (HOOC-ABA-COOH), to form the peptide-copolymer conjugates 
P1-ABA-P1 and P2-ABA-P2 respectively.  
The peptide-copolymer conjugates undergo multiple levels of self-assembly in 
aqueous solution. First, the amphiphilic copolymers can self-assemble to give 
nanoparticles with hydrophobic cores and hydrophilic shells, while the 
peptide-functionalities assemble the nanoparticles into fibers, and then further assemble 
β-sheets to form 3D nanoparticle scaffolds. To the best of our knowledge, this polymeric 
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nanoparticle fibers and 3D scaffolds are a fundamentally novel self-assembly system 
because these systems allow multiple active agents to be introduced into the assembled 
structure using a composition suitable for each active ingredient, and giving an 
unprecedented level of both temporal and spatial control over the structure of the scaffold 
and the release of the active agents. In this work we report on the design and synthesis of 
the scaffold and demonstrate the capability of controlled drug release (insulin as a model 
protein) and suitability as a versatile tissue scaffold. 
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2.2  Materials and methods 
2.2.1 Materials 
Fmoc amide rink resin (0.65 mmol/g), Fmoc amino acids, and 
2-(7-aza-1-H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium (HATU, coupling agent), 
were purchased from AAPPTec company (Louisville, KY). N,N-Dimethylformamide 
(DMF, 99.9%), N,N-diisopropylethylamine  (DIPEA,99.5%), piperidine (PIP, 99.5%) 
and cleaving agents, including trifluoroacetic acid (TFA, 99%), thioanisole (99%) and 
anisole (99%) were purchased from Sigma-Aldrich. All reagents for peptide synthesis 
were used as received. 1-Vinyl-2-pyrrolidinone (VP) (99%), 2-hydroxyethyl acrylate 
(HEA) (96%), 2-hydroxyethyl methacrylate (HEMA) (97%), methyl methacrylate  
(MMA) (99%), 1,4-dioxane (99+%), hexane (98.5%), 2,2-azobisisobutyronitrile (AIBN) 
(98%), and phosphate buffered saline (biotech) were purchased from Sigma-Aldrich. 
1,2-Ethanedithiol (98.0%) was from Fluka, ethyl alcohol (200 proof, anhydrous) was 
from PHARMCO-AAPER, and diethyl ether (anhydrous) was from Mallinckrodt Baker 
Inc. (Phillipsburg, USA). The monomers HEA, HEMA and VP were purified before use 
by passing through a neutral alumina column. MMA was distilled before use. All other 
reagents were used as received. SW-620 cell was purchased from ATCC and CellTiter 96 
AQueous Non-Radioactive Cell proliferation Assay (MTS) kit was from Promega Corp.  
2.2.2 Synthesis of peptides (P1 and P2) bearing opposite charges  
Peptides P1 (H2N-Thr-Thr-Thr-Thr-Ala-Glu-Ala-Glu-Ala-Glu-Ala-Glu-amide) and 
P2 (H2N-Thr-Thr-Thr-Thr-Ala-Lys-Ala-Lys-Ala-Lys-Ala-Lys-amide) were synthesized 
on rink amide resin  (1.0 g, 0.65 mmol amine/g per batch) by semi-automated solid 
phase peptide synthesis (Endeavor 90I, AAPPTec LLC, Louisville, KY, USA), using 
Fmoc chemistry. The side chains of threonine, lysine and glutamic acid were protected 
with tert-Butyl (tBu), t-Butyloxycarbonyl (Boc) and O-tert-Butyl (OtBu) groups, 
respectively.After swelling and washing the resin beads in DMF, the resin was 
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deprotected 2 times with a 20% PIP/DMF solution (15 mL each time) at room 
temperature (5 min the first time and 15 min the second time) with washing of DMF to 
remove the Fmoc protection group from the resin. Then the first amino acid (4x0.65 
mmol) was dissolved in DIPEA/DMF (5.2 mL, 0.5 M) in the presence of HATU (4x0.65 
mmol), and transferred into a reaction vessel to attach to the resin. After de-protecting the 
Fmoc protecting group from the previously attached amino acid, the remaining amino 
acids (each 4x0.65 mmol) were similarly dissolved in DIPEA/DMF in the presence of 
HATU and attached step-wise to the resin beads according to the designed sequence. 
After finishing the coupling reactions of the desired 12 amino acids, the peptide-bound 
resin beads were transferred into a reaction flask and treated with a cocktail of cleavage 
reagents, TFA/Thioanisole/Ethane dithiol/Anisole (90:5:3:2 v/v), to cleave the peptides 
from the resin beads. The cleaved peptide/cocktail solution was isolated from the solid 
resin beads by filtering through a glass column filled with glass wool, followed by 
precipitation into cold diethyl ether, placed in an ice/ethanol bath, to collect the 
synthesized peptide solids. The peptide solids were washed 3 times with cold diethyl 
ether and freeze-dried for storage. Scheme 2.1 shows the P1 and P2 design and the solid 
phase peptide synthesis.  
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(a) 
 
(b) 
Scheme 2.1.  The design and synthesis of (a) P1 and (b) P2, by solid phase peptide 
synthesis using Fmoc rink amide resin. 
After synthesis and isolation, P1 and P2 were analyzed by MALDI-TOF MS 
(Microflex LRF, Bruker Daltonics, Billerica, USA). Briefly, P1 and P2 were dissolved in 
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a matrix solution (50:50 water/acetonitrile with 0.1% TFA) to form two solutions, each 
with a concentration of ~100 pmol/µL. Separately, 20 mg of α-cyano-4-hydroxycinnamic 
acid (the matrix compound) was also dissolved in 1 mL of the described matrix solution, 
and the peptide and matrix solutions were then combined at a ratio of 1:10 (v/v). Then 2 
µL of each combined solution were placed on a ground steel plate, then dried, and the 
ground steel plate was set up for MALDI-TOF MS analysis using a suitable analysis 
model (LP_pepmix model, close to the theoretical molecular weight of the peptides). By 
MALDI-TOF the molecular weights of P1 and P2 were found to be 1246.42 [M(P1) + 
Na+] and 1220.01[M(P2)+H+] Da, which are in good agreement with the theoretical 
molecular weights of 1223.25 and 1219.45 Da respectively (Figure 2.1S a,b). 1H-NMR 
(Varian Unity INOVA 400 MHz, McKinley Scientific, Sparta, NJ, USA) confirmed the 
peptide structure, with the peaks were assigned as follows. 
P1 (DMSO-d6, ): 1.05-1.09 (9H, -CH3 from Thr), 1.22 (12H, -CH3 from Ala), 
1.77-1.89 (8H, -CH2- from Glu), 2.26 (8H, -CH2-C=O from Glu), 3.77 (3H, O-CH-C 
from Thr), 3.85 (3H, -OH from Thr), 4.03-4.32 (11H, -CH- from peptide backbone), 4.45 
(2H, C-NH2 from end amine), 7.04 (2H, O=C-NH2 from terminal amide), 7.70-8.06  
(11H, -NH- from peptide backbone). P2 (DMSO-d6, ): 1.05-1.10 (9H, -CH3 from Thr), 
1.16-1.22 (8H, γ –CH2- from Lys), 1.32 (8H,  -CH2- from Lys), 1.51 (12H, -CH3 from 
Ala), 1.65 (8H, β -CH2-from Lys), 2.75 (8H, -CH2-N from Lys), 3.78-3.86 (11H, -NH2 
from Lys and –OH from Thr), 4.03 (3H, β -CH- from Thr), 4.13-4.33 (11H, -CH- from 
peptide backbone), 4.43(2H, -NH2 from terminal amine), 7.03 (2H, O=C-NH2 from 
terminal amide), 7.75-8.10 (11H, -NH- from peptide backbone). 
2.2.3 Synthesis of S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT)  
The RAFT chain transfer agent, BDAT, was synthesized and purified according to a 
reported method (26). The detailed procedure is provided in supplementary information. 
The chemical structure of the purified BDAT was confirmed by 1H-NMR (CD3CL): –CH3 
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(s, 12 H) at 1.67 ppm and –COOH (s, 2H) at 13.0 ppm. The chemical reaction is shown in 
Scheme 2.2. 
 
 
 
Scheme 2.2. Synthesis of BDAT. 
 
2.2.4 Synthesis of hydrophilic block (Macro-CTA) and amphiphilic tri-block 
copolymer using BDAT as RAFT CTA  
The amphiphilic tri-block copolymers PVP-b-PMMA-b-PVP, 
PHEMA-b-PMMA-b-PHEMA, and PHEA-b-PMMA-b-PHEA, terminated with 
carboxylic acid groups, were synthesized in two steps. First, the hydrophilic block (PVP, 
PHEMA or PHEA) was synthesized by RAFT polymerization using BDAT as CTA, 
AIBN as the initiator, and the desired hydrophilic monomer, at ratios of 
[M]o:[CTA]o:[I]o=1000:5:1. The typical synthesis was done beginning with monomer (30 
mmol),BDAT (0.15mmol) and AIBN (0.030 mmol) in a solution of 1,4-dioxane (16 mL) 
in a 50 mL three neck round bottom flask. The reaction solution was first purged by 
nitrogen gas for 0.5 h, and then heated to 70 C. The reaction was maintained at that 
temperature under nitrogen atmosphere for 24 h. The product was collected by 
precipitation in cool diethyl ether, and the solvation/precipitation step was repeated 3 
times to obtain the purified polymers. In the second step, the purified hydrophilic 
polymer was used as a macro-CTA to synthesize the amphiphilic tri-block copolymer. 
The ratio of reactants used was MMA:macro-CTA: AIBN of 4.8:0.4:0.0012 g/g (48000 : 
45 : 1, mol:mol). These were dissolved together into 18 mL of a mixed solvent of 
1,4-dioxane/DMF (2:1, v/v) in a 50 mL three neck round bottom flask. The reaction 
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solution was purged with nitrogen gas for 0.5 h and then reacted at 70 C for 48 h under 
nitrogen atmosphere. The polymer was collected by solvating and precipitating in cool 
ethanol/acetone (7:1,v/v) 3 times to obtain the purified amphiphilic tri-block copolymer. 
The feedstock ratios and yield % of (co)polymers are given in Table2.1. 
Scheme 2.3 shows the synthetic route to prepare the hydrophilic block (macro-CTA) 
and amphiphilic copolymer with carboxylic acid terminals. 
 
Table 2.1. Summary of feedstock, MN and yield (%) from the RAFT synthesis of the 
hydrophilic macro-CTA and tri-block copolymers. 
Macro-CTA [M]o:[CTA]o:[I]o XN
a MN
a, Da 
Yield 
% 
PVP 1000:5:1 78 8954 84.0 
PHEMA 1000:5:1 66 8981 97.4 
PHEA 1000:5:1 74 8966 97.7 
Copolymer 
Mass Ratio 
(MMA)o: 
(Macro-CTA )o:AIBN 
g/g 
XN/XM MN
b, Da 
Yield 
% 
PVP-b-12PMMA-b-PVP 12:1:0.0012 78/382 47200 53.1 
PHEMA-b-12PMMA-b-PHEMA 12:1:0.0012 66/726 81668 53.3 
PHEA-b-12PMMA-b-PHEA 12:1:0.0012 74/644 73443 49.5 
a. MN by MALDI-TOF; XN units calculated as 
Monomer
BDATN
N
M
MM
X

 . 
b. MN calculated from 
1H NMR by ratio of integrated peaks. 
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Scheme 2.3. Synthesis of (a) hydrophilic block macro-CTA and (b) the amphiphilic 
triblock copolymers, by RAFT polymerization using BDAT as CTA. 
 
2.2.5 Characterization of hydrophilic blocks and tri-block copolymers 
The molar mass of the hydrophilic block was determined from MALDI-TOF MS 
analysis using DMF as solvent and 2,5-dihydroxybenzoic acid (DHB) as the matrix 
compound. The polymer solution (~2 mg/mL in DMF) and a DHB solution (20 mg/mL in 
DMF) were prepared separately, and then the polymer solution was added into the DHB 
solution at a ratio of 1:10 (v/v). Then 2 µL of the combined solution was dripped onto a 
ground steel plate and allowed to air dry over 48 h. The sample plate was analyzed by 
MALDI-TOF MS (LP_14 KDa). The molecular weight (MN) and repeat units (XN) 
(calculated from MN) of hydrophilic block are summarized in Table 2.1. 
The amphiphilic copolymer was analyzed by 1H-NMR, and the molecular weight 
(MN) was calculated by integrating the peak areas associated with the blocks. For 
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example, PVP-b-12PMMA-b-PVP shows the peak area of :3.34 (-CH2-N, from PVP 
block) and peak area of :3.53 (-OCH3 from PMMA block, -CH- from PVP block) are 
used to calculate the block ratio of XN(PVP):XM(PMMA) = 1:4.9 based on the below 
equation. 
17.35
49.4
3
2
),(
)(
3
2 
 

CHOCH
NCH
Area
Area
XnXm
Xn
 
The block ratio (XN:XM) of PHEMA-b-12PMMA-b-PHEMA and 
PHEA-b-12PMMA-b-PHEA were calculated in a similar manner from the 1H-NMR 
spectra (Figure 2.2S a,b and Figure 2.3S a,b, with calculation equation) and found to 
be 1:11 and 1:8.7 respectively. From these data the XN of the hydrophilic blocks and XM 
of the hydrophobic PMMA block for all three copolymers were found to be as follows: 
(PVP)39-b-(PMMA)382-b-(PVP)39, (PHEMA)33-b-(PMMA)726-b-(PHEMA)33 and 
(PHEA)37-b-(PMMA)644-b-(PHEA)37. The results are also given in Table 2.1. 
1H-NMR peak assignments for hydrophilic blocks and copolymers are given below. 
PVP Block (in D2O, ): 1.46-1.61(-CH2- from backbone), 1.90 (-CH2- from 
vinylpyrrolidone ring), 2.18-2.32 (-CH2-C=O from vinylpyrrolidone ring), 3.19 (-CH2-N- 
from vinylpyrrolidone ring), 3.52-3.66 (-CH- from backbone). PHEMA Block (in 
DMSO-d6, ): 0.79-1.10 (-CH3), 1.80 (-CH2-), 3.59 (-CH2-OH), 3.91 (-CH2-O-C=O), 
4.80 (-OH). PHEA Block (in D2O, ): 1.54-1.86 (-CH2- from backbone), 2.32 (-CH- 
from backbone), 3.53 (-OH), 3.68 (-CH2-OH), 4.08 (-CH2-O-C=O). 
The peak assignments for protons the 1H-NMR spectra of copolymers were made as 
shown below. PVP-b-12PMMA-b-PVP (in DMSO-d6, ): 0.73-1.04 (-CH3), 1.40-1.82 
(-CH2-), 3.34 (-CH2-N-), 3.53 (-OCH3, from PMMA block, also contains some -CH- from 
the PVP block). PHEMA-b-12PMMA-b-PHEMA (in DMSO-d6, ): 0.72-1.13 (-CH3), 
1.42-1.77 (-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the 
PHEMA block), 3.87 (-CH2-O-C=O). PHEA-b-12PMMA-b-PHEA (in DMSO-d6, ): 
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0.74-0.92 (-CH3), 1.80 (-CH2-), 2.38 (-CH-), 3.44-3.54 (-OCH3, from PMMA block, also 
contains–CH2-OH from the PHEA block), 3.98 (-CH2-O-C=O). 
2.2.6 Coupling of peptide to triblock copolymer 
The synthesized peptide was bonded to the triblock copolymer as shown in Scheme 
2.4 using the following procedure. The copolymer (0.25g) was dissolved in DIPEA/DMF 
(4.0 mL, 0.9 M DIPEA in DMF) at room temperature in a 25 mL three neck round 
bottom flask with magnetic stirring. The solution was degassed 15 min with nitrogen. 
HATU (2.2 mg) was then added, to activate the terminal carboxylic acid groups of the 
copolymer, and stirred for 8 min. P1 (0.022 g, 1.8 x 10-2 mmol, ~ 4 molar excess over the 
terminal carboxylic acid groups) was dissolved separately in DMF (2.0 mL, in a glass 
vial), and then transferred via syringe to the reaction solution. The coupling reaction was 
carried out for 45 min under nitrogen atmosphere at room temperature. P2 was coupled 
separately to another batch of copolymer using the same procedure.  
The peptide-functionalized copolymer was collected by precipitation into 40 mL of 
cold ethanol and centrifuged to remove un-reacted chemicals. The isolated solids were 
washed 3 times with 30 mL aliquots of cold ethanol and dried at 50 C for 12 h under 
reduced pressure.  
The peptide-functionalized copolymer conjugates are designated as follows: 
P1-PVP-b-12PMMA-b-PVP-P1, P1-PHEMA-b-12PMMA-b-PHEMA-P1, 
P1-PHEA-b-12PMMA-b-PHEA-P1, P2-PVP-b-12PMMA-b-PVP-P2, 
P2-PHEMA-b-12PMMA-b-PHEMA-P2 and P2-PHEA-b-12PMMA-b-PHEA-P2, 
respectively. The peptide-copolymer conjugates were characterized using FT-IR 
(Spectrum One, Perkin Elmer, Massachusetts, USA) to verify effective coupling 
reactions.   
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Scheme 2.4. Coupling reaction of P1 and P2 with amphiphilic copolymers. 
2.2.7 Self-assembly of peptide-copolymer conjugates in phosphate buffered saline 
solution (PBS) or deionized water (D.I. H2O) 
Peptide-copolymer conjugate self-assemblies were conducted in both sterile PBS 
solution and D.I. H2O. P1-PVP-b-12PMMA-b-PVP-P1 (11 mg) and 
P2-PVP-b-12PMMA-b-PVP-P2 (11 mg) were dissolved together in DMSO (2 mL) by 
sonication and magnetic stirring to form a clear solution. The conjugate/DMSO solution 
was then slowly injected into PBS (20 mL, pH=7.4) via an insulin syringe (31 G syringe) 
with an injection speed of ~ 0.4 mL/min under magnetic stirring at 600 rpm. After the 
injection was completed, the suspension was stirred an additional 40 min to give a 
well-dispersed suspension. The nanoparticle suspension was allowed to settle for 10 h, so 
that the self-assembled nanoparticles settled to the bottom layer giving a sponge-like 
appearance. The supernatant was replaced 4 times with fresh sterile PBS solution (or 
sterile D.I. H2O if the self-assembly was performed in D.I. H2O) and then dialyzed 24 h 
in D.I. H2O to remove any DMSO residue. 
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The self-assembled nanoparticle suspension was gently swirled and then 0.5 mL of 
the suspension was withdrawn using a 31 G insulin syringe. The suspension was then 
slowly injected from the syringe while moving it across the surface of a freshly cleaned 
glass slide (washed by D.I. H2O and then immersed in 70% v/v EtOH/H2O solution for 
10 h, and gently dried by kimwipe). As the syringe needle was moved slowly down the 
slide, a self-assembled nanoparticle fiber formed on the surface of the glass slide as the 
water in the PBS solution evaporated. This resulting nanoparticle fibers could be 
observed on the slide surface by optical microscopy (OLYMPUS BX60, Olympus 
America Inc., PA, USA), equipped with a camera (OPTIXCAM, Summit Series), power 
control (Olympus TH3) and observation software (TSview7). Self-assembly studies of 
peptide-functionalized PHEMA-b-12PMMA-b-PHEMA conjugates, and 
peptide-functionalized PHEA-b-12PMMA-b-PHEA conjugates were similarly carried  
out. The microscopy images of the self-assembled nanoparticle fibers and scaffolds are 
shown in Figure 2.4. 
2.2.8 Controlled release of Insulin from assembled nanoparticles 
Insulin was used as a model drug that was loaded into the different self-assembled 
nanoparticle compositions. Controlled release studies were performed for 22 days. 
Peptides- (P1- and P2-) functionalized PHEMA-b-12PMMA-b-PHEMA conjugates (1:1 
g/g) were dissolved in DMSO (3 mL) to form a precursor solution (14 mg conjugate/mL 
DMSO), then insulin (0.063 mg, 0.15 wt. % based on conjugate matrix) was added to the 
precursor solution and mixed uniformly. The insulin-containing precursor solution was 
then slowly injected into sterile PBS to form self-assembled insulin-loaded conjugate 
nanoparticles, and allowed to settle for 10 h.  
Two types of controls were also tested. Peptide-functionalized 
PHEMA-b-12PMMA-b-PHEMA conjugate nanoparticles, without insulin, were prepared 
and used as controls to determine any ‘background release’ of peptides (P1 and P2) from 
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the assembled conjugate nanoparticles. Also, a copolymer 
(PHEMA-b-12PMMA-b-PHEMA) without peptide-functionalization was loaded with the 
same quantity of insulin to give insulin-loaded copolymer nanoparticles to determine if 
the release rates of insulin from the peptide-conjugated nanoparticles differed from the 
non-peptide conjugated nanoparticles.  
All self-assembled nanoparticle suspension was then dialyzed 24 h using dialysis 
tubing (Nominal MWCO 3,500, from Fisher Scientific) in PBS buffer solution, to remove 
free peptides and organic solvent. The assembled nanoparticle suspension was then 
collected and stored at 4 C. 
The concentration of insulin-loaded conjugate nanoparticles, insulin-loaded 
copolymer nanoparticles, and conjugate nanoparticles without insulin, were all 
determined by gravimetric analysis, and found to be 1.8 mg/mL, 2.6 mg/mL and 2.0 
mg/mL respectively. For example, 3.0 mL of insulin-loaded conjugate nanoparticle 
suspension was vacuum dried to obtain 5.3 mg solid mass, and thus the nanoparticle 
concentration was determined to be 1.8 mg/mL. If using PBS solution, 3.0 mL of PBS 
solution was dried to get background mass, and thus net solid nanoparticle mass was 
obtained by taking off this background mass. 
The desired quantity of insulin-loaded conjugate nanoparticles, insulin-loaded 
copolymer nanoparticles, and non-insulin-loaded conjugate nanoparticles, was measured 
based on the known concentration of these nanoparticles in PBS suspension, and 
transferred to a 15 mL centrifuge tube. After centrifugation to remove supernatant with 
free insulin, fresh D.I. H2O was added to set up controlled release tests carried out at 37 
C for 22 days. At the desired time intervals the supernatant with released insulin was 
separated from solid nanoparticles by centrifugation at 4000 rpm for 15 min. Then a 
specific amount of fresh sterile deionized water was added and the solids gently 
re-dispersed and left to stand until the subsequent release test. The concentration of the 
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insulin in the collected supernatant was determined by micro-BCA protein assay 
according to the manual instructions. 
The morphology of each of the different types of insulin-loaded conjugate 
nanoparticles was also characterized by optical microscopy to confirm nanoparticle fibers 
and 3D scaffolds, as shown in Figure 2.8. 
2.2.9 MTS cytotoxicity assayusing SW-620 cell lines 
The synthesized peptides, amphiphilic copolymers, and peptide-copolymer 
conjugates were tested for biocompatibility using SW-620 cell lines by standard MTS 
cytotoxicity assay. P1 was dissolved in DMSO/PBS (50 v/v %) solution to form 2.8 
mg/mL of stock P1 solution, and P2 was dissolved in PBS solution to form 10.8 mg/mL 
of stock P2 solution. All three copolymer/DMSO precursor solutions were prepared and 
self-assembled in sterile D.I. H2O, and then dialyzed for 24 h in D.I. H2O to form 
copolymer nanoparticle stock solutions with concentration ranging from 2.3 mg/mL to 
2.7 mg/mL. All three peptide-copolymer conjugate/DMSO precursor solutions were 
prepared and self-assembled into D.I.H2O and dialyzed 24 h in D.I. H2O to form 
conjugate nanoparticle stock solutions with concentration ranging from 2.5 mg/mL to 3.7 
mg/mL. 
SW-620 cells were seeded at a concentration of ~1000 cells per well in a 96-well 
culture plate and incubated for 16 h at 37 °C with 5% CO2 in an humidified incubator. 
The media was removed and the cells were washed with fresh PBS the next day. Then 
fresh media with each sample solution was added to 96-well plate at a concentration of 1, 
10 and 100 µg/mL and each concentration was repeated with 6 replicates. Then the plate 
was incubated for 72 h at 37 °C with 5% CO2 in the incubator. After 72 h of incubation, 
20 µL of MTS solution was added into each well and incubated again at 37 °C in the 
humidified incubator for 4 h. Finally, the absorbance at 490 nm was recorded using an 
ELISA plate reader (BioTek Instruments Inc.). Three control solutions, PBS plus media, 
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PBS/DMSO 50 v/v % plus media, and pure media, were similarly subjected to the 
cytotoxicity test. For all samples, the final DMSO concentration was not more than 2% to 
avoid DMSO toxicity to cells. The samples are designated as follows: P1 and P2 are the 
two designed peptides; Copolymer NP1, NP2 and NP3 are nanoparticles assembled from 
copolymers of PVP-b-12PMMA-b-PVP, PHEMA-b-12PMMA-b-PHEMA, and 
PHEA-b-12PMMA-b-PHEA; Conjugate NP1, NP2 and NP3 are assembled conjugate 
nanoparticle fibers from peptide-copolymer conjugates of PVP-b-12PMMA-b-PVP, 
PHEMA-b-12PMMA-b-PHEMA, and PHEA-b-12PMMA-b-PHEA, respectively. 
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2.3 Results and Discussion 
2.3.1 Design of peptides (P1 and P 2) for -sheet self-assembly 
The rationale for the peptide design and coupling the peptides to amphiphilic triblock 
copolymers is to produce a peptide-directed self-assembly that undergoes multiple levels 
of assembly. Figure2.1a shows the complementary peptides labeled P1 and P2. When 
these are attached to amphiphilic copolymers, one batch conjugated to P1 and the other 
conjugated to P2 (labeled as P1-A-P1 and P2-B-P2 in Figure 2.1b), and the batches are 
combined, the chains undergo two levels of self-assembly. The amphiphilic block 
copolymer self-assembles into nanoparticles A and B, which need not be either the same 
size or same composition, while the complementary ionic peptides assemble these newly 
formed nanoparticles into continuous fibers of nanoparticles. These fibers can then 
further assemble to form a -sheet in aqueous solution within the appropriate pH range 
by adding additional complementary peptide (P1 and P2 with proper ratio. The broader 
implications of this are that multiple active agents can be introduced with appropriate 
compositions for desired release, both temporally and spatially. 
 
 
(a) 
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(b) 
Figure 2.1. Illustration of (a) the complementary peptides, negatively charged P1 and 
positively charged P2, and (b) cartoon representation of two amphiphilic triblock 
copolymers, self assembling into core-shell nanoparticles A and B, and peptide linking of 
the nanoparticles into a polymeric “nanoparticle nanofiber” (1D) directed by 
self-assembly of P1 and P2. Higher assembly into 2D and 3D scaffolds is not shown.  
 
Ionic complementary peptides showed excellent -sheet assembly but were 
self-repulsive in aqueous solution (27). Using this principle, two peptide sequences, one 
positively charged and the other negatively charged (Figure 2.1a), were designed with 
alternating hydrophobic and ionic hydrophilic amino acids that could mutually 
self-assemble into -sheet fibrils in aqueous solution.  
The designed peptides were synthesized by semi-automated solid phase peptide 
synthesis strategy (section 2.2) and characterized by MALDI-TOF MS (Figure 2.1S a,b) 
to confirm the molecular weight of 1246.42 [M + Na+] for P1 and 1220.01 [M+H+] for  
P2, showing excellent agreement with the theoretic molecular weight of P1 (MW: 
1223.25) and P2 (MW: 1219.45). The chemical structure of P1 and P2 were further 
confirmed by 1H-NMR analysis (Figure 2.2 a,b) to show desired chemical structure. 
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(a) 
 
(b) 
Figure 2.2.1H-NMR (DMSO-D6+1% TMS) spectra of the synthesized P1 (a) and P2 (b). 
Each peptide sequence was designed to include two parts (Scheme 2.1), the 
self-assembly part bearing complementary electrostatic charges, and the spacer part, 
using hydrophilic amino acid (Threonine), that is designed to separate the self-assembly 
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part from the amphiphilic block copolymer by increasing its solubility, and its mobility to 
facilitate coupling with the complementary peptide units. P1 is designed for negative 
charges from glutamic acid (E), which bears carboxylic acids that ionize when the pH is 
above 4.4. P2 has lysine (K), which has an amine side group that carries positive charges 
when the pH is below 10.0 (27).  Therefore, glutamic acid and lysine will 
electrostatically interact with each other when the pH is between 4.4 ~ 10.0 in aqueous 
(i.e. PBS) solution. This interaction contributes the main driving force for self-assembly, 
as illustrated in Figure2.1a. The hydrophobic alanine (A) also contributes to the 
self-assembly between P1 and P2 by burying its own hydrophobic domain of alanine side 
change.  
The use of electrostatic interaction to drive the self-assembly is preferred because 
they are stronger than either hydrogen-bonding interactions or hydrophobic interactions, 
and so will dominate the assembly process (28). This is illustrated by the different 
self-assembly behavior of the designed peptides in DMF/PBS solution, shown in Figure 
2.3. Figure 2.3a and b show a solution of P1 and P2 while Figure 3c shows a combined 
solution of P1 and P2. The solution of P1 alone exhibits H-bonding and can form viscous 
gelation when concentration is at 1.1wt.%, while P2 exhibits only a solution with 
significant flow at same concentration. The combination of P1 and P2 forms a viscous, 
non-flowing gel at a lower concentration (0.55 wt.% + 0.55 wt.%), showing stronger 
interaction than either P1 or P2 alone.  
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Figure 2.3. Photographs of the gels formed by P1, P2 and a mixture of P1 and P2 in 
DMF/PBS co-solvent (1:1 v/v) where (a) P1 (1.1 wt.%) gels in 1 mL of DMF/PBS; (b) 
P2 (1.1 wt.%) flows in 1 mL of DMF/PBS, able to flow; and (c) a strong gel is formed 
after mixing a 1 mL solution of P1 with a 1 mL of P2 solution (giving 0.55 wt.% of each 
peptide in 2 mL DMF/PBS). 
2.3.2 Synthesis and characterization of amphiphilic tri-block copolymers  
Reversible addition-fragmentation chain transfer (RAFT) polymerization was used to 
synthesize the amphiphilic tri-block copolymer with reactive carboxylic acid groups at 
both chain ends. This was done using BDAT as the chain-transfer agent (CTA) and AIBN 
as the initiator (Scheme 2.3) (29). BDAT was selected because it is an efficient CTA for 
many monomers. This gives us the ability to produce a range of ABA triblock copolymers 
to assemble core-shell nanoparticles that are suitable for many different active agents. 
Furthermore, BDAT is a highly efficient CTA giving reactive carboxylic acid 
terminals,which is required so that peptide conjugation is efficient, thereby giving 
efficient assembly into fibers. 
Before the copolymer synthesis the structure and purity of BDAT was confirmed by 
1H-NMR (in CDCl3). The proton peaks of the –CH3 (s, 12 H) at 1.67 ppm and –COOH (s, 
2H) at 13.0 ppm, are in agreement with the reported chemical structure (26). 
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The first step of the polymerization for all the copolymers in this work was the 
synthesis of the hydrophilic block, so that the shell of the final copolymer nanoparticle 
was hydrophilic. Thus, after polymerizing the appropriate monomer, using BDAT and 
AIBN, to give the PVP, PHEMA, or PHEA in high yield (Table 2.1), the polymer was 
used as a macro-CTA to synthesize the PMMA hydrophobic inner block in the second 
step, giving the desired tri-block copolymer. 
1H-NMR analysis confirmed the existence of all the appropriate peaks for the 
hydrophilic block and the block copolymer (Figure 2.4). For example, the 1H-NMR 
spectrum of PVP (in D2O) (Figure 2.4a), shows peaks for protons d (: 1.46-1.61), f (: 
2.18-2.32), g (: 1.90), h (: 3.19) and e (: 3.52-3.66) with the ratio of the integrated 
areas of d:f:g:h:e = 23.11:22.29:23.16:21.59:9.85  2:2:2:2:1. The number average 
molecular weight (MN) analyzed by MALDI-TOF MS (Table 2.1) was found to be 
similar for PVP and PHEA, but slightly lower for PHEMA. Accordingly the XN, 
calculated from the MN, was found to be 78, 74, and 66 for PVP, PHEA, and PHEMA 
respectively. Considering the symmetrical structure of BDAT, these repeat units are 
evenly distributed at both sides of CTA and therefore the structure of the macro-CTA is 
represented as: (PVP)39-BDAT-(PVP)39, (PHEA) 37-BDAT-(PHEA)37 and 
(PHEMA)33-BDAT-(PHEMA)33 respectively. 
The amphiphilic block copolymer was synthesized by combining the macro-CTA 
with MMA and fresh AIBN. The ratio of the blocks in the final tri-block copolymer was 
determined from 1H NMR (Figure 2.4). An example calculation is given for 
PVP-b-PMMA-b-PVP (Figure 4b) in section 2.4 with equation to calculate the actual 
block ratio of XN(PVP):XM(PMMA) to be 1:4.9. The block ratio (XN:XM) of 
PHEMA-b-PMMA-b-PHEMA and PHEA-b-PMMA-b-PHEA were calculated in a 
similar manner from the 1H-NMR spectra (Figure 2S a,b and Figure 3S a,b, with 
corresponding equation) and found to be 1:11 and 1:8.7 respectively. From these data the 
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XN of the hydrophilic blocks and XM of the hydrophobic PMMA block for all three 
copolymers were found to be as follows: (PVP)39-b-(PMMA)382-b-(PVP)39, 
(PHEMA)33-b-(PMMA)726-b-(PHEMA)33 and (PHEA)37-b-(PMMA)644-b-(PHEA)37. 
The high ratio of PMMA used relative to the hydrophilic monomer was chosen to 
ensure that sufficiently large core-shell nanoparticles would be obtained to allow the 
nanoparticles to be visualized by optical microscopy. In fact, the water-swollen particles 
that were produced when dripped into water were found to be spherical and possess a 
diameter near 1 µm, as shown in Figure 2.6. Smaller ratios of PMMA produce 
accordingly smaller particles that have a diameter between 100 to 500 nm by dynamic 
lighter scattering test. 
 
 
 
(a) 
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(b)  
Figure 2.4. 1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic polymer 
PVP and (b) tri-block copolymer PVP-b-12PMMA-b-PVP by RAFT polymerization. 
2.3.3 Coupling peptides to copolymers 
The carboxylic acid groups at the amphiphilic copolymer chain ends were coupled to 
the amine group of the P1 and P2 peptides is illustrated in Scheme 2.4. The 
peptide-functionalized copolymer conjugates were purified and vacuum-dried, and the 
coupling was confirmed by FT-IR (Figure 2.5). 
Figure 2.5 shows the P1 and P2 absorption bands of the carbonyl stretching 
vibrations (C=O) at ~1670 cm-1 and the amide nitrogen-hydrogen (O=C-N-H) bending 
vibrations at ~1530 cm-1. The FT-IR spectra of the peptide-coupled copolymer conjugates 
also show the absorption peaks from peptides between 1526 cm-1 to 1678 cm-1, which 
differs from the polymer carbonyl absorption at 1720 cm-1. These same peptide bands 
were also seen in the other peptide-coupled conjugate polymers shown in the 
Supplemental Information (Figure 2.4S a,b).These data confirm the peptide coupling to 
the copolymers. 
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Figure 2.5. Comparison of FT-IR spectra of the synthesized copolymer, P1(Peptide1), 
P2(Peptide2), and Peptide-PVP-b-12PMMA-b-PVP conjugates. 
 
2.3.4 Self-assembly of peptide-copolymer conjugates in aqueous solution 
The purpose of the copolymer design is to prepare self-assembled controlled-release 
“nanoparticle fibers” that can subsequently self-assemble to produce 3D scaffolds as 
directed by -sheet peptide assembly (Figure 2.1b). By this method, the mixing of two 
batches of complementary peptide-conjugated polymeric nanoparticles (A and B) results 
in their self-assembly into an ordered arrangement of nanoparticle fibers and 3D  
scaffolds. This simple 2-part system has the advantage of allowing each nanoparticle to 
be customized for a desired active ingredient(s) and also allowing the nanoparticle fibers 
to simultaneously serve as a two-drug delivery system and flexible scaffolds for cell 
migration and proliferation. Using controlled ratios and sequential addition multi-drug 
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delivery systems are achievable in the desired sequence within the resulting particle 
fibers. 
Self-assembled nanoparticle fibers and 3D scaffolds, are shown for a two-drug 
delivery system in representative microscopic images in Figure 2.6 and 2.7, in aqueous 
media (PBS solution or D.I. H2O). Figure 2.6a-c shows PVP-b-12PMMA-b-PVP, after 
the complementary peptide-conjugated nanoparticles were combined. The initially 
formed fibers are observed with t ~ 0 – 10 h, with the extent of the assembly increasing 
further with t > 10 h after combining the complementary peptide-copolymer conjugate 
pair, and finally a 3D assembly is observed. Figure 2.7 a,b shows 
PHEMA-b-12PMMA-b-PHEMA in deionized water with t ~10 h, and (b) 
peptide-coupled PHEA-b-12PMMA-b-PHEA in PBS at t~10 h. The self-assembly 
process appeared to progress somewhat more rapidly in PBS solution than in D.I. H2O. 
This is thought to be due to the presence of the alkaline ions in PBS solution being 
beneficial to the self-complementary assembly of the designed peptides (3). Although 
PBS is often better than D.I. H2O for peptide dissolution, for these assembled 
nanoparticle fibers PBS buffer media facilitates the formation of long NP fibers on glass 
slide surfaces when compared to results using D.I. H2O media. There may be other 
differences between the two media, but in this work none were noted. 
  
(a) (b) 
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(c) 
Figure 2.6. Conjugate NP fibers from peptide-coupled PVP-b-12PMMA-b-PVP in PBS 
with self-assembly times of (a) ~10 h showing fibers, (b) t >10 h, showing further 
assembly and (c) t >>10 h, showing 3-D scaffolds. 
 
  
(a) (b) 
Figure 2.7. Conjugate NP fibers from (a) peptide-coupled 
PHEMA-b-12PMMA-b-PHEMA in deionized water with t ~10 h, and (b) 
peptide-coupled PHEA-b-12PMMA-b-PHEA in PBS with t ~10 h. 
 
This approach has substantial versatility and is effectively a fundamental technology 
with significant control over each level of assembly. For example, any approach can be 
used to design the nano/microparticle composition and structure, as either a 
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homopolymer or a copolymer, with the advantage of an amphiphilic copolymer being that 
it will self-assemble into a core-shell design. This allows the particle interior to be 
designed to be suitable for a desired cargo such as an active ingredient, and to release the 
active ingredient at a desired rate, while the particle exterior can be designed to be stable 
in the delivery medium. The core and shell can then be selected for an appropriate release 
rate for the specific active ingredient. The peptide assembly also offers significant level 
of control, not only in the design of the assembly motif and its stability, but also in how 
the assembly manipulates the nano/microparticle arrangement. The assembly can be 
designed to couple so that all the nano/microparticles can carry the same drug, but release 
the drug at very different rates over an extended release time, or different particles can be 
assembled so that multiple drugs can be released from different nano/micro particles with 
each particle being released at a rate appropriate for that drug. This can be done for small 
molecules or in principle for proteins. 
Another block copolymer design was made using poly(ethylene glycol) methyl ether 
acrylate as the hydrophilic monomer to give a hydrophilic shell that readily forms a 
hydrogel. Our copolymer design, PPEG-b-12PMMA-b-PPEG, like the others, can serve 
as controlled release devices but in this case the outer shell, being ethylene glycol based, 
would resist protein adsorption and cell adhesion. The same peptide bonding motifs that 
are already described, P1 and P2, were used. The peptide-copolymer conjugates were 
placed in a DMF precursor solution (13 mg/mL) to self-assemble into a dense 3D 
nanoparticle scaffold by adding 2 mL of deionized water. The freeze-dried scaffold was 
characterized by FESEM and images are shown in Figure 2.8a. The same composition 
was tested, but with P1 and P2 simply being blended into the mixture rather than bonded 
to the amphiphilic PPEG-12-PMMA-PPEG copolymer (Figure 2.8b).The results clearly 
show the effect of bonding the peptides to the nanoparticles on the assembly process. The 
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overall density of the scaffolding can be manipulated by changing composition and 
peptide length. 
 
 
(a)                               (b) 
Figure 2.8. FESEM images show comparison of self-assembled scaffold morphologies  
(a) self-assembled from peptide-coupled PPEG-b-12PMMA-b-PPEG conjugates and (b) 
nanoparticle scaffolds control self-assembled from peptide physically mixed with 
PPEG-b-12PMMA-b-PPEG. 
2.3.5 Controlled release study of Insulin as model drug 
The advantage and rationale for the use of an amphiphilic block copolymer is to 
allow nanoparticles (or microparticles) to be prepared with a suitable composition to 
control the release rate for a desired drug, with the shell allowing the nano/microparticles 
to be stable in a given medium, and to serve as a tissue scaffold, or resist protein 
adsorption. In a preliminary test of the ability of assembled nanoparticles to serve as 
controlled release devices, insulin was used to test the ability to release a model protein.  
Insulin was loaded into the synthesized peptide-copolymer conjugates at a theoretical 
content of 0.15 wt.%. After combining aqueous solutions of complementary 
peptide-functionalized copolymer nanoparticles, each containing insulin, long 
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self-assembled nanoparticle fibers and 3D scaffolds were formed, as the representative 
images show in Figure 2.9. 
  
(a)                               (b) 
  
(c)                             (d) 
Figure 2.9. Optical microscopy images of insulin-loaded conjugate nanoparticle fibers 
and 3D scaffolds, self-assembled in PBS solution. Insulin-loaded nanoparticle fibers of  
(a) peptide-coupled PVP-b-12PMMA-b-PVP conjugates self-assembled in PBS with 
assembly time t~10h;  (b) peptide-coupled PHEMA-b-12PMMA-b-PHEMA conjugates 
in PBS with t~10h; (c) peptide-coupled PHEA-b-12PMMA-b-PHEA conjugates with 
t~10h; and (d) representative insulin-loaded nanoparticle scaffolds at condensed phase 
with t>10h. Images of (a), (b), (c) were prepared on a glass slide surface by gently 
shaking self-assembled conjugate nanoparticles to form a uniform suspension and then 
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transferring to the glass slide surface. Image (d) is of self-assembled nanoparticle 
scaffolds from peptide-coupled PVP-b-12PMMA-b-PVP conjugates with self-assembly 
time >10h without shaking the suspension, used as the representative morphology of 3D 
nanoparticle scaffolds. 
 
The self-assembled insulin-loaded nanoparticle fibers from peptide coupled 
PHEMA-12PMMA-PHEMA were used in a controlled release test run for 22 days at 37 
C. The released insulin solution was collected by centrifugation and the quantity was 
determined by micro-BCA test. The cumulative quantity of insulin released over 22 days 
is shown in Figure 2.10. The release is compared with insulin-loaded 
PHEMA-12PMMA-PHEMA nanoparticles alone, and for the peptides from peptide 
coupled PHEMA-12PMMA-PHEMA without insulin. 
 
Figure 2.10. Comparison of insulin released from PHEMA-12PMMA-PHEMA 
copolymer nanoparticle control and assembled peptide-coupled 
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PHEMA-b-12PMMA-b-PHEMA conjugate nanoparticle fibers tested by micro-BCA 
protein assay. 
The results show a steady release of insulin from the assembled conjugate 
nanoparticle fibers over a three-week period. A ‘background’ release is measured (blue 
triangles) that is due to residual peptides (P1 and P2) remaining in the formulation after 
the synthesis of the peptide-copolymer conjugates. Unfortunately, the assay does not 
differentiate the insulin from the residual peptides, but even accounting for this release, 
the data show that the conjugated peptide nanoparticle fibers give a controlled insulin 
release over a three-week period thatis slightly faster than the release from the copolymer 
nanoparticle controls.  
2.3.6 Biocompatibility study on SW-620 cell lines by MTS assay 
The cytotoxicity of the synthesized peptides, copolymers and peptide-copolymer 
conjugates were measured by MTS assay using SW-620 cell lines. The results are shown 
in Figure 2.11. The cells incubated with media alone or with PBS and/or DMSO were 
used as control and the results showed absorption intensity ranging from 0.64 to 0.88 at 
490 nm. When absorptions were compared to that of the controls, MTS test for all 
synthesized peptides, copolymers and peptide-copolymer conjugates showed similar or 
slightly higher absorption intensity at 490 nm. These results suggest that SW-620 cells 
cultured in the presence of synthesized biomaterial solution or nanoparticle suspension 
with concentration range at 1 ~ 100 g/mL are not adversely affected by these 
synthesized biomaterials. 
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Figure 2.11. Cytotoxicity test on SW-620 cell lines by MTS assay. 
Conjugates NP1, NP2 and NP3 represent self-assembled nanoparticles from 
peptide-coupled copolymers (PVP-b-12PMMA-b-PVP, PHEMA-b-12PMMA-b-PHEMA 
and PHEA-b-12PMMA-b-PHEA). Copolymer NP1, NP2 and NP3 are nanoparticles for 
the non peptide-coupled copolymers. Peptide-1 and Peptide-2 are the synthesized 
peptides (P1 and P2). 
 
2.4 Conclusion 
A novel fundamental technology was proved in this work that showed how 
peptide-directed self-assembly can be used to direct the assembly of individual polymeric 
nanoparticles into fibers and 3D scaffolds. This technology combines the advantages of 
versatile controlled release systems and flexible scaffolds for tissue engineering. In this 
work a single drug, insulin, was tested, but the broader implications of this technology 
are that multiple drugs can be loaded into the scaffolding and the release rate of each drug 
can be separately controlled by the selection of the nanoparticles used to form the 
scaffold. This is because different polymer compositions and structures (e.g. core-shell 
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morphology) can be employed, and the assembly of fundamentally different nano- and 
microparticles can be controlled.  Although only three different copolymers were 
described in this work, the technology allows other polymers to be used, and as long as 
the peptides can be coupled to the terminals to induce the assembly process, polymers 
can be prepared using any step growth or chain growth process.  
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Main Findings in This Chapter: 
In this chapter, we proved the hypothesis that ionic complementary 
peptide-functionalized amphiphilic copolymer could self-assemble into polymeric 
nanoparticle fibers and 3D scaffolds with or without model drug loading. This was done 
by functionalizing several sets of amphiphilic triblock copolymers with two oppositely 
charged peptides (P1 and P2), including PVP-b-PMMA-b-PVP, 
PHEMA-b-PMMA-b-PHEMA and PHEA-b-PMMA-b-PHEA, with reactive carboxylic 
acid terminals synthesized by RAFT polymerization using BDAT as CTA. Controlled 
release study using insulin as model drug showed sustained release of insulin over 3 
weeks from self-assembled nanoparticle scaffolds. Cytotoxicity test on SW-620 cell lines 
showed all synthesize peptides, copolymers and peptide-copolymer conjugates were 
biocompatible with SW-620 cell lines at concentration below 100 g/mL. 
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Abstract 
Conventional self-assembled peptide nanofiber scaffolds lack the ability to be 
simultaneously loaded with multiple drugs that have different chemical and physical 
properties, to allow individual controlover the release of each of the loaded drugs, and to 
provide uniform, or controlled but non-uniform (e.g. gradient), distribution of the drugs 
within the same scaffold system. In this work, a novel ionic complementary 
peptide-functionalized polymeric nanoparticle was designed and self-assembled into 1D, 
2D, and 3D polymeric nanoparticle scaffolds. Such self-assembled nanoparticle scaffolds 
have the potential to overcome each of the above-described limitations of conventional 
scaffolds. This new method allows the assembly of individual nanoparticles into a 
continuous fiber scaffold. Because of this design, each nanoparticle composition can be 
selected to allow it to be loaded with the desired drug and release that drug at an 
appropriate rate. In principle this approach also gives control over the spatial distribution 
of the drug-containing nanoparticles to allowblocks of nanoparticles with a given drug, or 
nanoparticle gradients to be formed in thescaffolds, while also yielding an injectable 
system. This process gives unprecedented flexibility into the design and preparation of 
the scaffold. The self-assembled nanoparticle scaffold formation was confirmed by 
optical microscopy and FESEM micrographs. Several model drugs, including 
hydrophobic and hydrophilic small molecules, were loaded in the scaffold system 
showing controllable and sustainable release over 3 weeks. The self-assembled 2D 
scaffold membrane was incubated with fibroblast cells (NIH3T3 cell lines) in a culture 
dish that demonstrated non-toxicity and non-inhibition to the cell proliferation. This type 
of nanoparticle scaffold combines the advantages of the precision associated with peptide 
self-assembly and the versatility of polymeric nanoparticle controlled release systems for 
a new type of tissue engineering. 
Keywords: peptide, self-assembly, nanoparticle scaffold, multi-drug controlled release 
74 
 
3.1 Introduction 
An efficient tissue growth is usually dependent on the delivery of various drugs (i.e. 
active biomedicine, growth factors) to cells within tissue regeneration. Thus there are 
important scientific relationships between tissue engineering and scaffolding system with 
drug delivery (1). For example, skin regeneration usually requires a complex delivery of 
growth factors and cytokines, such as fibroblast growth factor, keratinocyte growth  
factor, vascular endothelial growth factor and interleukin 1α, to release within the wound 
bed to promote cell proliferation and migration to achieve wound healing (2,3).  
Therefore, there is a need to fabricate a more sophisticated system with multi-drug 
delivery abilities within scaffolding for tissue engineering.  
Conventional polymeric hydrogels (both synthetic and natural polymers) have been 
widely developed to incorporate a single drug in scaffold system for tissue regeneration, 
for example, physically or chemically incorporating bioactive ingredients in 
poly(ethylene glycol) (PEG) hydrogels (4,5), poly(lactide)-b-poly(ethylene 
oxide)-b-poly(lactide) (PLA-b-PEO-b-PLA) or poly(lactic-co-glycol acid) (PLGA) 
hydrogels (6,7), or natural biomaterial gels (e.g. alginate, collagen, chitosan, gelatin) 
(8-14). Most recently, Caicco et al. (15) developed a physically blended hydrogel 
composite system of hyaluronan-methylcellulose (HAMC) as for the localized delivery 
and sustainable release of CyclosporinA (CsA), a promising neuroprotective and 
neuroregenerative agent for neural stem/progenitor cells, for treatment of stroke. The 
authors incorporated CsA in HAMC gel by three different methods and compared the 
release rate. The three incorporation types include a solubilized type (CsA/acetonitrile 
solution mixed with HAMC gel), a particulate type (CsA solid particulate dispersed in 
MC solution and then embedded in HAMC gel), and polyl(actic-co-glycolic acid)(PLGA) 
microsphere-encapsulated CsA type (CsA encapsulated in PLGA microspheres and then 
embedded in HAMC gel). Interestingly, the in-vitro controlled release test showed that 
solubilized CsA type released from HAMC gel only for 2 days, particulate type expanded 
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to 7-10 days, but CsA from PLGA microsphere-encapsulated type showed sustainable 
release over 21 to 28 days. Most importantly, the CsA released from PLGA microspheres 
retained bioactivity that was equivalent to that of fresh CsA when compared by a 
neurosphere assay (15). However, similarly with most of the other polymeric hydrogel 
scaffolds, this study is also limited to single drug incorporation. 
Self-assembled peptide nanofiber scaffolds have been gaining in popularity 
compared to traditional scaffolding for tissue engineering because of non-toxicity, 
biodegradability, and the porosity of fibril structures is similar to extracellular matrix 
(ECM) for cell attachment. Also, these materials assemble in situ into a hydrogel at 
physiological environment (16). The first generation self-assembling designer peptide, 
EAK16-II (AEAEAKAKAEAEAKAK), was discovered in a yeast protein, zuotin (17). 
This type of ionic complementary peptide spontaneously self-assembles into stable 
β-sheets in aqueous conditions across a broad range of temperature and pH, and even in 
the presence of a high concentration of the denaturing agents urea and guanidium 
hydrochloride (18,19). The self-assembling forces are the hydrophobic interactions of 
alanine (A) domains and ion-pair interactions between negatively charged glutamic acid 
(E) side chains with positively charged lysine (K) side chains. That this strong ion-pair 
interaction contributes to stable β-sheet formation was further supported by investigation 
of a complementary pair of designer peptides, the self-repulsive but mutually attractive 
peptide sequences that possessed positive charges (Ac-WKVKVKVKVK-amide) and 
negative charges (Ac-EWEVEVEVEV-amide) (20). On mixing this pair of 
complementary peptides, a rapid assembly into a viscoelastic hydrogel occurred at a 
concentration as low as 0.25 wt.%. This hydrogel retained mechanical strength, even after 
repeated shear-induced breakdowns, due to the electrostatic interactions. The strong 
electrostatic and selective interaction between the opposite charges demonstrated one of 
the key merits of using ion-complementary β-sheet motifs. 
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These designer self-assembling peptide hydrogels (e.g. EAK16-II, RADA16-I or II) 
have been widely used as both controlled drug delivery systems and 3D scaffolds. The 
drug delivery capability is typically done by physically incorporating a drug into the 
peptide scaffold during the gel formation (21,22), but it can also be chemically bonded 
onto the C-terminal or N-terminal (23), or sometimes combination of both methods to 
load multiple active agents (24,25). However, these methods still have significant 
limitations with respect to the quantity of drug(s) that can be incorporated, but 
furthermore the incorporation of drug(s) may have an impact on the subsequent 
self-assembly process or the mechanical stability of the formed hydrogel, and there is 
very limited ability to control the release of drugs with different properties. Therefore, the 
hydrogel itself must be designed in conjunction with the specific drug(s) that will be 
incorporated. Moreover, the effective distribution of multiple drugs in scaffolds is not 
easy to achieve.  
To address these limitations, we designed and reported a new type of ionic 
complementary peptide-directed self-assembly of polymeric nanoparticle fibers and 3D 
scaffolds to be a more powerful and versatile technique to allow multiple drug 
incorporation within a scaffolding system and to allow the release rate of each drug to be 
controlled appropriately (26). This new type of designed scaffold having multiple drug 
loading ability was achieved by functionalizing an amphiphilictriblock copolymer with 
two oppositely charged peptides (P1-ABA-P1 and P2-ABA-P2, ABA: triblock  
copolymer, P1: H2N-TTTT-AEAEAEAE-CONH2 and P2: 
H2N-TTTT-AKAKAKAK-CONH2), respectively. While the peptides controlled the 
nanoparticle assembly the copolymer composition gave domains that self-assembled into 
polymeric micro or nanoparticles for use as drug carriers that also possess the peptide 
functionalities (P1-NP-P1 and P2-NP-P2). These nanoparticles then further self-assemble 
into ‘nanoparticle fibers’ and eventually lead to 3D scaffolds with a ‘sponge-like’ 
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appearance in aqueous solution.  
In the present work, we continue the study of the self-assembly behavior and test the 
versatility of the methodology with a series of designed peptide-functionalized copolymer 
(P1-ABA-P1 and P2-ABA-P2) with different particle size, and with additional peptides 
(P1 and P2) to adjust the scaffold porosity and mechanical stability. Multiple drug 
loading and control of the drug releasing rate from different nanoparticle compositions 
are demonstrated in this work using several small molecules as model drugs, including 
hydrophobic molecule (4’,5’-dibromofluorecein), moderately hydrophobic molecule 
(nitrofurazone) and slightly water soluble hydrophilic molecule (amoxicillin). The 
biocompatibility test is conducted by incubating the self-assembled 2D scaffold 
membrane with fibroblast cells (NIH3T3 cell lines) in a humidified incubator at 37 °C for 
2 weeks, showing non-toxicity and non-inhibition to the cell proliferation and migration. 
The self-assembly of peptide-functionalized nanoparticles with additional host peptides 
(P1 and P2) and with different concentration is also conducted to form nanoparticle 
composite peptide hydrogels, to compare mechanical stability and morphology. 
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3.2 Experimental Section 
3.2.1 Materials 
All reagents for peptide synthesis were purchased from AAPPTec LLC (Louisville, 
KY) and used as received. Cleavage reagents, including trifluoroacetic acid (TFA, 99%), 
thioanisole (99%) and anisole (99%), were purchased from Sigma-Aldrich, and 
1,2-ethanedithiol (98.0%) was from Fluka. 1-Vinyl-2-pyrrolidinone (VP) (99%), 
2-hydroxyethyl methacrylate (HEMA) (97%), methyl methacrylate (MMA) (99%), 
1,4-dioxane (99+%), 2,2-azobisisobutyronitrile (AIBN) (98%), dimethyl formamide 
(DMF, 99.9%) and phosphate buffered saline (Biotech) were purchased from 
Sigma-Aldrich. Ethyl alcohol (200 proof, anhydrous) was from PHARMCO-AAPER, 
and diethyl ether (anhydrous) and dimethyl sulfoxide (DMSO) were from Mallinckrodt 
Baker Inc. (Phillipsburg, USA). Model drugs of 4’,5’-Dibromofluorescein (DBF) and cell 
adhesion peptide (RGDS) were from Sigma-Aldrich, nitrofurazone powder and 
amoxicillin capsules were from Jungle Laboratories Corporation and Shopko pharmacy 
(Made by Sandoz International, Germany, NDC code: 007881-2613-01). DBF and 
nitrofurazone were used as received, amoxicillin powder was removed from the capsules 
and was purified by dissolving in ethanol and removing undissolved components, and 
recrystallized before use. VP and HEMA were purified prior to use by passing through a 
neutral alumina column. MMA was distilled before use. All other reagents were used as 
received. Fibroblast cells (NIH3T3 cell line) were purchased from ATCC and cell media 
(DMEM/High Glucose) was from Hyclone Laboratories, Inc. (Utah, USA). Ultrapure 
deionized water (>17.6 M-cm) was obtained from MEG-PURE SYSTEM (MP-190 
LC).  
3.2.2 Synthesis and self-assembly of ionic complementary peptides (P1 and P2)  
Two ionic complementary peptides, P1 (H2N-TTTT-AEAEAEAE-amide) and P2 
(H2N-TTTT-AKAKAKAK-amide), were synthesized by a standard semi-automatic solid 
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phase peptide synthesis strategy (Endeavor 90I, AAPPTec LLC, Louisville, KY, USA), 
using Fmoc chemistry, on a rink amide resin. A detailed synthetic procedure, and 
characterization of the products by MALDI-TOF MS (Microflex LRF, BrukerDaltonics, 
Billerica, USA) and 1H-NMR (Varian Unity INOVA 400 MHz, McKinley Scientific, 
Sparta, NJ, USA)were reported elsewhere (26).  
Peptide self-assembly was tested in aqueous solution using different salt (NaCl) 
concentrations to study the effect of NaCl concentration on the self-assembly behavior of 
the designer peptides. Briefly, P1/deionized water solution (11 mg/mL) and P2/deionized 
water solution (11 mg/mL) were prepared by dissolving P1 in deionized water with 0.03 
mM of NaOH(pH 9.0) and P2 in deionized water with 0.03 mMHCl (pH 5.4).  The 
solutions of P1 (0.5 mL) and P2 (0.5 mL) were combined with magnetic stirring and 
sonicating for 30 min to give a uniform mixture, and then the NaCl concentration in the 
combined P1/P2 solution was adjusted to 0.03 mM, 10 mM and 30 mM by adding the 
appropriate amount of the NaCl solution (1 M). The combined P1/P2 solution was 
allowed to self-assemble for 24 h at room temperature.  
Approximately 10 L of each self-assembled peptide hydrogel was transferred onto 
the surface of a newly cleaned silicon wafer (cleaned by 10 wt.% HCl and 10 wt.% 
NaOH solutions each for 10 h respectively, and then washed by ethanol and deionized 
water several times with sonication) and air dried for 1 h at room temperature. The 
assembled peptide membrane was rinsed with 100 L of deionized water to remove 
unattached peptides and salt. The rinsing and washing process was repeated three times, 
and the specimen was allowed to air dry. Once dry, the peptide-covered wafer was coated 
with a platinum layer (10 nm) for FESEM characterization (Hitachi S-4700, Hitachi High 
Technologies America, Inc.). 
In addition to testing the peptide self-assembly in aqueous solution at different salt 
concentrations, the process was studied at different total peptide concentrations of 5.5 
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mg/mL and 11 mg/mL (P1:P2=1:1 wt./wt.) at a singleNaCl concentration (10mM). The 
self-assembled peptide gel was prepared on the silicon wafer surface in the same way as 
before and characterized by FESEM. 
3.2.3 Synthesis of amphiphilictriblock copolymers with reactive terminals by RAFT 
polymerization 
Amphiphilictriblock copolymers of PVP-b-PMMA-b-PVP and 
PHEMA-b-PMMA-b-PHEMA, were synthesized by RAFT polymerization 
usingS,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) as chain transfer agent 
(CTA) and AIBN as initiator. This CTA gave reactive carboxylic acid terminals at both 
chain ends (HOOC-ABA-COOH). The synthesis of BDAT was described elsewhere (26).  
The polymerization was done in two steps to build up the amphiphilic block 
copolymer. In the first step the hydrophilic block(PVP or PHEMA) was prepared in 
dioxaneat 70C (24 h under nitrogen atmosphere) usingthe following ratio of reagents: 
[M]o:[BDAT]o:[AIBN]o=1000:5:1. The product was precipitated in cool diethyl ether to 
obtain the PVP or PHEMA block as a solid. The precipitation was repeated 3 times to 
remove any unreacted monomer. The polymer containing the hydrophilic block was 
vacuum-dried at 50 C for 12 h. In the second step, the hydrophilic polymer was used as 
a macro-CTA to copolymerize with MMA in a dioxane/DMF (4:1 v/v) solvent mixture 
with additional AIBN added (0.0012 g). The reaction was continued at 70 C (48 h) under 
nitrogen atmosphere to obtain the amphiphilic triblock copolymer. The as-made 
copolymer solution was purified by precipitating in cool diethyl ether 3 times to remove 
unreacted residues and vacuum-dried at 50 C for 12 h.  
The length of the hydrophilic block was maintained as a constant (with actual XN= 
78 for PVP and 64 for PHEMA, see Table 3.1) but the length of the PMMA block, 
synthesized in the second step, was varied to adjust the ratio of the hydrophilic to 
hydrophobic block in the nanoparticles. This resulted in different core sizes, as well as 
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different nanoparticle sizes. The reactant ratios, and molar mass and yields of the 
copolymer products are summarized in Table 3.1. 
 
Table 3.1. Reactant ratios and products (Macro-CTA and Copolymer) by RAFT. 
Macro-CTA [M]o:[CTA]o:[I]o XNa MNa, Da 
Yield 
% 
PVP 1000:5:1 78 8954 84.0 
PHEMA 1000:5:1 64 8557 92.8 
Copolymer 
Mass Ratio 
(Macro-CTA )o:(MMA)o 
XN/XM MNb, Da 
Yield 
% 
PVP-b-1.5PMMA-b-PVP 
PVP-b-3PMMA-b-PVP 
PVP-b-6PMMA-b-PVP 
1:1.5 
 1:3 
1:6 
78/86 
78/186 
78/524 
17564 
27576 
61417 
72.8 
70.2 
53.7 
PHEMA-b-3PMMA-b-PHEMA 1:3 64/102 18769 65.8 
a. MN tested by MALDI-TOF; 
Monomer
BDATN
N
M
MM
X

 . 
b. MN calculated from 
1H NMR by ratio of integrated peaks. 
3.2.4 Characterization of hydrophilic block and tri-block copolymers 
The number average molecular weight (MN) of the hydrophilic block (PVP and 
PHEMA) was determined by MALDI-TOF MS and the number average degree of 
polymerization (XN) was calculated from the measured MN. These results are given in 
Table 3.1. A detailed analysis of the MALDI-TOF MS spectra is described elsewhere 
(26). 1H-NMR spectra (performed in DMSO-d6) and peak assignments are shown in 
Figure 3.1 (a, b). The integrated peak area from the PVP and PMMA blocks gives the 
block ratio XPVP:XPMMA and thus the number average molecular weight of the triblock 
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copolymer is determined. For example, analysis of PVP-b-1.5PMMA-b-PVP shows that 
theintegratedarea of the peak at : 3.14 (-CH2-N, from PVP block) and the peak areas at  
: 3.56 and 3.35 (-OCH3 from PMMA block, -CH- from PVP backbone) are used to 
calculate the block ratio of XPVP: XPMMA= 1:1.10 according to equation (1). 
49.24
41.11
3
2
),(
)(
3
2 
 

CHOCH
NCH
PVPPMMA
PVP
Area
Area
XX
X
      (1) 
The actual block ratios of other copolymers (PVP-b-3PMMA-b-PVP, 
PVP-b-6PMMA-b-PVP and PHEMA-b-3PMMA-b-PHEMA) are similarly calculated to 
be 1:2.38, 1:6.72 and 1:1.60. According to the known XN and the actual block ratios 
calculated, the XN and MN of tri-block copolymers are thus determined and listed in 
Table 3.1. 
The peak assignments for the 1H-NMR spectra of copolymers were made as shown 
below. PVP-b-PMMA-b-PVP (in DMSO-d6, ): 0.73-1.04 (-CH3), 1.40-1.82 (-CH2-), 
3.34 (-CH2-N-), 3.53 (-OCH3, from PMMA block, also contains some -CH- from the PVP 
block). PHEMA-b-PMMA-b-PHEMA (in DMSO-d6, ): 0.72-1.13 (-CH3), 1.42-1.77 
(-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA 
block), 3.87 (-CH2-O-C=O). 
 
3.2.5 Coupling reaction of copolymer with P1 and P2 
The synthesized peptides (P1 and P2) were coupled with the desired amphiphilic 
copolymer to form peptide-copolymer conjugates. The coupling reaction was performed 
betweenthe carboxylic acid terminals of the desiredpolymer and the amine terminalsof 
the desired peptide using 2-(7-aza-1-H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium 
(HATU) as the coupling agent, as shown in Scheme 3.1. The process for the 
PVP-b-6PMMA-b-PVP system is described in greater detail as an example. The 
copolymer (1.0 g, ~1.6 x 10-5mol) was dissolved in DIPEA/DMF (8.0 mL, 0.9 M DIPEA 
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in DMF) at room temperature in a 25 mL three neck round bottom flask with magnetic 
stirring. The reaction solution was degassed for 15 min with nitrogen and then HATU 
(0.012 g, ~3.2 x 10-5mol) was added to activate the carboxylic acid groups. P1 (0.10 g, 
8.2 x 10-5mol) was pre-dissolved in DMF (5.0 mL) in a glass vial, and then transferred 
into the activated copolymer solution via syringe. The reaction was continued for 45 min 
at room temperature with magnetic stirring and nitrogen gas bubbling through solution. 
P2 was similarly coupled with a second batch of copolymer. The peptide-copolymer 
conjugate was precipitated in cool diethyl ether and centrifuged to remove un-reacted 
chemicals. The precipitation was repeated 3 times to obtain purified conjugate solids, and 
dried under reduced pressure for 12 h at 50 C before storing in a sealed vessel in the 
refrigerator at 4 ˚C. 
 
Scheme 3.1. Synthesis of peptide-copolymer conjugates by coupling reaction of peptide 
amine terminal with copolymer carboxylic acid terminals. 
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Other copolymers that possessed different block ratios were coupled with P1 and P2 
using the same procedure. The peptide-copolymer conjugates were characterized by 
FT-IR (Spectrum One, Perkin Elmer, Massachusetts, USA) to verify the coupling  
reaction. The sample designationsfor the peptide-functionalized copolymer conjugates are 
shown in Table 3.2.  
3.2.6 Self-assembly study of peptide-copolymer conjugates in aqueous solution  
All peptide-copolymer conjugates were first self-assembled in aqueous solution to 
form the peptide-functionalized nanoparticles (P1-NP-P1 and P2-NP-P2). Then the 
individual nanoparticles bearing complementary peptides (P1-NP-P1 and P2-NP-P2) 
were combined together where they then assembled into 1D nanoparticle fibers and 
eventually formed 3D scaffolds as directed by the ionic complementary assembly 
between P1 and P2.  
The assembly process of the nanoparticles into nanoparticle fibers was accomplished 
in three steps as follows. First the P1-copolymer conjugates (20 mg) were dissolved in 
DMSO (2 mL) to give a clear precursor solution, and then the precursor solution was 
slowly injected (0.4 mL/min) into weakly basic deionized water (10 mL, pH 9.0, adjusted 
by 1 M NaOH solution) via a 31 G syringe while being stirred at 600 rpm by a magnetic 
stirrer to self-assemble into a P1-NP-P1 suspension. After completing the injection of the 
precursor solution, the magnetic stirring was continued for 30 min and then sonicated 2 
min to form a stable peptide-nanoparticle suspension. In the second step, the 
P2-copolymer conjugates were first solvated in DMSO to form a precursor solution and 
then added into weakly acidic deionized water (10 mL, pH 5.4, adjusted by 1 M HCl) to 
form a P2-NP-P2 suspension and sonicated for 2 min. 
The purpose of forming the nanoparticle suspensions in weakly basic (pH 9.0) and 
weakly acidic (pH 5.4) deionized water was to completely ionize the carboxylic acid side 
groups from P1 and amine side groups from P2 to bear negative and positive charges 
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respectively. This gave two separate suspensions of nanoparticles bearing complementary 
peptides that were self-repulsive ensuring no assembly until the two separate suspensions 
are combined.  
 
Table 3.2. Hydrodynamic diameter of the peptide-copolymer conjugate nanoparticles by 
DLS and self-assembly time for each nanoparticle pair. 
Peptide-Copolymer Conjugate 
Assembled 
NP name 
NP Size 
(nm) 
Assembly 
time (h) 
P1-PVP-b-1.5PMMA-b-PVP-P1 
P2-PVP-b-1.5PMMA-b-PVP-P2 
P1-NP1-P1 
P2-NP1-P2 
178±72 3 
P1-PVP-b-3PMMA-b-PVP-P1 
P2-PVP-b-3PMMA-b-PVP-P2 
P1-NP2-P1 
P2-NP2-P2 
227±97 6 
P1-PVP-b-6PMMA-b-PVP-P1 
P2-PVP-b-6PMMA-b-PVP-P2 
P1-NP3-P1 
P2-NP3-P2 
580±264 10 
P1-PHEMA-b-3PMMA-b-PHEMA-P1 
P2-PHEMA-b-3PMMA-b-PHEMA-P2 
P1-NP4-P1 
P2-NP4-P2 
283±125 6 
 
Table 3.2 shows the hydrodynamic diameter of the individual nanoparticle-peptide 
conjugates before scaffold assembly, and the time allowed for scaffold assembly after the 
complementary nanoparticle conjugates are combined. When larger nanoparticle 
conjugates were used the allowed assembly time was increased. For example, the stable 
P1-NP1-P1 suspension was injected into the stable P2-NP1-P2 suspension with gentle 
magnetic stirring at 400 rpm for 30 min to give a uniformly mixed suspension. Within 10 
minutes after the stirring was discontinued there was visual evidence of assembly with 
the appearance of a ‘sponge-like’ phase that was settling at the bottom of the vial. The 
allowed assembly time ranged from 3-10 h, with longer times being allowed for the larger 
nanoparticles.  
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The self-assembled nanoparticle scaffolds from smaller peptide-nanoparticles (from 
P1-NP1-P1 and P2-NP1-P2) and larger peptide-nanoparticles (from P1-NP3-P1 and 
P2-NP3-P2) were applied to silicon wafers to allow observation by FESEM. Briefly, the 
assembled nanoparticles (100 L) were transferred onto a cleaned silicon wafer surface 
(cleaned by 10 wt.% HCl solution and 10 wt.% NaOH solution for 10 h respectively, and 
then washed by ethanol and deionized water several times with sonication). The 
nanoparticle layer on silicon wafer surface was air dried to leave an assembled 
nanoparticle membrane (designated as a 2D scaffold) and then vacuum dried at 50 C for 
6 h. The nanoparticle membrane was coated with platinum (Pt, ~5nm) prior to FESEM 
characterization. 
3.2.7 Self-assembly study of peptide-functionalized nanoparticles with additional 
peptides 
A self-assembly study of the peptide-functionalized nanoparticles was performed in 
the presence of excess“free” peptides (P1 and P2) to determine if their presence effected 
the porous structure and mechanical stability of the final 3D nanoparticle scaffolds. 
P1-NP3-P1 and P2-NP3-P2 suspensions (Table 3.2) were similarly prepared in deionized 
water as described before, and the nanoparticle suspensions were dialyzed 24 h to remove 
organic solvent in 2 L of fresh weak basic deionized water (pH 9.0 for P1-NP3-P1) and 
weak acidic deionized water (pH 5.4 for P2-NP3-P2) with replacing fresh deionized 
water every 12 h. The concentration of both purified nanoparticle suspensions was 
gravimetrically determined to be 2.6 mg/mL. 
Then 0.5 mL of P1-NP3-P1 suspension was well mixed with 0.5 mL of P1 solution 
(11 mg/mL in deionized water with pH at 9.0) to form a mixed suspension of 
P1-NP3-P1/P1 (1.3 mg/mL of nanoparticle with 5.5 mg/mL of P1). A suspension of 
P2-NP3-P2/P2 (same concentration as P1-NP3-P1/P1) was similarly prepared. Then the 
P1-NP3-P1/P1 suspension was combined with the P2-NP3-P2/P2 suspension by magnetic 
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stirring at 400 rpm for 2 h, and allowed to settle during self-assembly to form 
nanoparticle/peptide co-assembled composite hydrogel after adjusting NaCl 
concentration to be 10 mM by adding 1M NaCl solution. The concentration of the 
nanoparticle/peptide composite hydrogel was 1.3 mg/mL of nanoparticle with 5.5 mg/mL 
of total peptides (P1 and P2). Using same procedure, 1.3 mg/mL of nanoparticle with 11 
mg/mL and 22 mg/mL of total peptides were prepared to compare their stability and 
porous structure of 3D nanoparticle/peptide hydrogel scaffolds. 
10 µL of the self-assembled nanoparticle/peptide composite hydrogel was dropped 
onto a cleaned silicon wafer surface to air dry, giving2Dnanoparticle/peptide membranes. 
The membrane was then rinsed with 100 µL of fresh deionized water 3 times to remove 
un-bonded peptides and salts and again allowed to air dry. Another 10µL of the composite 
hydrogel (1.3 mg/mL nanoparticle with 22 mg/mL P1 and P2) was placed in a silicon 
wafer and dried under reduced pressure at room temperaturewithout washing with 
deionized water in order to compare the 3D morphologies of the 
co-assemblednanoparticle/peptide scaffold because vacuum drying can quickly remove 
solvent to retain a 3D structure, but air drying only gives a compact 2D membrane. 
Allsamples were then coated with a layer of platinum (5 nm) for FESEM 
characterization. 
 
3.2.8 Controlled release test with hydrophobic fluorescein as model drug 
A controlled release study was performed for 23 days in deionized water using 
4’,5’-dibromofluorescein (DBF) as model for a small hydrophobic drug. The 
peptide-copolymer conjugates together with the DBF were dissolved in DMSO to form 
two host solutions, DBF/P1-PVP-b-1.5PMMA-b-PVP-P1 (38 mg + 0.2 wt.% 
DBF)/DMSO (4mL) solution and DBF/P2-PVP-b-1.5PMMA-b-PVP-P2 (38 mg + 0.2  
wt.% DBF)/DMSO (4mL) solution. The DBF/P1-copolymer host solution was then 
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slowly injected into weakly basic deionized water (10 mL, pH 9.0) to give a 
self-assembled DBF-loaded P1-NP1-P1 suspension. The DBF/P2-copolymer host 
solution was similarly injected into weakly acidic deionized water (10 mL, pH 5.4) to 
give a self-assembled DBF-loaded P2-NP1-P2 suspension. The DBF-loaded P1-NP1-P1 
suspension was then injected (23G syringe) into the DBF-loaded P2-NP1-P2 suspension 
with gentle magnetic stirring at 400 rpm for 1h to give a uniform mixture. The mixed 
nanoparticle suspension was allowed to self-assemble into a3Dnanoparticle scaffold at 
the bottom of the vial. 
The concentration of the DBF-loaded nanoparticle scaffold suspension was 
gravimetrically determined. This was done bygently shaking the suspensionto gain a 
uniform dispersion, and then 2.0 mL of the suspension was measured and gently heated 
to remove solvent to obtain a dimensionally stable dry mass (7.0 mg). The remainder of 
the nanoparticle suspension was then centrifuged to isolate the uncaptured DBF in the 
supernatant. The nanoparticle scaffoldsolids were also collected and washed with fresh 
deionized water (2.0 mL each time) and centrifuged at 4000 rpm for 10 min to isolateany 
additionaluncaptured DBFthat had been adsorbed onto the nanoparticle surface. This 
washing and centrifuging process was repeated two additional times, and all the 
supernantants were combined to aid in collecting all uncaptured DBF. The combined 
supernatant was evaporated in a dark environment, and the isolated DBF was then 
dissolved in a solution of deionized water/ethanol (1:1, v/v) and transferred into a 
volumetric flask to allow the uncaptured DBF to be quantified by fluorescence 
spectrometry. Thewashed DBF-loaded nanoparticle solids were then dispersed in 3.0 mL 
of fresh deionized water and set up at 37±1 C for a controlled release test. At each time 
interval, the released DBFsolution was isolated from the solid nanoparticles by 
centrifugation at 4000 rpm for 10 min, and then the DBF-containing supernatant was 
collected for testing. Then 3.0 mL of fresh deionized water was added to replace the 
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collected fluid and thecontrolled release test on the nanoparticles was continued. An 
equivalent volume of ethanol was added to each liquid aliquot collected from the sample 
being tested so that the releasedDBFwas in a 1:1 water/ethanol solution foranalysis.  
Separately, a series of standard DBF solutionswere prepared using deionized 
water/ethanol (1:1, v/v) to givea standard curve to quantify uncaptured DBF and released 
DBF from the nanoparticle scaffolds. The uncapturedDBFsolution, the released 
DBFsample solution, and standard DBF solution, were analyzed by fluorescence 
spectrometer (SPEX FLUOROLOG equipped with SPEX 1681 0.22 m Spectrometer and 
SPEX dM 3000 power controller, HORIBA Scientific, USA) with slit setup at 0.50 mm 
and emission intensity collected at 532 nm. The concentration of uncapturedDBFand each 
released DBFsample were quantitatively determined according to the standard curve and 
Beer’s Law (Figure 3.1S, supplementary data). And the actual loading content (wt. %) of 
DBF in nanoparticles was calculated based on equation (2). 
%100.%
int



 lenanoparticloadeddrug
druguncaptureddrugial
W
WW
wtActual      (2) 
All other peptide-copolymer conjugates were loaded with model drug of DBF using 
the same procedure, and the actual loading content (wt. %) was determined. The results 
are shown in Table 3.3. The cumulative release of DBF (wt.%) based on initially loaded 
DBF amount was calculated and results are shown in Figure 3.10. 
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Table 3.3. Loading efficiency of model drug (DBF) in different nanoparticles. 
Scaffold/NPs 
DBF 
Theo. Loading 
wt. % 
Act. Loading 
wt. % 
Loading 
Efficiency% 
S-1 
P1-NP1-P1 
0.20 0.19 95 
P2-NP1-P2 
S-2 
P1-NP2-P1 
0.20 0.16 80 
P2-NP2-P2 
S-3 
P1-NP3-P1 
0.20 0.19 95 
P2-NP3-P2 
S-4 
P1-NP4-P1 
0.20 0.18 90 
P2-NP4-P2 
 
3.2.9 Multiple-drug loading and controlled release test using nitrofurazone and 
amoxicillin as model drugs 
Controlled release studies were also done to test the simultaneous release of multiple 
drugs contained within one self-assembled scaffold system. These tests used 
nitrofurazone as a moderately hydrophobic model drug and amoxicillin asahydrophilic 
model drug. P1-NP-P1 and P2-NP-P2 were separately loaded with 5.0 wt.% of 
nitrofurazone and 5.0 wt.% of amoxicillin respectively using the same procedure as for 
DBF loading.  
The two drug-loaded nanoparticle suspensions (P1-NP-P1 and P2-NP-P2) were then 
mixed together to self-assemble into a two-drug loaded nanoparticle scaffold. The 
nanoparticle scaffold concentration, uncaptured drug quantities and controlled release 
tests were performed using the procedures described for DBF, except the controlled 
release test time wasonly 96 h due to the rapid release of the hydrophilic model drug, 
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amoxicillin. The amount of uncaptured and released drugs was quantified using an HPLC 
equipped with a UV-vis detector (SPD-20AT/SPD-20A, SHIMADZU Corporation,  
Kyoto, Japan). An example of calibration curve of nitrofurazone and amoxicillin for 
quantitative analysis is shown in Figure 3.2S a,b (supplementary data). The actual 
quantity of nitrofurazone and amoxicillin that were loaded into the nanoparticles is given 
in Table 3.4. The cumulative release of both drugs (wt.% based on initially loaded 
amount) was determined and these results are shown in Figure 3.11. 
 
Table 3.4. Loading efficiency of model drugs (Nitrofurazone and Amoxicillin) in 
different nanoparticles. 
Scaffold/NPs 
Nitrofurazone Amoxicillin 
Theo. 
Load 
wt. % 
Act. 
Load 
wt.% 
Load 
Effi. % 
Theo. 
Load 
wt. % 
Act. 
Load 
wt.% 
Load 
Effi. % 
S-1 
P1-NP1-P1 5.0 2.9 58 -- -- -- 
P2-NP1-P2 -- -- -- 5.0 1.3 26 
S-2 
P1-NP2-P1 5.0 4.5 90 -- -- -- 
P2-NP2-P2 -- -- -- 5.0 1.6 32 
S-3 
P1-NP3-P1 5.0 3.1 62 -- -- -- 
P2-NP3-P2 -- --  5.0 1.2 24 
S-4 
P1-NP4-P1 5.0 4.7 94 -- -- -- 
P2-NP4-P2 -- -- -- 5.0 1.3 26 
 
3.2.10 Cytotoxicity test on NIH3T3 cell lines 
Nanoparticle scaffolds that were self-assembled from P1-NP(x)-P1 and P2-NP(x)-P2 
(Table 3.2, NP(x) represents NP1, NP2, NP 3, or NP4), possessing different particle sizes 
and/or compositions, were tested for biocompatibility with NIH3T3 fibroblast cells. This 
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testing was done by incubating NIH3T3 fibroblast cellsin a glass culture dish that already 
possessed an assembled 2D scaffoldingmembraneon the bottom of the dish. The study 
was done to test the effects of the different scaffolds on cell viability and activity. 
Each self-assembled nanoparticle scaffold (Table 3.3, S-1 to S-4) was similarly 
prepared using the same self-assembly procedure. For example, the P1-NP1-P1 
suspension was self-assembled from P1-PVP-b-1.5PMMA-b-PVP-P1/DMSO (40 
mg/4mL) precursor solution in weakly basic deionized water (10 mL, pH 9.0), and the 
P2-NP1-P2 suspension was prepared from P2-PVP-b-1.5PMMA-b-PVP-P2/DMSO (40 
mg/4mL) precursor solution but in weakly acidic deionized water (10 mL, pH 5.4). The 
two suspensions were then coupled together with gentle magnetic stirring at 400 rpm for 
30 min and settled for 3 h to obtain scaffold sample S-1. Other scaffold samples (S-2 to 
S-4) were prepared using the same method, but longer assembly time was allowed for 
bigger nanoparticles. All scaffold samples were dialyzed using a dialysis tube (Nominal 
MWCO 3,500, from Fisher Scientific) in PBS solution for 48 h to remove organic solvent 
and free peptide (P1 and P2). Fresh PBS (1L for each sample) was replaced for dialysis at 
every 24 h interval. The purified nanoparticle scaffold was then transferred into a 
centrifuge tube (15 mL) and stored at 4 C for application. 
The concentration of the purified scaffold was gravimetrically determined. 2.0 mL of 
uniformly dispersed scaffold suspension (S-1) was measured and gently heated to remove 
solvent, leaving dry mass of 7.2 mg after taking off the background mass of 2.0 mL of 
dried PBS. So the scaffold concentration of S-1 was determined to be 3.5 mg/mL. Other 
nanoparticle scaffold samples (S-2, S-3 and S-4) were determined to be 2.9, 3.0, and 3.6 
mg/mL respectively. 
Based on the known concentrations, approximately 500 g of dry scaffold mass were 
transferred into each pre-sterilized glass culture dish. The suspension drop was air dried 
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at room temperature overnight, leaving an assembled scaffold membrane (a circle layer 
with diameter of ~2cm) on the dish bottom. 
Fibroblast cells were cultured in cell media and passaged at ~95% confluency so that 
the cells were able to be cultured for extended periods of time.  Cell concentration was 
determined to be 1.5105 cells/mL by cytometry. To each culture dish containing S-1 to 
S-4scaffold membrane, fibroblast cell seeds (~1.5105 cells) were transferred onto the 
membrane surface and incubated for ~15 min at 37 °Cwith 5% CO2in a humidified 
incubator, and then 5 mL cell media was slowly added to avoid directly flushing onto the 
membrane. The culture dish was then incubated at 37 °C with 5% CO2 in the incubator 
and media was refreshed after 12 h and then replaced every 24 h. The cell growth status 
was observed every 24 h using optical microscopy (Nikon Eclipse Ti, Nikon Instruments 
Inc., USA) and the incubation was allowed to proceedfor 7 days. 
In order to improve cell adhesion ability, cell adhesion peptides (RGDS, 1 wt.% 
based on peptide-copolymer conjugates) were physically encapsulated into nanoparticles 
using the same procedure that was used to load the model drugs, and similarly purified by 
dialysis in fresh PBS.The RGDS-loaded nanoparticle scaffold membrane was similarly 
prepared on a glass dish, air dried and then incubated with fibroblast cells using same 
procedure. Both cell proliferation and migration were observed every 24 h by optical 
microscopy. 
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3.3 Results and Discussion 
3.3.1 Rationale for peptide design and study of peptide self-assembly  
The purpose of this project was to design a new type of self-assembled polymeric 
nanoparticle scaffold with far greater versatility than other scaffolding systems, including 
multi-drug loading abilities and the ability to vary mechanical strength of the scaffolding, 
for tissue engineering. The methodology is outlined in Figure 3.1, which demonstrates 
the use of 2 different nanoparticles assembled into an alternating pattern. The ends of two 
batches of amphiphilic copolymers are separately functionalized with the our designed 
peptides (P1 and P2) to form peptide-copolymer conjugates, one carrying negative 
charges from P1, and the other carrying positive charges from P2. These 
peptide-copolymer conjugates undergo two-levels of self-assembly in aqueous solution. 
The first level is the assembly of the core-shell nanoparticle itself, which would be done 
separately. In principle any biologically acceptable composition could be selected for a 
desired drug to control its release and a desired nanoparticle size (influenced by the ratio 
of hydrophilic to hydrophobic monomers and polymer molecular weight) and a desired 
mechanical strength (influenced by the same variables). For best control a single drug is 
incorporated into a single nanoparticle, and the numbers of each nanoparticle type would 
control the total “dose” of each drug. Once the drugs are the appropriate batches of 
peptide-functionalized nanoparticles are combined to self-assemble into nanoparticle 
fibers directed by ionic complementary assembly between P1 and P2, and finally, 
depending on the conditions and assembly time allowed, form 3D nanoparticle scaffolds 
with multi-drug loading.  
As already described, the advantages of this nanoparticle self-assembly approach 
includes: (1)The ability to incorporate multiple drugs, regardless of that drug’s 
hydrophilicity or hydrophobicity, within the scaffolding; (2)The ability to control the 
distribution of the different drugs within the scaffold; (3) The ability to separately control 
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the release of each drug from a nanoparticle whose composition can be designed for that 
specific drug; (4)The ability to adjust the porosity and mechanical strength of the final 
hydrogel; and (5) The ability to introduce this system into a patient by injection followed 
by controlled self-assembled of the scaffold in situ. 
 
 
Figure 3.1. General procedure shows fabrication of polymeric nanoparticle scaffold with 
multi-drug loading abilities. 
The key step to achieve these features is the two designed ionic complementary 
peptides (P1 and P2) with opposite charges that can assemble into β-sheets in aqueous 
solution with appropriate pH range. The two peptides were synthesized by 
semi-automatic solid phase peptide synthesis strategy with sequence of 
H2N-TTTT-AEAEAEAE-amide (P1) and H2N-TTTT-AKAKAKAK-amide (P2). The 
spacer part (TTTT) is designed to decrease the steric hindrance of copolymer domain to 
the assembly units (AEAEAEAE for P1 and AKAKAKAK for P2) and thus increase the 
mobility of the assembly units, and also to increase the solubility of the peptides in 
aqueous solution. 
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The synthesized peptides were characterized by MALDI-TOF MS, 1H-NMR to 
confirm the synthesized sequence and chemical structure matching well with theoretical 
ones. It was also demonstrated that P1 and P2 in PBS/DMF (1:1 v/v) at total peptide 
concentration of 11 mg/mL showed self-repulsive but mutually attractive self-assembly 
behavior. All of the work was concretely presented in previous report (26). 
Considering biological applications of the self-assembled scaffold, here we further 
study the self-repulsive but mutually attractive property of the designer peptides (P1 and 
P2) in aqueous solution with different salt (NaCl) concentration, because it was reported 
that alkaline salt concentration could significantly affect ionic peptide self-assembly 
behavior by forming ion-pair bridge between opposite charges, or mask the ion-pair 
interaction if excessive cation/anion existed (27).  
Here, the self-assembly of P1 and P2 was conducted by dissolving P1 in sterile 
deionized water (pH 9.0, adjusted by 1M NaOH solution) and P2 in sterile deionized 
water (pH 5.4, adjusted by 1M HCl solution).  Each peptide forms clear aqueous 
solution with excellent solubility more than 22 mg/mL, but when the two peptide 
solutions are combined together, the self-assembly is triggered to form hydrogel after 
settling for 3 h even the concentration is as low as 5.5 mg/mL. The results are shown in 
Figure 3.2. 
 
Figure 3.2. Gels formed from self-assembly of P1 and P2 (1:1 wt./wt.) at different total 
peptide concentration and salt concentration. (a) Gel of P1+P2 at 5.5 mg/mL with NaCl 
concentration of 10 mM. (b) Gel of P1+P2 at 11 mg/mL with NaCl concentration of 0.03 
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mM. (c) Gel of P1+P2 at 11 mg/mL with NaCl concentration of 10 mM. (d) Gel of 
P1+P2 at 11 mg/mL with NaCl concentration of 30 mM. 
The gel formation was compared at different NaCl concentration, which showed that 
P1 self-assembles with P2 most quickly at a10 mMNaCl concentration, but the gel is 
weakened when the NaCl concentration increases to 30 mM (Fig. 3.2d). A self-assembled 
peptide gel, at a total concentrationofpeptide of 11 mg/mL (P1+P2, 1:1 wt./wt.) and with 
NaCl concentration of 10 mM, was dropped on a silicon wafer surface and air dried to 
form a membrane, that was then coated with Pt/Pd layer (5 nm), was observed by 
FESEM. The images are shown in Figure 3.3. 
Figure 3.3 shows the snowflake-like morphology on top with some smooth 
membrane on bottom of the self-assembled peptide membrane before rinsing with 
deionized water. But after rinsing with deionized water to remove the salt, the 
self-assembled morphology was converted to amorphous aggregation (Fig. 3.3b). This 
change is mainly due to the high water solubility of the designer peptides (P1 and P2). 
The high water solubility of peptides usually leads to unstable self-assembled structure 
and requires high critical concentration to form nanofiber structure (17,18). This appears 
to be the main reason for our designer peptides that only show certain extent of assembly 
structure but not very stable nanofiber structure due to its high water solubility and short 
assembly units (only 8 repeat units, P1: AEAEAEAE and P2: AKAKAKAK). 
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(a)                        (b) 
Figure 3.3. FESEM micrograph of self-assembled peptide membrane of P1+P2 (no 
nanoparticle conjugates are present) at a total concentration of 11 mg/mL with NaCl 10 
mM. (a) Membrane without rinsing with deionized water. (b) Membrane rinsing with 
deionized water. 
 
3.3.2 Synthesis of amphiphilic copolymer with different ratio of hydrophilic and 
hydrophobic blocks 
In previous work we synthesized peptide-functionalized amphiphilic copolymer 
(PVP-b-12PMMA-b-PVP or PHEMA-b-12PMMA-b-PHEMA, hydrophilic to 
hydrophobic block ratio=1:12:1) to self-assemble into peptide-funcitonalized polymeric 
microparticle (P1-NP-P1 and P2-NP-P2) with a hydrodynamic size of ~1m, to study 
their self-assembly behavior in aqueous solution to form 1D nanoparticle fibers and 3D 
scaffolds directed by ionic complementary interaction between P1 and P2 (26). The 
present work continues that study, and expands its goals to better understand the effect of 
nanoparticle size on self-assembled scaffold morphology, mechanical stability, and to 
prove individual control over the release rate of different drugs within the scaffold.  
To do this, amphiphilic copolymers with different block ratio are designed and 
synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization 
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using S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) as the effective 
chain-transfer agent (CTA) (28). The different block ratio is designed to form 
nanoparticles with different particle size. The theoretical block ratio of hydrophilic to 
hydrophobic block (PVP:PMMA) was ranged from 1:1.5:1 to 1:6:1 (Table 3.1). The 
synthesized copolymers were characterized by 1H-NMR to determine the actual block 
ratio, as shown in Figure 3.4. As Figure 3.4a shows, the integrated peak ratio at : 3.14 
(–CH2-N, h from PVP block) to : 3.56 and 3.35 (-OCH3, a from PMMA block, and 
-CH-,e from PVP backbone ) increases as block ratio of PVP:PMMA increase. Using 
equation (1) and the integrated peak area ratio, the actual block ratio of hydrophilic to 
hydrophobic block (XPVP:XPMMA) of each block copolymer was determined and thus the 
repeat units (XM) of PMMA block and the copolymer molecular weight (MN) were 
calculated according to the repeat units number of XN and XM.  The actual block ratio 
and molecular weight of PHEMA-b-PMMA-b-PHEMA was similarly calculated 
according to the 1H-NMR analysis (Fig. 3.4b). The results are shown in Table 3.1.  The 
self-assembled polymeric nanoparticle sizes with different block ratio are tested by DLS 
and shown in Table 3.2. 
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(a) 
 
(b) 
Figure 3.4.1H-NMR spectra of amphiphilic copolymers with different block ratio. (a) 
PVP and PVP-b-PMMA-b-PVP with block ratio of PVP:PMMA from 1:1.5 to 1:6; (b) 
PHEMA and PHEMA-b-PMMA-b-PHEMA with block ratio of PHEMA:PMMA=1:3. 
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3.3.3 Coupling reaction of copolymer with peptides 
Each copolymer is then coupled with peptides (P1 and P2) to form P1-copolymer and 
P2-copolymer conjugates via the coupling reaction between peptide amine terminals and 
copolymer carboxylic acid terminals, as Scheme 3.1 shows. The peptide-copolymer 
conjugates were purified by precipitation in cool diethyl ether followed by centrifugation 
and drying under reduced pressure. The coupling reaction was qualitatively verified by 
FTIR, as shown in Figure 3.5.  
 
(a) 
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(b) 
 
(c) 
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(d) 
Figure 3.5. Comparison of FT-IR spectra of peptides (P1 and P2), copolymer and 
peptide-copolymer conjugates. (a) PVP-b-1.5PMMA-b-PVP coupled with P1 and P2. (b) 
PVP-b-3PMMA-b-PVP coupled with P1 and P2. (c) PVP-b-6PMMA-b-PVP coupled 
with P1 and P2. (d) PHEMA-b-3PMMA-b-PHEMA coupled with P1 and P2. 
 
As Figure 3.5 shows, FT-IR spectra of copolymers show two carbonyl absorption 
peaks at 1730 cm-1 from the PMMA block and 1664 cm-1 from the PVP block. When the 
hydrophilic block ratio (PVP or PHEMA) is adjusted from 1:6 to 1:1.5, the absorption 
intensity at 1664cm-1 also increase.After the copolymer is coupled with peptides (P1 and 
P2), both P1- and P2-copolymer conjugates show weak absorption peaks at 
approximately 1628 cm-1 and 1530 cm-1, and also feature absorption peaks of the peptide 
amide bonds from P1 and P2. Also, the original absorption peak at 1664 cm-1 from the 
hydrophilic block (PVP or PHEMA) is weakened or covered by peptide absorption. 
These results qualitatively confirm the effective coupling reaction between copolymer 
with peptides to form peptide-copolymer conjugates. 
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3.3.4 Self-assembly study of peptide-functionalized nanoparticles 
The purpose of this work is to fabricate self-assembled ‘nanoparticle fibers’ that can 
subsequently self-assemble to produce 3D scaffolds as directed by -sheet peptide 
assembly with multi-drug loading abilities (Fig. 3.1). In previous work we already 
showed that peptide-functionalizedmicroparticles with particle size of ~1 m could 
effectively assemble to form 1D nanoparticle fibers and eventually lead to 3D scaffolds 
after condensation (Fig. 3.6).  
 
  
(a)                       (b) 
  
(c)                       (d) 
Figure 3.6. Optical microscopy images of self-assembled 1D nanoparticle fibers and 3D 
nanoparticle scaffolds on glass slide surfaces. Microparticle fibers and scaffolds from 
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peptide-functionalized PVP-b-12PMMA-b-PVPconjugates are shown in(a) and (b). 
Microparticle fibers and scaffolds from peptide-functionalized 
PHEMA-b-12PMMA-b-PHEMA conjugates are shown in(c) and (d).Both 1D 
nanoparticle fibers wereprepared by gently shaking self-assembled nanoparticle 
suspension (10 h assembling time) and then transferring via 31G syringe onto glass slide 
surface with slowly moving syringe needle down along slide surface. Both 3D scaffolds 
were prepared without shaking self-assembled nanoparticle suspension. 
 
The effect of particle size on the self-assembly behavior, the assembled scaffold 
morphology and its mechanical stability were also studied. The self-assembled 
nanoparticles from various peptide-copolymer conjugates with different block ratios 
(Table 3.1) were tested by dynamic light scattering (DLS) with particle size ranging from 
178±72 nm to 580 ±264 nm as the length of the hydrophobic block (PMMA block) was 
increased (Table 3.2). The self-assembly process between P1-NP-P1 and P2-NP-P2 is 
illustrated in Figure 3.7. 
 
Figure 3.7.Self-assembly process between P1-NPA-P1 and P2-NPB-P2 with DBF loading 
as indicator. 
 The peptide-functionalized nanoparticle pair (P1-NPA-P1 and P2-NPB-P2) were 
loaded with DBF as an indicator to verifythe self-assembly. As Figure 3.7 shows, 
initially stable P1-NPA-P1 and P2-NPB-P2suspensions are coupled together with 
magnetic stirring. The self-assembly between these two nanoparticles begins once 
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magnetic stirring is stopped. It is directed by the ionic complementary assembly between 
P1 and P2, and forms a ‘sponge-like’ bottom layer in the vial. Our study shows that the 
self-assembly proceeds more quickly for smaller nanoparticles (3 h for P1-NP1-P1 and 
P2-NP1-P2) than for bigger particles (10 h for P1-NP3-P1 and P2-NP3-P2) (Table 3.2). 
The self-assembled 2D nanoparticle  scaffold membrane was prepared by 
transferring ~100 L of the ‘sponge-like’ layer onto the silicon wafer surface and air 
dried, which was then coated with 5 nm Pt/Pd layer. FESEM micrographs of the scaffold 
membrane with different particle size are shown in Figure 3.8. 
  
(a)                                (b) 
  
(c)                               (d) 
Figure 3.8. FESEM micrographics of self-assembled nanoparticle membrane on silicon 
wafer surface after being air dried. (a) Scaffold membrane assembled from P1-NP1-P1 
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and P2-NP1-P2; (b) Scaffold membrane assembled from P1-NP3-P1 and P2-NP3-P2; (c) 
Cleaved scaffold interface morphology from P1-NP3-P1 and P2-NP3-P2; (d) Scaffold 
loaded with 0.2 wt.% of model drug (DBF) within nanoparticles. 
Figure 3.8 shows the morphologies of the assembled 2D scaffold membrane on 
silicon wafer surfaceand air dried under room temperature.  The smaller nanoparticles 
(P1-NP1-P1 and P2-NP1-P2, DLS size: 178±72 nm) self-assembled to form more 
compact membrane with smooth surface and smaller pores (Fig. 3.8a), while bigger 
nanoparticles (P1-NP3-P1 and P2-NP3-P2, DLS size: 580±264 nm) assembled to 
formmembrane with rough surface and bigger pores (Fig. 3.8b). However, the 
micrographics from the cleaved interface clearly show 3D fibrous structure inside of the 
scaffold membrane with or without loading of model drug (DBF) (Fig. 3.8c, d). The 
FESEM micrographics also show that the dried nanoparticle size is about 20-50 nm for 
smaller nanoparticles and 50-100 nm for bigger nanoparticles, which is much smaller 
than the size tested by DLS, mainly due to hydrodynamic size of wet nanoparticles and 
slight aggregation in aqueous solution. 
On comparing themorphologies ofscaffold membranesassembledfrom smaller and 
larger nanoparticles (Fig. 3.8a and b) it is not difficult to understand that smaller 
nanoparticles undergo faster self-assembly than the larger ones (Table 3.2) because 
smaller nanoparticlescan move more easily to be directed by electrostatic interactions 
between P1 and P2, and the nanoparticles themselves have stronger inter-particle 
interaction force. Therefore, the smaller nanoparticles self-assemble to form more 
compact scaffolds with smaller pores, but are more mechanically stable than those from 
larger nanoparticles. Therefore there is a balance between nanoparticle size and 
mechanical stability and pore size for such assembled nanoparticle scaffolds when they 
are to be used for tissue engineering. 
3.3.5 Self-assembly study of peptide-functionalized nanoparticle with additional 
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peptides 
In order to further increase the mechanical stability and combine the advantage of 
self-assembling peptide scaffolds, peptide-functionalized nanoparticles (P1-NP3-P1 and 
P2-NP3-P2, total concentration 1.3 mg/mL) are co-assembled with additional peptides 
(P1 and P2) with total peptide concentration (P1:P2= 1:1 wt./wt.) ranged from 5.5 mg/mL 
to 22 mg/mL. The co-assembled composite gel status is shown in Figure 3.9. From left to 
right, as the peptide concentration increases, the stability of the co-assembled composite 
gels are correspondingly increased by forming gels, but self-assembled nanoparticle 
suspension control (Fig. 3.9a) shows at flow status with ‘sponge-like appearance’. The 
stability of composite gels is compared by sonicating 30 seconds, only nanoparticles 
co-assembled with 22 mg/mL of peptides remained stable gel status (Fig. 3.9d), while the 
composite gels with low peptide concentration was broken into viscous solution status 
(Fig. 3.9b,c). 
 
Figure 3.9. Peptide-functionalized nanoparticles (P1-NP3-P1 and P2-NP3-P2) 
co-assembled with additional peptides (P1+P2, 1:1 wt./wt.) to form composite peptide 
gels. (a) Self-assembled nanoparticle control without peptides; (b) With total peptide 
concentration at 5.5 mg/mL; (c) With total peptide concentration at 11 mg/mL; (d) With 
total peptide concentration at 22 mg/mL. 
 
The self-assembled morphologies of P1-NP3-P1 and P2-NP3-P2 with additional 
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peptides are further characterized by FESEM microscopy, as shown in Figure 3.10.  
FESEM micrographics of Figure 3.10 a,b,c are prepared by dropping composite gels on 
silicon wafer surface and air dried under room temperature with washing away 
un-bonded peptides by rinsing with deionized water (3 x 100 L).  While Figure 3.10 
d,e,f are morphologies of composite gel co-assembled with 22 mg/mL of peptides 
without washing and dried at room temperature under reduced pressure in a vacuum 
oven. 
  
(a)                            (b) 
 
(b)                           (d) 
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(e)                           (f) 
Figure 3.10. FESEM micrographs of the co-assembled composite peptide gels prepared 
by assembling of peptide-functionalized nanoparticles (P1-NP3-P1 and P2-NP3-P2) with 
additional ionic complementary peptides (P1 and P2) at different total peptide 
concentration and then transferring onto silicon wafer surface.(a) Co-assembled gel with 
peptide concentration at 5.5 mg/mL; (b) Co-assembled gel with peptide concentration at 
11 mg/mL; (c) Co-assembled gel with peptide concentration at 22 mg/mL.(a), (b) and (c) 
are gel membranes on silicon wafer surface after air drying and washing with deionized 
water. (d), (e) and (f) are representative morphologies of co-assembled gel with peptide 
concentration at 22 mg/mL without washing and dried at room temperature under reduced 
pressure. 
 
Comparing the morphologies of self-assembled membrane on silicon wafer surface 
by air drying and washing with deionized water, the self-assembled nanoparticles without 
additional peptides formed compact porous 3D nanoparticle scaffolds with fiber structure 
(Fig. 3.8 b,c).However, the co-assembled composite gels with additional peptides at 
concentration from 5.5 mg/mL to 22 mg/mL appear that assembled nanoparticles are 
embedded into peptide layers without apparent 3D network structure after washed with 
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deionized water (Fig. 3.10 a,b,c), even though the membrane is stably stick onto silicon 
wafer surface. Again, the conversion to amorphous aggregation morphology is caused by 
water washing due to high water solubility of the designer peptides (P1 and P2). This is 
evidenced by comparing the morphology change of the co-assembled composite gel with 
22 mg/mL of peptides before and after washing with deionized water, and air dried or 
dried under reduced pressure (Fig. 3.10 c compared with d,e,f). It is shown that the 
co-assembled composite gel membrane is amorphous aggregation without any 3D 
network structure (Fig. 3.10c) if washed deionized water and air dried, but Figure 3.10 
d,e,f clearly show the 3D fibrous structurewith somewhat film structure if without 
washing and dried under reduced pressure. 
Interestingly, there are several new features from this co-assembled composite gel 
scaffoldwith total peptide concentration at 22 mg/mL comparing with other reported ionic 
complementary peptide nanofiber scaffold. At first, it shows fiber structure 
withmicroscale diameter, much larger than conventionalself-assembling peptide 
nanofiber (29), even though our co-assembled fiber diameter is not in uniform size. 
Secondly, the single fiber length is ranging from tens to hundreds micrometer, also much 
longer than traditional peptide nanofibers with length from hundreds nanometer to 
several micrometers (29). Thirdly, the 3D scaffolddominant structure is from 
self-assembling peptide scaffolds but with microscale porous structure, no apparent 
nanoparticle scaffolds is visible from both FESEM images. This is considered that 
peptide-functionalized nanoparticles are effectively co-assembled with host peptides and 
uniformly distributed in peptide scaffolding system. These new features probably will 
expand the peptide scaffold applications where requires larger porosity with longer 
diameter, ease of multiple drug loading capability and controlled release rate of each 
drug. 
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3.3.6 Controlled release test of multi-drug models 
The purpose of this project is to design self-assembled polymeric nanoparticle 
scaffolds with the ability to load different types of drugs allowing for controlled release 
for each drug. In prior work insulin was used as macromolecular model drug and loaded 
into nanoparticle scaffolds (0.15 wt.% loading quantity) without destroying the 
self-assembled structure. This system showed sustainable release over 3 weeks (26). To 
further study multi-drug loading abilities and the simultaneous sustainable release of each 
drug, several compounds with different properties are used as model drugs and loaded in 
nanoparticle scaffolds, and the controlled release was tested. The compounds were DBF 
as a hydrophobic small molecule model, nitrofurazone as a less hydrophobic small 
molecule model and amoxicillin as hydrophilic small molecule model drug.  
The theoretic and actual loading levels of the model drugs in each type of 
nanoparticles are summarized in Table 3.3 and Table 3.4. The cumulative release of each 
model drug from the self-assembled nanoparticle scaffolds is shown in Figure 3.11. 
 
(a) 
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(b) 
 
(c) 
Figure 3.11. Cumulative release (wt.%) of model drugs from self-assembled nanoparticle 
scaffolds with different particle size and composition.(a) Cumulative release of DBF from 
various assembled scaffolds; (b) Simultaneous cumulative release of nitrofurazone from 
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self-assembled scaffolds; (c) Simultaneous cumulative release of amoxicillin from 
self-assembled scaffolds. 
DBF is first used as hydrophobic small molecule model drug and loaded in both 
P1-NP-P1 and P2-NP-P2 to perform controlled release test over 3 weeks from 
self-assembled scaffolds to determine long release period. The theoretical loading 
quantity is set up to 0.2 wt.% and high loading efficiency is achieved between 85 to 95% 
for these hydrophobic small molecules. The releasing profile in Figure 3.11a shows only 
1.5 to 5.5 wt.% of DBF released from scaffold over 3 weeks, and smaller nanoparticles 
generally released more quickly than bigger ones, except S-3  showing faster than from 
S-2 (Table 3.3, S-3 has bigger particle size than S-2). 
Simultaneous loading of multiple drugs and governing release rate of each drug from 
same scaffold is one of the main objectives of this project. Here we use nitrofurazone 
(less hydrophobic small molecule) and amoxicillin (slight water soluble hydrophilic small 
molecule) as model drugs to load in P1-NP-P1 and P2-NP-P2 separately, and then couple 
these two peptide-functionalized nanoparticles to self-assemble into scaffold to perform 
simultaneous controlled release test of both drugs from same scaffold. For these two 
model drugs, the theoretical loading quantity is increased to 5.0 wt.% with actual loading 
efficiency ranging from 58 to 94 % for nitrofurazone and from 24 to 32% for amoxicillin. 
Again, the high loading efficiency for less hydrophobic small molecules (nitrofurazone) 
is still achieved though the loading quantity is increased to 5.0 wt.%. While loading 
efficiency for hydrophilic small molecule (amoxicillin) is relatively reduced due to its 
water solubility. 
Figure 3.11 b,c show the simultaneous releasing profiles from the self-assembled 
nanoparticle scaffolds. Two main results can be read from their releasing profiles: (1) 
Hydrophilic molecules (amoxicillin) release more quickly than hydrophobic molecules 
(nitrofurazone); (2) The general trends are that smaller nanoparticles release drugs more 
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quickly than bigger nanoparticles (S-1>S-2>S-3),where hydrophobic core (PMMA) is 
increased for these nanoparticle scaffolds, except nitrofurazone released from S-3 showed 
inverse trend (Fig. 3.11 b).  
While comparing release behavior of nitrofurazone and amoxicillin from S-2 and S-4 
(self-assembled from peptide-functionalized PVP-b-3PMMA-b-PVP and 
PHEMA-b-3PMMA-b-PHEMA), the nanoparticle composition of hydrophilic shell is 
changed, but the particle size is very close, the releasing behavior shows significant 
difference.  It appears that hydrophilic shell of PHEMA enhanced amoxicillin release 
rate, but reduced nitrofurazone release. This is most likely due to hydrogen bonding 
interaction with drugs from hydroxyl groups of PHEMA shell, while PVP shell does not 
possess such groups. This means the shell property is another factor to govern release rate 
of drugs with different hydrophilicity, but not only be controlled by hydrophobic core 
domain and particle size. 
Even though the detailed release rate of drugs from core-shell nanoparticles is 
complexly influenced by several factors, such as drug properties, actual loading quantity, 
core-shell ratio, porous structure and shell properties, the basic principle is that 
hydrophobic molecules (i.e. DBF and nitrofurazone) prefer to be encapsulated into 
hydrophobic core (i.e. PMMA) of the self-assembled core-shell polymeric nanoparticles, 
while hydrophilic molecules (i.e. amoxicillin) are more likely to be captured in 
hydrophilic shell (i.e. PVP or PHEMA). So the general trends are that the bigger 
hydrophobic core domain more easily encapsulates with hydrophobic molecules, while 
the hydrophilic molecules are more likely to be captured in more hydrophilic shell 
domain. The releasing rate of hydrophobic drugs (i.e. DBF or nitrofurazone) is mainly 
governed by diffusion through hydrophobic core to hydrophilic shell and then entering 
into aqueous media, so that they release more quickly from smaller nanoparticles than 
bigger ones. While the hydrophilic drugs (i.e. amoxicillin) are mostly captured in 
116 
 
hydrophilic shell and thus have shorter diffusion route to aqueous media, showing higher 
releasing rate, but release rate can be affected by both diffusion speed and molecular 
interaction force with shell functional groups. 
3.3.7 Cytotoxicity test with NIH3T3 cell lines 
The cytotoxicity test of the self-assembled scaffolds with different particle size and 
composition was conducted by incubating Fibroblast cells (NIH3T3 cell lines) with 
self-assembled nanoparticle scaffold membrane (~500 g for each scaffold membrane) in 
each glass culture dish with cell media in a humidified incubator with 5% CO2 at 37 C. 
The cell growth behavior was monitored by optical microscopy observation every 24 h 
with total testing period for one week. At 72 h, the optical microscopy images of the cell 
proliferation status in each culture dish were recorded and the results are shown in Figure 
3.12. 
 
  
(a)                              (b) 
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(c)                               (d) 
Figure 3.12. Cytotoxicity tests of an assembled scaffold membrane with Fibroblast cells 
in a glass culture dish. The micrographs were recorded after incubating for 72 h in a 
humidified incubator with 5 % CO2 at 37 C. The nanoparticle scaffold samples in each 
culture dish are: (a) S-1 from P1-NP1-P1and P2-NP1-P2; (b) S-2 from P1-NP2-P1and 
P2-NP2-P2; (c) S-3 from P1-NP3-P1and P2-NP3-P2; (d) S-4 from P1-NP4-P1 and 
P2-NP4-P2 (see Table 3.3). Scale bar 100 m. 
 
Figure 3.12 shows that the nanoparticle scaffold membranes, prepared with different 
particle sizesand copolymer compositions (S-1 to S-4, Table 3.3) showedno toxicity nor 
did they inhibit fibroblast cell growth at concentrations of ~500 g scaffold/5 mL cell 
media. All theself-assembled scaffold membrane remained stable in the cell media 
throughout the incubation period, except S-3 (assembled from P1-NP3-P1 and 
P2-NP3-P2, Fig. 3.12 c), which broke down into small pieces after incubating 72 h in cell 
media. However, optical microscopy images also showed that the fibroblast cells did not 
effectively adhere to this membrane surface for migration and proliferation. 
In order to improve cell adhesion to membrane surface, we tried to physically 
incorporate cell adhesion peptides (RGDS) into nanoparticles and then self-assemble into 
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2D membrane for cell tests.Here we loaded peptides (RGDS, 1 wt.%) in nanoparticles of 
both P1-NP2-P1 and P2-NP2-P2, and P1-NP4-P1 and P2-NP4-P2 (Table 3.3), to 
self-assemble into RGDS-loaded S-2 and S-4. The peptide-loaded scaffold membrane 
was similarly prepared and incubated with fibroblast cells in a humidified incubator for 1 
week with optical microscopy observation every 24 h.  Figure 3.13 shows optical 
micrographics taken after incubating 108 h.Again, both scaffold membrane did not show 
toxicity or inhibition to cell growth with stable structure. But unfortunately, our study 
shows that physical incorporation of cell adhesion peptides in nanoparticle scaffold did 
not apparently improve cell adhesion efficiency to membrane surface. 
 
(a)                          (b) 
Figure 3.13.  Fibroblast cell proliferation and migration on self-assembled nanoparticle 
membrane surface after the nanoparticle was physically incorporated with cell adhesion 
peptides (RGDS). (a) S-2 self-assembled from P1-NP2-P1 and P2-NP2-P2; (b) S-4 
self-assembled from P1-NP4-P1 and P2-NP4-P2. 
 
3.4 Conclusion 
A novel type of self-assembled fibrous nanoparticle scaffolding system was 
demonstrated that employs peptide-functionalized polymeric nanoparticles that 
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self-assemble into continuous ‘nanoparticle-fibers’ in aqueous solution. This type of 
nanoparticle scaffold possesses all the advantages of nanoparticles’ abilities to contain 
and control the release of active ingredients (demonstrated here with model hydrophobic 
and hydrophilic drugs) with the ability of peptides to assemble into controlled 1D, 2D, 
and 3D structures. Combining these capabilities into a single “device” allows the 
simultaneous incorporation of multiple drugs, each with the desired quantity and release 
rate appropriate for that drug, along with the ability to obtain a uniform distribution of 
these drugs in a scaffolding system, or if desired a non-uniform distribution, and couples 
these abilities with the flexibility of hydrogel scaffold if desired. The porosity of the 
nanoparticle scaffolds, and the release rate of incorporated drugs, can be controlled by 
adjusting polymeric nanoparticle size and composition. This can be accomplished by any 
controlled polymerization route, but was done hereby RAFT polymerization. The 
versatility of this fundamental technique can be expanded to other biocompatible 
amphiphilic copolymers as long as it contains reactive end groups that are able to couple 
with ionic complementary peptides. This system can also co-assemble with host ionic 
complementary peptides to form nanoparticle-peptide composite gel scaffolds, which can 
further broaden the applications of polymeric controlled drug delivery system and peptide 
nanofiber scaffolds for tissue engineering. Our studies show that optimization of the 
scaffold surface is required to improve cell adhesion to nanoparticle surface s, which can 
be accomplished by immobilizing cell adhesion ligands on polymeric nanoparticle 
surfaces. In this work we also noted that the designer peptide self-assembly is easily 
converted into an amorphous aggregate after washing with aqueous solution, which was 
due to an overly water-soluble peptide structure, so alternative designer peptides can be 
designed with less solubility to increase the mechanical stability and lower the critical 
concentration to form stable self-assembled peptide nanofibers with enhanced mechanical 
strength. 
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Main Findings in This Chapter: 
Amphiphilic triblock copolymers were synthesized by RAFT polymerization using 
BDAT as CTA. These amphiphilic copolymers were shown to self-assemble into 
core-shell nanoparticles, tobe functionalized with ionic complementary peptides (P1 and 
P2), and then to undergo furtherself-assembly into fibrous nanoparticle scaffolds with 
porosity and morphology depending on nanoparticle size. The nanoparticle scaffolds 
were prepared with different model drugs that were hydrophobic and hydrophilic, and 
that could be loaded into different sets of peptide-functionalized nanoparticles and 
self-assembled into nanoparticle scaffolds. Controlled release tests showed simultaneous 
release with different releasing rates from the scaffolding system, and that the releasing 
rate of these model drugs were effectively governed by particle size and composition. The 
peptide-functionalized nanoparticles can also co-assemble with host ionic complementary 
peptides (P1 and P2) to form composite peptide hydrogels, showing uniform distribution 
of nanoparticles in peptide hydrogel scaffolds with microscale diameter and in a fiber 
length that is hundreds ofmicromemters long, which is much larger scale than traditional 
peptide nanofiber scaffolds. The designed nanoparticle scaffolds with different particle 
size and shell composition demonstratedexcellent biocompatibility with NIH3T3 
fibroblast cell lines and also possessed excellent stability in cell media throughout the cell 
test period. 
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Abstract 
A simple, one-step and one-pot method was used to synthesize amphiphilic 
self-assembling chitosan-g-PMMA nanoparticles (~100 nm diameter by SEM, but 
~150-200 nm in water by DLS), containing ~25-28 wt% (~82–93% capture efficiency) of 
the fungicide tebuconazole. The matrix composition was selected to be environmentally 
low impact, while the nanoparticle preparation conditions were designed to ensure the 
nanoparticles sufficiently small to be able to penetrate the pit-pores of solid wood. These 
nanoparticles were delivered into southern pine sapwood blocks at target fungicide 
retentions of 0.2, 0.4 and 0.8 kg tebuconazole/m3 wood. SEM analysis of a 1919455 
mm nanoparticle-treated wooden stake confirmed penetration throughout the interior of 
the treated stake. Leaching studies confirmed that biocide introduced into sapwood via 
nanoparticle carriers leached only about 9% as much fungicide as solution-treated 
controls, while soil jar tests showed the nanoparticle-treated wood blocks effectively 
protected the wood from biological decay when tested against G. trabeum, a brown rot 
fungus.  
 
Keywords: controlled release, chitosan-g-PMMA nanoparticle, amphiphilic nanoparticle, 
core-shell structure, tebuconazole, biocide leach 
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4.1 Introduction 
Amphiphilic block and graft copolymers are routinely used to prepare 
self-assembling core-shell nanoparticles. Such copolymers are readily prepared from 
synthetic polymers, biopolymers, or combinations of both (1-8). Polysaccharides and 
proteins are well-suited for preparing grafted amphiphilic copolymer nanoparticles 
because of the large number of polymerizable groups they possess along their backbone. 
Chitosan is possibly the most commonly selected polysaccharide for grafted 
amphiphilic copolymer nanoparticles. Its repeat units bear either a primary amine group 
or an amide group if that unit is not hydrolyzed. The large number of amine groups can 
be utilized in either grafting-to or grafting-from reactions. A recent review describes the 
synthesis, properties, and uses of many different chitosan amphiphiles (8,9). One 
“grafting from” reaction uses these amines to react with peroxides under mild conditions 
yielding amine radicals that can efficiently react with hydrophobic monomers to form 
amphiphilic core-shell nanoparticles (1). 
Chitosan’s biocompatibility, biodegradability, and antimicrobial activity are why it is 
employed in many biomedical and cosmetic applications. A recent review describes the 
synthesis, properties, and uses of many different chitosan amphiphiles (8). However, 
high-value applications still account for most nanoparticle uses, improvements in 
technology as well as consumer trends are allowing nanoparticle uses to penetrate 
commodity areas as well. For example, one recent publication describes amphiphilic 
chitosan micelles for the controlled release of rotenone (9). However, that used a 
multi-step synthesis and the encapsulation efficiency was low. Another report, from 2003 
described controlled release of agrochemicals from chitosan (10), but those were 
microparticles. 
The objective of this project was to study the beneficial effects of using nanoparticles 
in wood preservation. We had previously studied controlled release nanoparticles in solid 
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wood, prepared using synthetic polymers under dilute conditions in a 
solvent-displacement route (11-13). The nanoparticle-treated wood was tested against 
both a brown and white rot fungus, and biological efficacy compared well with the 
solution-treated controls. At that time no work was done to test the biocide leaching.  
The rationale for employing controlled release nanoparticles to deliver organic 
biocides into solid wood was the hypothesis that a controlled biocide release would 
maintain an effective protection of the solid wood and might also reduce biocide leaching 
into the environment. The significance of reducing biocide leaching from treated wood is 
that when biocide leaches from wood it leaves the wood less well-protected from 
biological attack, and the leached biocide can have detrimental effects on the 
environment into which it is released. If less biocide is lost to the environment, then 
potentially the wood could be effectively protected with less biocide, which is beneficial 
to both the environment and to the cost of the preserved wood. In this application solid 
nanoparticles are favored over liquid micelles, which are more easily delivered into wood 
than solid particles, because of the desire to control the biocide release and to avoid the 
use of surfactant. The amphiphilic design is preferred because this allows a hydrophobic 
core composition to be used to manipulate the release rate while the shell can be 
hydrophilic to give a stable suspension in water. The nanometer size, preferably below 
150 nm, is required because of the anatomy of solid wood, where the small size is 
required to penetrate the pit pores to enter into the wood interior.  
Our recent study supported the hypothesis of reduced biocide leach using 
gelatin-g-PMMA nanoparticles (1), but ungrafted gelatin complicated analysis of the  
data, and the gelatin may have promoted biological decay within the wood. The purpose 
of this paper is to prove the hypothesis that decreased biocide leach occurs by use of 
controlled-release nanoparticles, to quantify the decrease in biocide leaching, to show 
that wood preservation is not decreased, and to confirm nanoparticle penetration into 
130 
 
wood interior on larger wood specimens than those used in standard soil jar studies. Here 
we prepared fungicide-containing chitosan-g-PMMA core-shell nanoparticles using the 
grafting approach outlined in Scheme 4.1. Chitosan was selected as the shell material 
despite the fact that the NPs could be prepared at only ~2-5 wt% polymer solids in an 
aqueous medium containing acetic acid, because it was speculated that chitosan might 
enhance wood preservation, while gelatin, which can be used to prepare nanoparticles by 
this approach at 10 wt% solids appeared to contribute to biological decay and made 
analysis more difficult. 
 
Scheme 4.1. Synthetic route producing self-assembled chitosan-g-PMMA nanoparticles. 
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4.2 Experimental Part 
4.2.1 Materials  
Chitosan (~ 70% deacetylation) from crab shell was donated by Cochin University of 
Science and Technology (Cochin, India). Tebuconazole fungicide was donated by 
Lanxess Corporation (Pittsburg, PA). Methyl methacrylate (MMA, 99.0%) and 
2-hydroxyethylmethacrylate (HEMA, 97%) were from Sigma Aldrich (Milwaukee, USA) 
and were distilled prior to use. Ammonium persulfate (APS, 95%) and benzophenone 
(99%) were from Mallinckrodt Chemical Works (St. Louis, USA) and Sigma Aldrich, and 
were used as received. Fungal tests used Gloeophyllum trabeum (ATCC 11539), a 
basidomycete brown rot wood decay fungus. Wood blocks were 19x19x19 mm, unless 
otherwise noted, and were cut from southern pine sapwood in the MTU School of Forest 
Resources and Environmental Science. 
4.2.2 Preparation of Nanoparticles 
Nanoparticles were prepared using a modification of the methods reported by Li (14) 
and Qian (15). Briefly, chitosan was dissolved in deionized water (DI H2O) containing 
acetic acid (0.67 g acetic acid/g chitosan). For example, 0.5 g chitosan was dissolved in 
0.43 wt% AcOH to give 75 mL of solution at 50 C. The reaction solution was purged 
with nitrogen gas for 0.5 h prior to the addition of MMA (MMA to Chitosan 2:1 w/w). 
The total concentration of chitosan and MMA ranged from 1-5 % w/w. Tebuconazole (30 
w% based on the combined mass of chitosan and MMA) was dissolved in about 5 mL of 
acetone and then added dropwise to the reaction solution under magnetic stirring. After 
mixing for 10 min, the reaction temperature was increased to 70 C. APS (0.037% w/v), 
dissolved in a small amount of deionized water, was then added to initiate the grafting 
reaction. The reaction was kept at 70 C with magnetic stirring at 400 rpm for 24 h. This 
procedure was also used to prepare nanoparticles without tebuconazole by skipping the 
tebuconazole addition step. The yield of chitosan-g-PMMA NPs without tebuconazole 
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ranged from ~ 94-99% with a grafting efficiency of ~ 74-87%. 
4.2.3 Nanoparticle Size 
The particle size of as-made nanoparticles was determined (in aqueous suspension) 
by Dynamic Light Scattering (Coulter NP4 Plus, Beckman Coulter, Fullerton, CA) and by 
SEM (Shimadzu QP5050A, Shimadzu Corporation, Germany) using freeze-dried 
nanoparticles. 
 
4.2.4 Nanoparticle Composition 
Nanoparticle composition (without tebuconazole) was determined by gravimetric 
analysis. The as-made nanoparticle suspension was collected, gently heated to evaporate 
most solvent, and then vacuum dried at 50 C for 48 hrs. The dried NPs were extracted 
with 315 mL of chloroform to separate any PMMA homopolymer, and then 320 mL of 
warm deionized water containing 0.67 g acetic acid to separate any ungrafted chitosan. 
The extracts were vacuum dried at 50 C for 48 hrs to obtain the mass of PMMA and 
ungrafted chitosan. The residual mass was chitosan-g-PMMA.  
 
4.2.5 Tebuconazole Content in Nanoparticles 
An aliquot of the tebuconazole-containing nanoparticle suspension was weighed, 
gently heated to remove most solvent, and then vacuum dried at 50 C for 48 hrs to get 
the initial mass of tebuconazole-containing NPs. The tebuconazole component was 
extracted from the dried NPs using 315 mL of ethanol, and the combined extracts were 
then vacuum dried at 40 C to get the tebuconazole mass. The solid extracts were 
confirmed to be pure tebuconazole by 1H NMR. The calculation of the actual content of 
tebuconazole in NP suspension and the needed amount of the as-made NPs suspension to 
treat wood blocks by pressure-treatment is shown in equations (1) and (2):  
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4.2.6 Delivery Efficiency into Wood Blocks 
Wood blocks were submerged in alcohol for 24 hrs to remove some soluble 
extractives and wood sawdust near the surface pores, which would interfere with GC-MS 
analysis and gravimetric analysis. Then wood blocks were treated with NP suspensions in 
accordance with procedures given as the standard method in Wood Pressure Treatment 
(AWPA E11-97) (16). The quantity of as-made nanoparticle suspension needed to deliver 
target retentions of 0.2, 0.4 or 0.8 kg tebuconazole/m3 wood, assuming quantitative 
delivery, was taken and diluted to 90 mL. The 90 mL volume was required to sufficiently 
cover 6 wood blocks having dimensions of 19x19x19 mm when these blocks were placed 
in a beaker. The wood blocks were covered with a plastic mesh and aluminum blocks to 
keep them submerged throughout the treatment process. The beaker was then transferred 
into the pressure cylinder and subjected to a pressure treatment consisting of a partial 
vacuum of less than 25 mmHg for 0.5 h, followed by pressurization to 100 psi for 1 h. 
Specimens were removed, and the remaining suspension was transferred into a 
pre-weighed aluminum dish and heated to dryness to determine the NP mass that was not 
absorbed by wood. Because some extractives are absorbed into the suspension during the 
wood treatment, a measurable residue also results from treating wood “blanks” with  
water. Therefore the measured mass from wood “blanks” is used to adjust the undelivered 
mass from the NP-treated wood specimens. Therefore the delivery efficiency percentage 
is calculated as:  
 (3)  % Delivery = [(dry NP mass in wood – average mass loss from blanks)/initial dry 
NP mass] x 100  
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4.2.7 Leaching Tests 
The leaching test was performed according to The American Wood Preservers 
Association Standard (AWPA E11-97) (16).The leachate was collected in a beaker and 
heated at 80 C to remove water, and then acetone was added to the dried leachate. The 
beaker was sealed for 3 hrs to completely extract the tebuconazole from the leachate. 
Then the acetone solution was transferred to a volumetric flask and a known quantity of 
benzophenone was added to the solution for use as an internal standard to allow a 
quantitative analysis by GC-MS. 
4.2.8 GC-MS Analysis 
AGas Chromatograph/Mass Spectrometer (Shimadzu 5050A, Shimadzu Corporation, 
Germany) equipped with a programmed-temperaturevaporizer was used to measure the 
amount of leached tebuconazole collected as described. MS withelectron-impact (EI) 
ionization (electronenergy 70 eV) was performed in selectedion monitoring (SIM) mode. 
The injection temperature and volume were 280 C and 1 L, which was 100% delivered 
into chromatography column under a flow rate of 1 mL He/min as the carrier gas. The 
oven temperature, initially at 50 ˚C, was raised to 100 C and held for 3 min to remove 
solvent. Then the MS detector began to identify the analyte while ramping the 
temperature at 10 C/min, and finally holding 5 min at 325 C to remove possible 
residues in column. The quantitative analysis was based on the peak areas from mass 
chromatograph. The internal response factor (IRF) was firstly identified by a standard 
solution with a known amount of tebuconazole (TEB) and benzophenone (BEN). The 
IRF was calculated according to equation 4: 
(4) 
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After determining the IRF, the leached tebuconazole amount could be calculated based on 
the internal standard method according to equation 5. 
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4.2.9 Soil Jar Decay Test 
Treated southern pine wood blocks (19x19x19 mm) were dried at 40 ˚C for 24 h. The 
mass was measured to ± 0.005 g. All blocks were exposed to the brown rot fungus, 
Gloeophyllum trabeum ATCC 11539 for 12 weeks. Decay testing was done using 
American Wood Preservers Association (AWPA) testing method E-10-07, "Standard 
Method of Testing Wood Preservatives by Laboratory Soil Block Cultures”. 
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4.3 Results and Discussion 
4.3.1 Study of Reaction Conditions 
 NP diameter typically shows a strong dependency on the concentration of the 
medium in which they are made regardless of if they are made by reaction, 
solvent-displacement or precipitation. To be used as controlled release devices in solid 
wood an NP diameter below 150 nm was desired for good penetration into the wood 
interior. Consequently, the first study tested the effect of the reaction concentration on NP 
diameter (Fig.4.1). Because the NPs will be introduced into the wood in aqueous  
medium, the diameter of the water-swollen NPs will affect their ability to penetrate the 
wood interior. Figure 4.1 shows the particle size of the water-swollen NPs, measured by 
DLS, of chitosan-g-PMMA NPs (designated C2M, indicating that the polymer matrix 
was made using a mass ratio of 2 parts of MMA to 1 part chitosan) after 24 h of reaction 
at concentrations, based on polymer solids. The polymer solids concentration ranged 
from 1.5 up to 5 wt% in acidic H2O (0.43 wt% AcOH). The results show that a 
concentration of 2 wt% or less is required to afford nanoparticles with a water-swollen 
diameter below 200 nm. The C2M water-swollen diameter was ~167±56 nm and 
typically increased by ~20-30 nm when prepared with biocide. Therefore, 2 wt% C2M in 
D.I. H2O was used as the maximum acceptable concentration for these studies, although 
the diameter was larger than desired. 
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Figure 4.1. Particle size (by DLS) of C2M NPs as a function of reaction concentration. 
The particle size can be decreased by increasing the protonation of the chitosan 
amine groups (by increasing acetic acid from 0.67g to 2.0 g/g chitosan). At either 
concentration of acetic acid the diameter of the NPs can be further decreased by 
sonication. For example, the final NP diameter of C2M NPs made at 0.67 g of acetic acid 
per gram of chitosan resulted in decreasing the diameter from 167±56 nm to 132±48 nm. 
Interestingly, the NP diameter was not significantly altered by the ratio of the MMA to 
chitosan in the range we studied (1, 2 or 3 parts MMA to 1 part chitosan).  The NPs with 
1, 2, and 3 parts of MMA to 1 part of chitosan (CM, C2M, and C3M respectively), 
prepared at 2 wt% increased by ~ 22 nm as MMA content increased from 1:1 to 3:1 with 
respect to chitosan.  
Interestingly, changing the ratio of MMA to chitosan does not significantly affect 
particle size, though it does increase the extent of PMMA homopolymer, as shown in 
Figure 4.2. The increase in the extent of homopolymerization is coincident to a slight 
decrease in the extent of grafting to chitosan. The amount of ungrafted chitosan is 
relatively constant. The ungrafted chitosan is probably the major contributor to the 
water-swollen diameter of the nanoparticles, which are typically ~50-100 nm larger than 
the diameter observed by SEM.  
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Figure 4.2. Composition of CM, C2M, and C3M NPs (142±60, 167 ±56 and 166±51 nm, 
respectively when prepared at 2 wt% in 75 mL D.I. H2O with 0.43 wt% AcOH). 
 
4.3.2 Characterization of Fungicide-Containing Nanoparticles  
In the second study the amount of tebuconazole introduced into the NPs and the 
effect of the tebuconazole on NP diameter was determined. In this work we arbitrarily 
selected a target tebuconazole quantity to be 30% of the final NP mass. Table 4.1 shows 
that the tebuconazole is incorporated at ~93% yield. This high incorporation efficiency of 
the water-insoluble biocide supports the conclusion that this polymerization does not 
follow an emulsion polymerization route, but proceeds in a micellar route, leading to a 
final solid NP. The final suspension, after sonication, affords water-swollen 
C2M-tebuconazole NPs of ~150 nm. 
One important advantage of using this radical grafting approach to amphiphilic 
copolymer NPs is that it is easy to “tune” the core composition from hydrophobic (only 
MMA) to increasingly hydrophilic by increasing the HEMA content. Even small changes 
in core hydrophilicity can alter the biocide release rate, which is diffusion controlled. 
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Here the core composition was changed slightly by replacing 2 wt% of MMA monomer 
with HEMA monomer, giving C2MH NPs. The results, shown in Table 4.1, show the 
water-swollen C2MH-tebuconazole NPs have a larger diameter than that found for 
C2M-tebuconazole NPs (189±74 compared to 149±57 nm). However, SEM found no 
significant difference in the average diameter of these NPs. The tebuconazole 
incorporation efficiency remained high, but was less than that obtained for C2M NPs, 
down from ~93% to ~82%. This indicates that increasing the hydrophilicity of the system 
compromises the efficiency of the micelle “capture” of tebuconazole. Again, the high 
entrapment efficiency shows that this polymerization proceeds by a micellar route (17) 
rather than a typical emulsion route. That is, the biocide was present within a 
chitosan-stabilized micelle together with the acrylic monomer(s) at the start of the 
polymerization. Possibly the HEMA content allowed more tebuconazole to be retained in 
the shell and this was lost during NP isolation. 
 
Table 4.1. NP size and tebuconazole content in C2M and C2MH NPs 
Sample 
NP size,nm 
(DLS/SEM) 
NPs 
(g) 
Tebuconazole 
(g) 
Tebuconazole, 
wt% 
(Theo./Actual) 
C2M-30% Teb. 149±57/100~150 0.3500 0.0972 30.0 / 27.8 
C2MH-30%Teb. 189±74/100~150 0.5100 0.1257 30.0 / 24.6 
 
4.4. Wood Leaching and Wood Preservation 
4.4.1 Nanoparticle delivery into wood blocks 
Aqueous suspensions of tebuconazole-containing C2M and C2MH NPs (C2M-Teb 
and C2MH-Teb) were prepared and used to pressure-treat southern pine sapwood blocks 
according to the standard method of wood pressure treatment (AWPA E11-97) (16). The 
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delivered NP mass was determined by measuring the undelivered mass, and the retention 
of tebuconazole in the wood blocks was calculated from the absorbed NP mass, as 
described in the Experimental. The results are shown in Table 4.2.  
Table 4.2.Nanoparticle delivery and tebuconazole retention in wood blocks. 
Sample 
Target retention 
Kg Teb/m3 
Delivery 
Efficiency % 
Actual retention Kg 
/m3 
C2M-TEB. 
0.20 66.1 0.13 
0.40 59.9 0.24 
0.80 54.7 0.44 
    
C2MH-TEB. 
0.20 68.5 0.14 
0.40 55.7 0.22 
0.80 56.6 0.45 
    
TEB.Control 
0.20 100 0.20 
0.40 100 0.40 
0.80 99.4 0.795 
 
Previous studies with nanoparticle-treated southern pine sapwood (1,11-13) showed 
good biological efficacy and good penetration, but treatment was limited to 19x19x19 
mm blocks. One of the objectives of this work was to further prove good penetration of 
wood, using large wooden “field” stakes (1919455 mm). Several stakes were treated 
and sectioned to verify penetration of the wood interior is achieved even on larger 
wooden parts.  
Figure 4.3 a shows an image of a treated field stake. Despite NP aggregates reducing 
delivery efficiency, good penetration of the wood stake was achieved as shown by 
FESEM images (Fig. 4.3 b and 4.3 c) showing interior sections. Figure 4.3 b shows a 
region deep in the interior of the wood stake while Figure 4.3 c shows a section nearer 
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the surface. 
 
(a) 
 
  
(b)                            (c) 
Figure 4.3. A wooden stake after NP treatment is shown, with a central section indicated 
(a, top); after the indicated central section is cut, then specimens suitable for FESEM are 
taken from two locations, one deep in the interior (b, bottom left) and from near the 
surface (c, bottom right). 
 
4.4.2 Leaching from wood blocks 
The primary purpose of this work was to prove the hypothesis that use of 
controlled-release biocide-containing NPs will reduce biocide leaching without 
compromising wood preservation. Wood blocks were treated to give theoretical 
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biocide-retentions of 0.2, 0.4, and 0.8 kg tebuconazole/m3 sapwood. Figure 4.4a-b shows 
the measured biocide leach from solution-treated tebuconazole controls with leach from 
wood treated with C2M-TEB and C2MH-TEB NPs at theoretical loadings of 0.4 and 0.8 
kg/m3 wood respectively. In both cases the solution-treated control leached significantly 
more tebuconazole than the nanoparticle-treated wood, and the C2MH-TEB 
nanoparticle-treated wood leached more tebuconazole than the C2M-TEB 
nanoparticle-treated wood.  
Based on the cumulative leach the C2MH-TEB treated wood typically leached about 
two to three times the amount of tebuconazole as the C2M-TEB treated wood. Because 
the retentions of the C2MH-TEB and C2M-TEB treated sapwood were similar the 
leaching data are comparable with each other, but not with the solution-treated  
specimens. Therefore, Figure 4.4 c re-plots the leach data for TEB-solution treated wood 
with the nanoparticle-treated wood, where the actual retentions are all close to 0.4 kg/m3. 
Figure 4.4c plots the leach from a TEB-solution treated wood with an actual 
tebuconazole content of 0.4 kg/m3, on the same axes as the C2MH-TEB and C2M-TEB 
nanoparticle-treated wood systems (0.8 kg/m3 target retention) with actual retentions of 
0.45 and 0.44 kg/m3 respectively. Despite the nanoparticle-treated wood having higher 
tebuconazole retentions than the solution-treated control, it releases ~2300 µg of 
tebuconazole compared to ~200 µg for the C2M-TEB treated wood, and yet, which 
means that the C2M-TEB treated-wood leached less than 9 % of the amount of biocide 
compared to the solution control, and, as the next section shows, did not sacrifice wood 
preservation based on results from a soil jar test. 
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(a) 
 
(b) 
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(c) 
Figure 4.4. Cumulative leaching quantity of a.i. from wood blocks treated with TEB 
solution control, C2M-TEB and C2MH-TEB NP formulations. 
 
4.4.3 Wood Preservation Efficacy By Soil Jar Decay Test 
Soil jar decay tests were performed on already-leached wood blocks treated with 
C2M-TEB and C2MH-TEB NPs and a solution treated tebuconazole control, according 
to the AWPA standard method. The decay test results are shown in Figure 4.5. 
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Figure 4.5. Weight loss of leached southern pine sapwood from soil jar decay tests. 
Theoretical retentions were 0.2, 0.4, and 0.8 kg tebuconazole/m3 wood. For 0.2 kg/m3 
wood actual tebuconazole retentions were 0.2, 0.13, and 0.14 kg/m3 for TEB, C2M-TEB, 
and C2MH-TEB respectively. For 0.4 kg/m3 wood actual tebuconazole retentions were 
0.4, 0.24, and 0.22 kg/m3 for TEB, C2M-TEB, and C2MH-TEB respectively. For 0.8 
kg/m3 wood actual tebuconazole retentions were 0.795, 0.44, and 0.45 kg/m3 for TEB, 
C2M-TEB, and C2MH-TEB respectively. 
 
The weight loss of the C2M controls (wood treated with C2M nanoparticles that 
contain no biocide) may be slightly greater than the untreated pine controls when the 
nanoparticle “blanks” are introduced at higher levels. If this difference is real than 
chitosan, like gelatin, may slightly promotes fungal decay by G. trabeum, but the 
standard deviations are high, so the trend is not definitive. The weight loss for the 
tebuconazole-containing nanoparticle treated specimens show no significant difference in 
the preservation efficacy at any retention with any formulation except the C2MH-TEB 
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treated wood at a theoretical retention of 0.2 kg/m3, but with actual retention of 0.14 
kg/m3. Therefore, the tebuconazole introduced in controlled-release NPs retain efficacy 
against G. trabeum, and does so with substantially less leach than tebuconazole 
introduced in solution. 
4.5 Conclusion 
A simple, efficient, and versatile one-step route was used to prepare self-assembling 
and biocide-containing core-shell nanoparticles from chitosan grafted with acrylic 
monomers. The method gives high biocide capture efficiency and a high yield of 
nanoparticles (~150 nm) that can be delivered into southern pine sapwood. SEM 
investigation of nanoparticle-treated field stakes showed nanoparticles penetrated 
throughout the wood interior. The biocide-containing nanoparticles, C2M-Teb, captured 
93% of the available biocide during their preparation, effectively protected sapwood from 
biological attack, and showed only ~9% of the biocide leach as wood blocks treated with 
a tebuconazole solution. Using this method the nanoparticles’ core composition can be 
manipulated by replacing portions of MMA with other acrylic monomers during the 
nanoparticle synthesis. This allows the core composition to be appropriately “tuned” for 
other biocides. When just 2% of the MMA was replaced with HEMA the nanoparticles 
possessed a more hydrophilic core, resulting in slightly larger nanoparticles. The wood 
blocks treated with these nanoparticles leached much more biocide than the C2M 
nanoparticle-treated wood, but it was still only ~26% of the biocide leached by the 
solution-treated tebuconazole control wood blocks. This shows that very small changes in 
the core-composition can effectively tune biocide release and minimize biocide leaching. 
The results demonstrate this method can efficiently incorporate the biocide, significantly 
reduce biocide leach without compromising wood preservation, and the core-composition 
is easily altered to allow the nanoparticles to be “tuned” appropriately for other organic 
biocides. 
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Main Findings in This Chapter: 
The biocide-loaded chitosan-g-PMMA nanoparticlesfor low leaching wood 
preservation were prepared by one-pot synthesis route with biocide capturing efficiency 
as high as 93%. The biocide leached from treated wood via nanoparticle was only 9% 
leached as much quantity as from solution control. The reduced biocide leaching did not 
compromise wood protection efficacy against biological decay. FESEM analysis 
confirmed the nanoparticles effectively penetrated throughout wooden stake with 
dimension of 19x19x445 mm.  High biocide capturing efficiency, controllable release 
rate from nanoparticles, simple and one-pot synthesis route, effective protection efficacy, 
and cost-effective match the market requirements of using nanotechnology for wood 
preservation. 
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Abstract 
Copper-based nanoparticle wood preservatives typically contain a mixture of 
nanoparticle sizes. We wanted to know if nanoparticle size was a significant effect in 
quantity of leach and if the leachate contained nanoparticles. To do this we prepared 
copper oxide nanoparticles with uniform diameters of 10 nm and 50 nm, and measured 
the leachate from southern pine sapwood treated with these nanoparticles. We also 
studied the effect of polymer stabilizers on nanoparticle leaching. It was found that 
significant numbers of nanoparticles leached from the treated wood.  The trends showed 
that nanoparticle size was a major factor in leaching. The 50 nm nanoparticles leached 
slightly less than a soluble copper salt control, but 10 nm nanoparticles leached 
substantially more than the control. Polymer stabilizers increased leaching. The 
cumulative leaching, calculated as % loss of initial Cu2+ retention, was 15.6%, 14.3%, 
and 12.3% Cu2+ for 10 nm nanoparticles stabilized with a slightly acidic stabilizer, a 
slightly basic stabilizer, and unstabilized 10 nm nanoparticles, versus only 6.7% for the 
quaternary ammonium control. An effort to determine if 10 nm nanoparticles had greater 
efficacy against gloeophyllum trabeum brown rot fungus failed due to unexpectedly low 
retention levels. These findings indicate that nanoparticle size is a major factor in 
leaching and that nanoparticles themselves can leach from treated wood.  
 
 
Keywords: biocide, copper oxide, leaching, nanoparticle, wood preservation 
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5.1 Introduction  
Solid wood intended for exterior use must be protected from biological decay by 
treatment with wood preservatives (1). Copper chromated arsenic (CCA) was long the 
dominant preservative used to treat wood for home applications, but as CCA was being 
phased out for use around the home, alternative forms of copper were developed. These 
newer copper-based preservatives, including the so-called “micronized” copper, were 
recently reviewed (2). 
 Soluble forms of copper, such as the ammoniacal copper systems (ACQ, A, B, C, and 
D), copper amine systems and copper azole systems, as well as water-borne and oil-borne 
copper naphthalene systems, are now typically used. However, “micronized” copper 
particle systems are making significant inroads in the wood preservative industry. These 
solid copper salts may be delivered in aqueous suspensions that may include other 
biocide components, along with unspecified polymeric dispersants (2). The term 
“micronized” suggests larger particles, but these commercial systems appear to be much 
smaller with many particles less than 100 nm in diameter (3) so they should more 
properly be termed “nanocopper” systems. For example, Osmose’s copper carbonate 
formulations are thought to be comprised of nanoparticles with an average diameter of 
approximately 80, 120, and 250 nm (4). A formulation with an average diameter of 
approximately 40 nm for “refractory” wood species also exists (5). 
 Use of bioactive nanoparticles has been debated both for concerns about the 
environmental implications and some disagreement about “threshold levels” (minimal 
level required for biological effect) of copper-based nanoparticles. Also, questions remain 
about if these nanoparticles are more effective for protection against fungal attack than 
soluble systems. Copper-based nanoparticles are often claimed to have higher efficacy 
and lower leach than soluble forms of copper wood preservatives. However, the 
published literature on “nanocopper” is somewhat limited and not always in agreement. 
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Different commercial systems tested against Gloeophyllum trabeum report threshold 
values as low as 0.6 kg CuO/m3 wood to as high as 4.2 kg CuO/m3 wood. Some research 
has shown that these copper systems have greater efficacy than traditional soluble copper 
systems, while other research notes that greater efficacy is not observed against all 
species (2). For example, Clausen and co-workers found that copper-based nanoparticles 
(from Nanoarc) were more effective in soil jar tests than soluble copper salts against G. 
trabeum and T. versicolor, but had only similar or less effect when tested against 
Antrodia sp., various species of mold, and termites (Reticulitermes flavipes kollar) (6). 
Some reports using Formosan termites showed similar efficacy between nanoparticle and 
soluble copper systems (2). Environmental concerns with nanoparticle copper systems 
stem largely from uncertainties about the environmental fate of the nanoparticles (4,7-9) 
and awareness of the toxicity of copper oxide nanoparticles to non-target species (10). 
Studies that address biocide leaching from wood treated with nanoparticle copper 
systems appear to be largely confined to the patent literature (11), although published 
studies do address the fate of nanoparticles under various conditions. For example, two 
recent studies described the fate of copper oxide nanoparticles in soils (12,13). Those 
researchers found that the nanoparticles tended to aggregate, but many factors influenced 
their mobility in soils, including dissolved organic matter and ionic strength. Another 
recent publication addressed the fundamental issues affecting the aggregation and 
deposition of engineered nanomaterial in aquatic environments (14). Benn and 
Westerhoff also showed that Ag nanoparticles could leach from socks during washing, 
and that significant differences in leaching occurred based on the type of sock tested, 
which suggested that the manufacturing process strongly influenced nanoparticle 
leaching (15). 
As stated above, toxicity of nanoparticles against different species is also in question. 
For example, antimicrobial activity of different nanoparticles, including CuO, was found 
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against the beneficial soil microbe Pseudomonas putida KT2440. Nano-CuO and 
solvated copper ions both had toxicity against this microbe, but the bulk form (micro 
meters to macro size) of CuO was non-toxic (16). The authors also cited a report that 
claimed that ZnO nanoparticles of 8 nm were more toxic to S. aureus than nanoparticles 
of 50-70 nm (17). 
Outside of the patent literature and abstracts from professional meetings little research 
on leaching of CuO nanoparticles is published. The most detailed information found was 
a review by Freeman and McIntyre (2)that referenced professional meetings and 
workshops, and more recently by Kartal and co-workers (6). These works described 
results from commercial systems with proprietary compositions that were not always 
specific about nanoparticle size. It was also unclear if these formulated systems contained 
additives that had biological activity or that may have enhanced adhesion to wood, i.e. 
“fixation”. If fixation was promoted in these systems the mechanism was likely to be 
based on approaches similar to those in conventional copper systems. Those systems 
often use amines that promote adhesion through chemical interactions with acid and 
phenolic groups of lignin, or use ethanolamine to form a 5-member ring complex with 
solubilized copper ions that also preferentially interact with lignin (2,18).We are not 
aware of reports of nanoparticles themselves being leached from treated wood, but if this 
occurs, it seems that there is a probability of leaching being affected not only by the 
treating composition but also wood species and treating conditions.  
Answering all these questions is beyond the scope of this paper. Our objective here is 
to answer the following basic questions regarding copper-based nanoparticle  
preservatives: does nanoparticle-treated wood leach copper as nanoparticles; if 
nanoparticles are leached is nanoparticle size a factor; do polymer stabilizers affect the 
amount of copper leached; and can extremely small CuO nanoparticles give biological 
efficacy against fungal attack at extremely low levels of treatment?  
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To answer these questions we treated pine sapwood with CuO nanoparticles, 
synthesized using procedures known to give nanoparticles with uniform size (19), and a 
soluble copper salt (ACQ) as a control. We collected and measured leachate by 
standardized methods and used Transmission Electron Microscopy (TEM) to both verify 
the uniformity of nanoparticle size initially, and to check the leachate for the presence of 
CuO nanoparticles. The effect of nanoparticle size on leaching was studied using 10 and 50 
nm CuO nanoparticles. To study the effects of polymer additives on leaching we stabilized 
some CuO nanoparticles with a slightly basic polyvinylpyrrolidone (PVP) and others with 
a slightly acidic modified chitosan. To determine if the nanoparticles have biological effect 
at low “loading” levels of CuO nanoparticles in the treated pine sap wood at levels below 
the typical minimal treatment levels for copper which is often taken as 2 kg Cu2+/m3 of 
wood.  
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5.2 Experimental Section 
5.2.1 Materials  
Poly(vinylpyrrolidone) (Mw ~24,000 g/mol), glycidyltrimethylammonium chloride 
(GTMAC), sodium hydroxide (pellets, 97+ %), copper (II) acetate monohydrate ( 98+ %) 
and acetic acid (99.7+ %) were purchased from Sigma-Aldrich. Chitosan (70% 
deacetylation) was donated by Cochin University of Science and Technology (Cochin, 
India). Copper standard solution (1 mg Cu2+/mL in 2 % HNO3 aqueous solution), H2SO4 
conc. (98.0 %), and hydrogen peroxide (30% aqueous solution) were purchased from 
ACROS ORGANICS, VWR, and Mallinckrodt Chemicals, respectively. All reagents 
were used as received. ACQ solution (15 mg Cu2+/mL) and wood blocks cut to 
dimensions of 19 mm x 19 mm x 19 mm from southern pine sapwood were donated by 
MTU School of Forest Resources and Environmental Science, and was used as received. 
Fungal tests used Gloeophyllum trabeum (ATCC 11539), a basidiomycete brown rot 
wood decay fungus. 
 
5.2.2 Preparation of Water-Soluble Modified Chitosan (HTCC) 
A water-soluble chitosan derivative, [(2-hydroxy-3-trimethylammonium)propyl] 
chitosan chloride (HTCC) was synthesized according to the reported procedure (20), 
where chitosan (3.0 g, ~70% deacetylated) was dispersed in 30 mL of deionized (D.I.) 
water at 85 °C in a round bottom flask equipped with condenser and magnetic stirring  
bar. GTMAC (10.7 mL, 55.5 mmol) was then added to the chitosan suspension in 3 
portions (3.6 mL x 3) at 2 h intervals. The reaction was maintained for 24 h at 85 °C with 
vigorous magnetic stirring. The resulting yellowish solution was diluted with 50 mL of 
D.I. water and allowed to stand for 6 h. The product was collected from the upper layer 
by precipitating in cold acetone. The product was re-dissolved in D.I. water and 
precipitated two additional times to purify it. The solid product was dried under vacuum 
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at 50 °C for 12 h to yield 7.57 g of water-soluble chitosan derivative. Scheme 5.1 shows 
the chemical reaction. 
 
 
Scheme 5.1.  Synthesis of [(2-hydroxy-3-trimethylammonium) propyl] chitosan 
(HTCC), a water-soluble chitosan derivative. 
5.2.3 Preparation of Polymer-Stabilized and Unstabilized CuO Nanoparticles 
CuO nanoparticles (~10 nm) were prepared using a modification of reported methods 
(19,21,22). Glacial acetic acid (1.0 mL, 17.5 mmol) was added to aqueous copper acetate 
(300 mL, 0.02 M) at room temperature. The temperature was increased to 100 C, and 
then finely ground sodium hydroxide (1.0 g, 25 mmol) was quickly added with vigorous 
magnetic stirring. The reaction was continued for 6 h to yield a dark suspension. The 
CuO nanoparticles were collected by centrifugation at 4000 rpm, washed with D.I. water 
(3 x 10 mL) to remove the unreacted chemicals, and re-dispersed in D.I. water by 
sonication. CuO nanoparticles with ~10 nm diameter were produced as long as the 
concentration of the copper acetate solution was 0.02–0.12 and the temperature and molar 
ratio of copper acetate : acetic acid : sodium hydroxide were constant. The purified CuO 
nanoparticle suspension was diluted with D.I. water to 100 µg/mL for TEM analysis 
(JEOL JEM-4000FX, Tokyo, Japan) and showed a uniform size of ~10 nm. CuO 
nanorods with ~50 nm diameter were prepared by changing the feedstock ratio and 
temperature. At 50 C, 2.5 g (62.5 mmol) of sodium hydroxide was added to 300 mL of 
0.1M aqueous solution (30 mmol) of copper acetate mixed with 2.5 mL (40 mmol) of 
glacial acetic acid. The reaction mixture was maintained at 50 C for 30 min and then 
increased to ~120 C for 5 h. The as-made suspension was cooled down to room 
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temperature, and the CuO nanoparticles were collected by centrifugation, washed with 
D.I. water (3 x 10 mL) and centrifuged at 4000 rpm to remove unreacted chemical and 
isolate small size nanoparticles, and re-dispersed in D.I. water. The purified CuO nanorod 
suspension was similarly diluted to 100 µg/mL for TEM analysis, and showed nanorods 
with ~50 nm length and ~10 nm diameter.  
 Polymer-stabilized CuO-10 nanoparticles were prepared the same way as the 
unstabilized nanoparticles above except in the presence of HTCC or PVP as a stabilizer. 
For example, HTCC (0.96 g, theoretical wt. ratio of 1:1 HTCC:CuO) was dissolved in a 
0.04 M aqueous solution of copper acetate (12 mmol in 300 mL D.I. water) mixed with 
glacial acetic acid (2.0 mL, 35 mmol) in a 500 mL round bottom flask. The mixture was 
vigorously stirred for 1 h at 100 °C to give a clear blue solution. Then finely ground 
NaOH pellets (2.0 g, 50 mmol) were quickly added and the reaction was kept for 6 h at 
100°C with vigorous magnetic stirring. After cooling down to room temperature the 
HTCC-stabilized CuO nanoparticles were similarly collected by centrifugation, washed 
with D.I. water (3x10 mL), and then re-dispersed in D.I. water by sonication to form a 
stable HTCC-stabilized CuO nanoparticle suspension. TEM micrographs showed a 
uniform particle size of ~10 nm. 
 HTCC-stabilized CuO-50 nanoparticles were prepared in the same way as CuO-50 
except in the presence of HTCC. Particle size by TEM was ~50 nm. 
 The nanoparticles are designated as follows: CuO nanoparticles without polymer 
stabilizing are designated CuO-10 and CuO-50 for the 10 nm and 50 nm nanoparticles 
respectively, while CuO nanoparticles with a PVP polymer stabilizer are PVP-CuO-10, 
and HTCC stabilized nanoparticles are HTTC-CuO-10 or HTTC-CuO-50, depending on 
the nanoparticle size. The synthesis is illustrated in Scheme 5.2. 
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Scheme 5.2. Synthesis of polymer-stabilized CuO nanoparticles by aqueous thermal 
hydrolysis using D.I. water as the solvent and heating at reflux. 
 
5.2.4 Preparation of ACQ  
ACQ was prepared for us in the Department of Forest Resources and Environmental 
Science using the following standard procedure. Copper carbonate (equivalent to 68.75% 
CuO, 931.4 g), didecyldimethylammonium chloride (DDAC, 80% solution, 399.6 g), and 
ethanolamine (100%, 1760 g) were added to water (908.1 g) and stirred to give a solution 
that is 24% in the active ingredient. The prepared ACQ solution was then diluted with 
D.I. water to a solution with a concentration of 15 mg Cu2+/mL.  
5.2.5 Measurement of Cu2+ Concentration  
The Cu2+concentration in the suspensions and ACQ solution was measured by 
atomic absorption spectrophotometry (BUCK Scientific Model 200A, BUCK Scientific 
Inc, USA). Briefly, 2.0 mL of as-made nanoparticle suspensions or ACQ solution was 
transferred to a beaker and heated to dryness, followed by adding concentrated H2SO4 (3 
mL) and H2O2 (2 mL, 30 % solution) to digest under gentle boiling until a clear light blue 
solution was obtained. The digested sample was transferred to a 250 mL volumetric flask 
and D.I. water was added to scale. A series of copper standard solutions was prepared to 
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give the calibration curve shown in Figure 5.1. The concentration of Cu2+was calculated 
using Beer’s law and found to be 4.6 mg Cu2+/mL (CuO-10 control), 4.8 mg Cu2+/mL 
(PVP-CuO-10), 3.8 mg Cu2+/mL (HTTC-CuO-10), 5.6 mg Cu2+/mL (CuO-50 control), 
6.8 mg Cu2+/mL (HTCC-CuO-50) and 15 mg Cu2+/mL (ACQ solution). 
5.2.6 Treatment of Wood Blocks 
Wood blocks (19x19x19 mm) were extracted in warm alcohol for 24 h to remove 
soluble extractives and wood sawdust near the surface pores and then dried at 40 ºC for 
48 h in order to achieve maximum delivery of CuO nanoparticles. The pre-treated wood 
blocks were then treated with a nanoparticle suspension or ACQ solution according to the 
standard method of Wood Pressure Treatment (AWPA E11-97). The quantity of 
nanoparticle suspension needed to deliver target retentions of 0.64, 2.0, and 4.0 kg Cu2+/ 
m3 wood was measured and the suspension was then diluted to 90 mL by D.I. water. The 
volume of 90 mL was required to sufficiently cover 6 wood blocks having dimensions of 
19 mm x 19 mm x 19 mm when these blocks were placed in a beaker. The wood blocks 
were covered with a plastic mesh and aluminum blocks to keep them submerged 
throughout the pressure-treatment process. The beaker was transferred into the pressure 
cylinder and subjected to a pressure treatment consisting of a partial vacuum of less than 
25 mm Hg for 30 min, followed by pressurization to 100 psi for 1 h. The specimens were 
removed from cylinder, and dried at 40 ºC for 48 h and then dried at air atmosphere under 
room temperature for 24 h. The mass of each dry block was weighed, and the density of 
each treated dry block was calculated according to equation (1): 
Block
Block
Block
V
M
         (1) 
Where the volume for each block was: )(6859)(191919
33 mmmmVBlock  . 
Wood blocks treated for desired target retentions were digested to determine the 
actual copper retention. The wood blocks were first ground into powder, and a known 
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quantity of that powder was weighed out and identified as MSample. Each sample was 
digested by adding the appropriate amount of H2SO4(conc.) and hydrogen peroxide (30 % 
aqueous solution). Then the samples were heated until all solids were digested to form a 
clear solution, then transferred into a volumetric flask, and diluted to scale using D.I. 
water. Previously prepared standard copper solutions were analyzed by atomic absorption 
spectrophotometer to give a calibration curve. Then sample solutions were analyzed to 
measure the concentration of copper ion (CCu
2+) and the actual concentration of copper 
was calculated according to the calibration curve and Beer’s law. The actual retention of 
Cu2+ in each block was calculated by equation (2): 
   
S a m p l e
B l o c kCuCu
M
VC
tentionActual


 22
Re         (2) 
A wooden stake with dimensions of 19 mm x 19 mm x 455 mm was also treated with 
PVP-stabilized CuO nanoparticles. A central section was cut out and FESEM analysis 
(Hitachi S-4700, Hitachi High Technologies America, Inc.) was performed to confirm 
effective penetration of nanoparticles throughout the interior of the treated stakes. 
 
5.2.7 Leaching Tests  
Leaching tests were performed according to The American Wood Preservers 
Association Standards (AWPA E11-97) (23). Leachate was collected in a beaker and 
heated at 80ºC to remove water. H2SO4(conc.) (~4mL) and H2O2 (2-4 mL, 30 % solution) 
were added to digest the solids (the digestion reagent quantities were determined 
according to the amount of leachate). The beaker was covered with a watch glass and 
heated to boiling until the digestion was completed and a clear solution formed. The 
digestion dissolves solid nanoparticles so Cu2+ ions can be detected. Due to the small 
quantity and small size of the nanoparticles we did not attempt to separate CuO 
nanoparticles to quantify the relative numbers of nanoparticles versus Cu2+ ions in the 
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leachate because the relative error would be too high. 
The digested solution was transferred into a volumetric flask (250.00 mL volumetric 
flask for high concentration leachate, 50.00 mL or 25.00 mL volumetric flask for low 
concentration leachate), and D.I. water was added to the scale. A series of Cu2+ standard 
solutions was prepared for calibration curves by atomic absorption analysis (Figure 5.1). 
By this method, leachate was collected at regular leaching intervals, and the concentration 
(X value) of Cu2+ in the leachate was measured by its absorbance (Y value) on the 
calibration curve regression equation, so the quantity of the Cu2+of each leachate was 
obtained by equation (3). 
       solutionSampleCu VXAmount 2         (3) 
 
 
Figure 5.1. A standard curve for analysis of copper in nanoparticle suspensions or 
leachate by atomic absorption spectrophotometry. 
 
5.2.8 Soil Jar Decay Test  
Treated wood blocks (southern pine sapwood, 19mm x 19mm x 19mm) were dried at 
40 C for 24 h. Another batch of wood blocks were leached in water for three weeks, and 
then dried at 40 C for 24 h. The mass of the dried wood blocks was measured to ±0.0005 g. 
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These two batches were designated as “unleached” and “leached” specimens. All blocks 
were exposed to the brown rot fungus, Gloeophyllum trabeum ATCC 11539 for 12 weeks 
using American Wood Preservers Association (AWPA) testing method E-10-07, “Standard 
Method of Testing Wood Preservatives by Laboratory Soil Block Cultures”. 
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5.3 Results and Discussion  
5.3.1 Preparation and Characterization of Polymer-Stabilized CuO Nanoparticles 
Both alco-thermal (21) and aqueous-thermal (19) methods were initially tested as 
routes to give CuO nanoparticles. The aqueous-thermal method was selected to use here 
because it gave nanoparticles with a uniform size that were relatively stable even without 
a polymer stabilizer.  CuO nanoparticles of ~10 nm are designated as CuO-10, and when 
prepared in the presence of either PVP or HTCC polymer-stabilized nanoparticles are 
obtained that are designated as PVP-CuO-10 and HTTC-CuO-10, respectively (Scheme 
5.2). 
The aqueous-thermal method is reported to give 10 nm nanoparticles when the 
copper acetate concentration was 0.02 M. We obtained spherical 10 nm diameter 
nanoparticles as long as the copper acetate concentration in the aqueous solution was kept 
between 0.02–0.12 M, and the ratio of copper acetate : acetic acid : sodium hydroxide 
was kept constant. When polymer stabilizer was used the ratio of PVP or HTCC to CuO 
was maintained at 1:1 w/w. The size and shape of the nanoparticles prepared under these 
conditions was verified by TEM (Fig.5.2a, b).Suspensions of PVP-stabilized and 
HTCC-stabilized CuO nanoparticles appeared to be stable for several months at a 
concentration of 3.8 – 4.8 g CuO/L. 
  
(a)                          (b) 
Figure 5.2. Representative TEM images of (a) unstabilized CuO-10 nanoparticles and (b) 
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PVP-stabilized CuO-10 nanoparticles, prepared by aqueous-thermal hydrolysis. 
 
Based on these studies the only variable that had a significant effect on the final size 
of the CuO nanoparticles was the concentration of the initial copper salt and the reaction 
temperature. CuO nano-rods with a length of ~50 nm and a diameter of ~10 nm were 
made by adding sodium hydroxide at 50 C and heating at 120 C using copper acetate 
concentration at 0.1 M. In the presence of HTCC or PVP a stable polymer-stabilized CuO 
nano-rod was prepared. TEM images of CuO-50 and HTCC-CuO-50 nano-rods are 
shown in Figure 5.3 a,b respectively. 
 
(a)                            (b) 
Figure 5.3.TEM images of (a) CuO-50 nano-rods and (b) HTCC-CuO-50 nano-rods. 
 
5.3.2 Nanoparticle and ACQ Retention in Wood Blocks 
PVP-stabilized CuO nanoparticles, HTCC-stabilized CuO nanoparticles, and 
unstabilized CuO nanoparticle suspensions were prepared and used to pressure-treat 
southern pine sap wood blocks (19 mm × 19 mm × 19 mm) according to the standard 
method of wood pressure treatment (AWPA E11-97). Target retentions ranged from 2.0 
to 4.0 kg Cu2+/m3 wood. Similarly, an ACQ solution control (15 mg Cu2+/mL) was used 
to give the same target retention in southern pine sapwood blocks. The various 
nanoparticle suspensions appeared stable the actual delivery efficiency in the wood was 
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usually ~30-45% and only 48.1% for the ACQ control. The data do not suggest a 
significant impact of the polymer on the retention of the treated wood. The low retention 
is attributed to the high dilution of the suspensions needed to cover the wood blocks with 
fluid during the pressure-treatment process. The results are summarized in Table 5.1, 
showing retentions as both kg of Cu2+ per m3 wood and CuO per m3 wood. It should be 
noted that as a “legacy” of traditional wood treatment formulations in some circles 
copper content is often reported as if it exists as CuO even if it is added as CuCO3 or as a 
soluble copper salt. That is why in Table 5.1 we show ACQ as Cu2+ and as if it were 
CuO even though it is a soluble salt, and for comparison with our actual CuO 
nanoparticle retentions.   
 
Table 5.1. Delivery efficiency and Cu2+/CuO retention in wood blocks. 
Sample 
Target retention 
Kg/m3 
Cu2+/CuO 
Delivery 
Efficiency 
% 
Actual retention 
Kg/m3 
Cu2+ /CuO 
PVP-CuO-10 
10 nm Nanoparticles 
2.0/2.5 44.8 0.896/1.12 
HTCC-CuO-10 
10 nm Nanoparticles 
2.0/2.5 44.0 0.880/1.10 
CuO-10 
10 nm Nanoparticles 
2.0/2.5 40.1 0.802/1.00 
CuO-50 
50 nm Nanoparticles 
2.0/2.5 
4.0/5.0 
33.2 
30.3 
0.660/0.825 
1.21/1.513 
HTCC-CuO-50 
50 nm Nanoparticles 
2.0/2.5 38.1 0.760/0.950 
ACQ Control 2.0/2.5 48.1 0.962/1.203 
 
Despite the lower than expected delivery efficiency, nanoparticle penetration 
throughout the wood was verified by FESEM. PVP-CuO-10 nanoparticles were used to 
treat southern pine field stakes (19 mm × 19 mm × 455 mm) and a central section of the 
stake was sectioned out and visualized by FESEM to confirm effective penetration 
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throughout the wood. Figure 5.4a shows PVP-CuO-10 nanoparticles absorbed onto the 
pit pairs from a region nearer the wood surface. Figure 5.4b is an image from deep in the 
interior of the wooden stake. 
 
Figure 5.4. FESEM micrographs of wood sectioned from the center portion of a 19 mm x 
19 mm by 455 mm southern pine field stake showing PVP-CuO-10 nanoparticles (a) near 
the surface (scale bar 300 nm) and (b) deep in the interior (scale bar 400 nm). 
 
5.3.3 Leaching Tests 
The results of the AWPA standard leaching tests are shown in Figure 5.5 and 
reported as a percentage of Cu2+ based onthe original retention, regardless of if the copper 
was introduced as CuO or as ACQ. Several significant findings can be seen from these 
data.  
First, based on our results, the size of the CuO nanoparticles is the most significant 
factor affecting leaching. Wood specimens treated with 10 nm nanoparticles (solid 
symbols in Figure 5.5), all leached significantly more copper than was released from the 
wood treated with 50 nm CuO nanoparticles. Second, the polymer stabilizers used here 
(the weakly acidic HTCC and the weakly basic PVP) enhanced leaching compared to the 
unstabilized CuO nanoparticles, with unstabilized CuO-10 nanoparticles leaching 12.3% 
of its original retention, compared 15.6 % of the original retention of the weakly acidic 
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HTCC-CuO-10 nanoparticles and 14.3% of the weakly basic PVP-stabilized CuO-10 
nanoparticles. The HTCC-capping also promoted leaching in the CuO-50 nanoparticles 
(hollow triangle symbols in Figure 5.5) when compared to the ACQ salt (hollow black 
diamonds) The unstabilized CuO-50 nm nanoparticles leached only approximately 5 % of 
the copper compared to 6.7% for the ACQ control and approximately 7% for the 
HTCC-stabilized CuO-50 nanoparticles.  
 We are aware of only one other publication, by Kartal and co-researchers, that 
addresses leaching of copper oxide nanoparticles (6) and those authors found favorable 
leach resistance of copper and zinc oxide nanoparticles compared to their more soluble 
equivalents. They used commercial nanoparticle formulations so the exact composition, 
nanoparticle size, and uniformity of size were not provided. However, given that 
commercial formulations all appear to use nanoparticles that are larger than CuO-10, our 
results are consistent with those reported findings, which are that nanoparticles leach 
slightly less than soluble salts, and polymer stabilizers (here HTCC and PVP) facilitate 
leaching. However, the results with CuO-10 nanoparticles indicate that nanoparticle size 
is a factor to be considered in leaching. We can only speculate that the reason the CuO-10 
nanoparticles leach so much more than the CuO-50 nanoparticles is simply that their 
small size makes them more mobile than CuO-50 and so the solid phase nanoparticles 
leach out of the wood more readily than solubilized Cu2+ ions or 50 nm nanoparticles. It 
is also likely that CuO-10 and CuO-50 nanoparticles were retained on the surface and 
these are contributors to leachate residues. Whatever the reason may be, the final result 
from this small study remains the same: CuO-10 nm nanoparticles leach significantly 
more than CuO-50 nm nanoparticles. 
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Figure 5.5. Cumulative leaching of Cu2+ from wood blocks (plotted as a percent of 
original retention). 
 
 We also wanted to know if the nanoparticles themselves were leaching, TEM 
micrographs (Fig.5.6a) the presence of significant numbers of nanoparticles in the 
leachate and EDS analysis (Fig.5.6b) confirmed that these were copper. We suspect that 
the polymer stabilizers increased the leaching of nanoparticles, perhaps simply by 
preventing aggregation of nanoparticles within the wood, making them more mobile, but 
we were not able to prove this. A similar trend was observed for HTCC-CuO-10 
nanoparticles with the confirming TEM and EDS given in Figure 5.6c and 5.6d, 
respectively. 
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(a)                      (b) 
 
(c)                       (d) 
Figure 5.6. TEM images of CuO nanoparticles found in leachate from polymer-stabilized 
CuO-10 nanoparticle and unstabilized CuO-10 nanoparticle treated wood blocks and 
verified by EDS to be CuO.(a) CuO-10 nanoparticles in leachate burst released after the 
first 24 h; (b) its EDS spectrum; (c) HTCC-CuO-10 nanoparticles in leachate collected 
between 24 h and 48 h; (d) its EDS spectrum. 
 
The significance of these results lies in the perception that smaller nanoparticles are 
desirable as a means to enhance biological effect, and that less soluble forms of wood 
preservatives are thought of as a means to reduce biocide leaching. However, this study 
shows that smaller (10 nm) nanoparticles are more prone to leaching than a soluble 
copper salt. Besides the still unresolved concerns of nanoparticles released into the 
environment, increased leaching is also undesirable because loss of the preservative 
reduces the longevity of the preserved wood. Another significant result was that 50 nm 
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nanoparticles were less susceptible to leaching than the 10 nm nanoparticles, indicating 
that if enhanced efficacy is achieved with smaller nanoparticle size then there will be an 
optimal size that achieves the best efficacy without increased susceptibility to leaching. 
Finally, this work showed that both a weakly acidic (HTCC) and a weakly basic (PVP) 
polymer stabilizer enhanced the leaching of the 10 nm nanoparticles, and HTCC also 
slightly enhanced the leaching of the 50 nm nanoparticles. PVP was not evaluated with 
the larger nanoparticles, though the fact that wood is slightly acidic suggests PVP, or an 
even more basic stabilizer, might give better results than we observed. Therefore, 
nanoparticle stabilizers and/or post-conditioning protocols should be tested with different 
sizes of nanoparticles, to determine if they are as effective with smaller nanoparticles as 
they are with larger ones, to determine if they reduce leaching or perhaps even promote 
leaching of the nanoparticles.  
 
5.3.4 Biological Efficacy against G. trabeum in Soil Jar Decay Tests 
The final objective of this work was to determine if 10 nm nanoparticles, due to their 
very high surface area, might afford protection against fungal attack at very low treating 
levels. Wood specimens were treated with PVP-CuO-10 and ACQ as a control. The 
retention efficiency was lower than expected so the actual biocide content was lower than 
intended, at 0.127 kg Cu2+/m3 wood for the PVP-CuO-10 and 0.188 kg Cu2+/m3 wood for 
the ACQ when the target retention was 0.32 kg/m3. No significant biological effect was 
evident at this level, nor was any significant difference detected on comparing the ACQ 
and PVP-CuO-10 nanoparticles (Fig. 5.7). Higher retentions were not attempted because 
of the significant leaching of the polymer-stabilized and unstabilized CuO-10 
nanoparticles. 
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(a) 
 
(b) 
Figure 5.7. Weight loss of southern pine sapwood treated with PVP-CuO-10 
nanoparticles and ACQ measured using soil jar decay tests of (a) leached wood blocks, 
and (b) unleached wood blocks. The target retentions shown are based on Cu 2+. 
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5.4 Conclusion 
This research produced three major findings concerning leaching of copper from 
nanoparticle-treated wood, though it must be noted that we used small sample sizes. 
These are: nanoparticles are leached in significant numbers from pine sapwood treated 
with 10 nm or 50 nm copper oxide nanoparticles, that nanoparticle size is a significant 
factor in the relative abundance of leaching, and that polymer stabilizers enhance 
nanoparticle leaching. Due to the high potential error inherent in trying to separate 
nanoparticles of this size, we did not determine if all the released copper was in the form 
of nanoparticles, but both the total leaching and the abundance of nanoparticle leaching 
was significantly higher for CuO-10 nanoparticles than for CuO-50 nanoparticles. We 
found that both weakly acidic (HTCC) and weakly basic (PVP) polymer stabilizers 
increased nanoparticle leaching compared to the un-stabilized nanoparticles of the same 
size. An attempt was made to determine if the CuO-10 nanoparticles had greater 
biological effect than the larger CuO-50 nanoparticles. However, our nanoparticle 
retention levels were below the minimum required for any significant effect to be 
determined, so we did not answer that question. Although neither the environmental fate 
nor negative environmental impact of different “nano copper” based wood preservatives 
are yet known, the major implications from this work are that larger “nano copper” 
nanoparticles would be more advantageous than otherwise similar treatments using 
smaller “nano copper” because the greater leaching will likely leave the wood less 
well-protected. 
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Main Findings in This Chapter: 
Copper oxide nanoparticles with uniform size distribution of ~10 nm and ~50 nm 
were prepared by thermal hydrolysis with or without presence of polymer stabilizers. 
Leaching test of copper oxide nanoparticle-treated wood showed that copper leached 
more quantity from ~10 nm treated wood than soluble copper salt (ACQ) control, but ~50 
nm nanoparticle treated one leached slightly less copper than ACQ control. The higher 
quantity of copper leaching from nanopartcile-treated wood was confirmed by TEM and 
EDS analysis that the nanoparticles themselves were leached from treated wood. It was 
found that both weakly acidic (HTCC) and weakly basic (PVP) polymer stabilizers 
increased nanoparticle leaching compared to the un-stabilized nanoparticles of the same 
size. Biological activity of ~10 nm copper oxide nanoparticle was compared with 
ACQ-solution treated wood, but nanoparticle retention levels were below the minimum 
required for any significant effect to be determined. The major implications from this 
work are that reasonably larger copper oxide nanoparticles would be more advantageous 
than otherwise similar treatments using smaller nanoparticles because the greater 
leaching from smaller nanoparticle treatment would sacrifice wood protection period. 
Our research shows the trends that nanoparticle size is main factor to affect copper 
leaching. 
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Chapter 6 
Future Work  
In chapter 2 and 3, the self-assembly study of peptide-functionalized amphiphilic 
copolymer confirmed the hypothesis that ionic complementary peptides could direct 
peptide-functionalized polymeric nanoparticles to self-assemble into nanoparticle fibers 
and 3D scaffolds by ionic complementary self-assembly between two oppositely charged 
-sheet peptides. The 1D nanoparticle fiber has a length range from tens to hundreds 
micrometer. Smaller nanoparticle self-assemble into more compact and stable 3D scaffolds 
than bigger nanoparticles, but with less porosity. 
The self-assembly of the designed peptides (P1: H2N-TTTT-AEAEAEAE-amide and 
P2: H2N-TTTT-AKAKAKAK-amide) in aqueous solution (PBS and neutral deionized 
water) were also studied. Results showed that reasonable salt (NaCl) concentration 
facilitated the peptide self-assembly to form a stable membrane with a distinct  
morphology, but no nanofiber structure was observed. And if the self-assembled peptide 
membrane was washed with deionized water to remove salt, the morphology was altered 
and gavean amorphous aggregate, which is attributed to high water solubility of the 
designed peptides (P1 and P2).  
Based on the analysis of the data from these studies, in future work, several aspects can 
be further conducted to improve the self-assembly system for practical application. 
1. Reduce the spacer parts of both P1 and P2 from four units to two units, and 
increase self-assembly units from 8 to 12, so the peptide structure for P1 and P2 are shown 
as:  P1 (H2N-TT-AEAEAEAEAEAE-amide) and P2 
(H2N-TT-AKAKAKAKAKAK-amide). Reduce threonine (T) and increase self-assembly 
units, alanine (A), glutamic acid (E) and lysine (K) can increase the stability of the 
self-assembled -sheets structure, and also can perform self-assembly in a lower peptide 
concentration. Or we can substitute valine (V) or leucine (L) for alanine (A) to increase the 
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hydrophobicity of P1 and P2, but still keep same self-assembly unit numbers to form P1: 
H2N-TTTT-VEVEVEVE-amide and P2: H2N-TTTT-VKVKVKVK-amide. So 
self-assembly of P1 and P2 with new sequence can also form more stable -sheets structure 
at lower peptide concentration. 
2. Synthesize P2 using another type of resin to keep the amine protection group after 
P2 is cleaved from resin, so that when P2 is used to couple with copolymer, only the 
peptide amine terminal is reacted with the carboxylic acid group of copolymer terminal. 
Because lysine also has an amine group on the side chain, without a protection group, some 
coupling will occur at thelysine amine to form a branched structure (Figure 6.1). Such a 
branch structure detrimental to the subsequent assembly between P1 and P2. 
 
Figure 6.1. Branch structure if copolymer is coupled with lysine amine groups but not the 
peptide amine terminal. 
 
3. Cytotoxicity tests showed that NIH3T3 cells did not effectively adhere to the 
self-assembled 2D nanoparticle membrane surface. In order to increase cell adhesion to 
scaffolds, both 2D and 3D, the nanoparticle surface probably needs modification with 
some types of cell adhesion peptides or other type of receptor to increase cell adhesion. The 
surface modification can be done by functionalizing cell receptors (i.e. cell adhesion 
peptides) with vinyl groups and then copolymerizing them with hydrophilic monomer to 
build up a hydrophilic block,so the cell receptors are formed on the hydrophilic shell of the 
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nanoparticle surface. The nanoparticle surface functionalization with receptors is shown in 
Figure 6.2.  
 
 
Figure 6.2. Cartoon shows covalently incorporate cell receptors in hydrophilic block to 
self-assemble into core-shell nanoparticle with cell receptors on nanoparticle surface. 
 
Such surface functionalized nanoparticles can interact with cell surfaces to increase 
cell adhesion. If the self-assembled nanoparticle scaffold is mixed with a specific cell type, 
it is possible that the cells themselves will also interact with nanoparticles to form in-situ 
self-assembled 3D scaffolds. Then the incorporated drugs released from the nanoparticles 
can stimulate cell proliferation and migration to guide cells to develop into the desired 
mature cell type for specific tissue regeneration applications. 
4.  Techniques for determining bioactivity are needed if bioactive drugs are 
incorporated and released from the designed solid nanoparticles.  Also, specific 
quantitative analysis techniquesare needed to determine the release rate of bioactive drugs 
from nanoparticle. These two steps are important if this self-assembled nanoparticle 
scaffold is used to load growth factors for tissue regeneration because most growth factors 
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are required to remain bioactive so its functionality will stimulate cell activities to work 
normally. If multiple growth factors are simultaneously loaded, maybe a more advanced 
technique is required to determine release rate and bioactivities of each growth factor. 
5.  In vitro cell tests with self-assembled scaffolds with or without loading of drugs 
also must be done. This is important to know the cell growth behavior inside the scaffolds, 
and also monitor the stability of the scaffolds when culturing in cell media. 
6. Possible toxicity of decomposed components from scaffolds must be tested before 
the scaffolds are tested in vivo. 
The above work was not done by the author because offinancial and time limitations, 
but the work described above is expected to improve the design and efficacy of the 
scaffolds and achieve better control of the self-assembled structure. 
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Appendix A 
Supplementary Data for Chapter 2 
Studies of Novel Self-Assembly Structures from Peptide-Functionalized 
Polymeric Micro- and Nanoparticles for Tissue Engineering 
Xiaochu Ding, Jagadeesh Janjanam, Ashutosh Tiwari, Marty Thompson, Patricia A. 
Heiden*, 
Department of Chemistry, Michigan Technological University, Houghton, MI 49931, 
USA 
*Corresponding author: +1 906 487 3452; Fax: +1 906 487 2061. 
Email address: paheiden@mtu.edu (P.A. Heiden). 
 
 
1. MALDI-DOF MS analysis of the designed peptides (a) P1 and (b) P2. 
 
 
 
 
(a) 
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(b) 
Figure 2.1S. MALDI-TOF MS analysis of the designed peptides.(a) P1 
(H2N-TTTT-AEAEAEAE-amide) and (b) P2 (H2N-TTTT-AKAKAKAK-amide).P1 and 
P2 have theoretical molecular weight of 1223.25 and 1219.45 Da. MALDI-TOF MS 
analysis shows strong MS peak at 1246.42[M(P1)+Na+] and 1220.01[M(P2)+H+] Da. 
 
The Figure 2.1S shows the spectra of molecular weight of the designer peptides, P1 
(H2N-TTTT-AEAEAEAE-amide) and P2 (H2N-TTTT-AKAKAKAK-amide), by 
MALDI-TOF MS analysis. 
2. Synthesis of S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) 
The RAFT chain transfer agent, BDAT, was synthesized by adding carbon disulfide 
(2.74 g, 0.036 mol), chloroform (10.75 g, 0.09 mol), acetone (5.23 g, 0.09 mol) and 
tetrabutylammonium hydrogen sulfate (0.241 g, 0.71 mmol) into room temperature 
ligroin (12 mL) in a 250 mL round bottom flask. The flask was equipped with an efficient 
condenser and a magnetic stir bar and maintained under a nitrogen atmosphere. Then 
NaOH (50 wt.% in H2O) (20.16 g, 0.252 mol) was added drop-by-drop to the reaction 
mixture over 1.5 h at a rate sufficient to keep the reaction temperature below 25 C. After 
the addition was completed the reaction was continued overnight at 22-25 C. Then 
deionized H2O (90 mL) was added to dissolve the yellow solids. This was followed by 
addition of HClconc.(12 mL, via syringe) to acidify the aqueous solution and produce 
yellow crystalline solids. The crude product was collected by vacuum filtration and 
washed several times with deionized H2O. After drying under reduced pressure at room 
temperature for 12 h, 3.26 g of crude BDAT product was obtained. The product was 
purified by recrystallization in toluene/acetone (3:1 v/v) to afford a yellow crystalline 
product. 
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3. 1H-NMR analysis of PHEMA-b-12PMMA-b-PHEMA, 
PHEA-b-12PMMA-b-PHEA and their block ratio calculation equation 
 
 
(a) 
 
 
(b) 
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Figure 2.2S. 1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic polymer 
of PHEMA and (b) tri-block copolymer of PHEMA-b-12PMMA-b-PHEMA by RAFT 
polymerization. 
Proton peak assignments of hydrophilic block (PHEMA) and amphiphilic block 
copolymer (PHEMA-b-12PMMA-b-PHEMA). PHEMA Block (in DMSO-d6,): 
0.79-1.10 (-CH3), 1.80 (-CH2-), 3.59 (-CH2-OH), 3.91 (-CH2-O-C=O), 4.80 (-OH). 
PHEMA-b-PMMA-b-PHEMA(in DMSO-d6,):0.72-1.13 (-CH3), 1.42-1.77 
(-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA 
block), 3.87 (-CH2-O-C=O). 
The integrated peak area of : 3.91 (-CH2-O-C=O from PHEMA block) and : 3.53 
(-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA block) are used to 
determine actual block ratio of PHEMA to PMMA (XN:XM) to be 1:11 based on below 
equation. 
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(a) 
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(b) 
Figure 2.3S.1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic PHEA 
and (b) tri-block copolymer of PHEA-b-12PMMA-b-PHEA by RAFT polymerization. 
Proton peak assignments of hydrophilic block (PHEA) and amphiphilic block copolymer 
(PHEA-b-12PMMA-b-PHEA). 
PHEA Block (in D2O, ): 1.54-1.86 (-CH2- from backbone), 2.32 (-CH- from 
backbone), 3.53 (-OH), 3.68 (-CH2-OH), 4.08 (-CH2-O-C=O).  
PHEA-b-12PMMA-b-PHEA(in DMSO-d6,):0.74-0.92 (-CH3), 1.80 (-CH2-), 2.38 
(-CH-), 3.44-3.54 (-OCH3, from PMMA block, also contains–CH2-OH from the PHEA 
block), 3.98 (-CH2-O-C=O). 
 
The integrated peak area of : 3.98 (-CH2-O-C=O from PHEA block) and :  
3.44-3.54 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEA block) 
are used to determine actual block ratio of PHEA to PMMA (XN:XM) to be 1:8.7 based on 
below equation. 
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4. Coupling peptides to copolymers by FTIR analysis 
 
 
(a) 
 
(b) 
Figure 2.4S. Comparison of FT-IR spectra of the synthesized copolymer, P1(Peptide1), 
P2(Peptide2), and Peptide-copolymer conjugates. (a) Comparison of IR spectra of 
P1(Peptide1), P2(Peptide2) and Peptide- PHEMA-b-12PMMA-b-PHEMA conjugates. (b) 
Comparison of IR spectra of P1(Peptide1), P2(Peptide2), and Peptide- 
PHEA-b-12PMMA-b-PHEA conjugates. 
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Appendix B 
Supplementary Data for Chapter 3 
Smart Self-Assembly of Peptide-Functionalized Amphiphilic Copolymer 
Nanoparticles: Novel Fibers and 3D Scaffolds with Ability for Multiple 
Drug Loading and Independent Controlled Release 
XiaochuDinga, Trevor Moserb, Qi Gaob, TolouShokuhfarb, Patricia A. Heidena*, 
aDepartment of Chemistry, Michigan Technological University, Houghton, MI 49931, 
USA 
bDepartment of Mechanical Engineering and Engineering Mechanics, Michigan 
Technological University, Houghton, MI 49931, USA 
*Corresponding author: +1 906 487 3452; fax: +1 906 487 2061. 
Email address:paheiden@mtu.edu (P.A. Heiden). 
1. Calibration curve for quantitative analysis of controlled release using different 
model drugs 
 
Figure 3.1S. Calibration curve of DBF used for quantitative determination of uncaptured 
DBF and controlled released DBF sample solutions. 
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(a) 
 
 
(b) 
Figure 3.2S. Calibration curves of (a) nitrofurazone and (b) amoxicillin used for 
quantitative determination of uncaptured model drugs and simultaneously released model 
drugs(nitrofurazone and amoxicillin) from same scaffold. 
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Appendix C 
Peptide Synthesis Program 
Peptide 1:  TTTT-AEAEAEAE 
T= Threonine, A= Alanine, E= Glutamic Acid (negative charge between pH 4.4-10) 
Use Endeavor 90 peptide synthesizer (AAPPTec LLC) to synthesize peptide 1. It is 
conducted on a 0.65 mmol/g Rink Fmoc-amide resin (0.65 mmol amide groups).  
Aminno acid is made in 4× excess to Rink Fmoc-amide resin (4×0.65 mmol amino acid 
in 5.2 mL of 0.9 M DIPEA/DMF solution for coupling each amino acid). 
 
Synthesizing Program: 
 
1. ** swelling & deprotection** 
2. Wash RV1 with 10.00 mL from DMF 2 times. 
3. Fill RV1 with 25.00 mL from DMF. 
4. Blank. 
5. Mix RV1 via Mechanical Mix for 45 minutes. 
6. Empty RV1. 
7. Fill RV1 with 15.00 mL from PIP. 
8. Mix RV1 via Mech/N2 Mix for 5.00 minutes. 
9. Empty RV1. 
10. Blank. 
11. Fill RV1 with 15.00 mL from PIP. 
12. Mix RV1 via Mech/N2 Mix for 20 minutes. 
13. Empty RV1. 
14. Blank. 
15. ** clean PIP from the fluid lines** 
16. Clean lines with 50.00 mL from DMF. 
17. Blank. 
18. ** wash Rink resin** 
19. Wash RV1 with 10 mL from DMF 4 Times. 
20. Fill RV1 with 10 mL from DMF. 
21. Delay 5.00 minutes. 
22. Empty RV1. 
23. Blank. 
24. Blank. 
25. ** Fmoc-Glutamic Acid 1** 
26. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
27. Fill RV1 with 5.20 mL from AA1. 
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28. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
29. Empty RV1. 
30. Fill RV1 with 10.00 mL from DMF. 
31. Wash RV1 with 10.00 mL from DMF 4 Times. 
32. Fill RV1 with 10 mL from DMF. 
33. Delay 5.00 minutes. 
34. Empty RV1. 
35. Fill RV1 with 15.00 mL from PIP. 
36. Mix RV1 via Mech/N2 Mix for 5 minutes. 
37. Empty RV1. 
38. Fill RV1 with 15.00 mL from PIP. 
39. Mix RV1 via Mech/N2 Mix for 20 minutes. 
40. Empty RV1. 
41. Blank. 
42. Fill RV1 with 10.00 mL from DMF. 
43. Wash RV1 with 10.00 mL from DMF 4 Times. 
44. Fill RV1 with 10 mL from DMF. 
45. Delay 5.00 minutes. 
46. Empty RV1. 
47. Blank. 
48. Blank. 
49. ** Fmoc-Alanine 2** 
50. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
51. Fill RV1 with 5.20 mL from AA2. 
52. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
53. Empty RV1. 
54. Fill RV1 with 10.00 mL from DMF. 
55. Wash RV1 with 10.00 mL from DMF 4 Times. 
56. Fill RV1 with 10 mL from DMF. 
57. Delay 5.00 minutes. 
58. Empty RV1. 
59. Fill RV1 with 15.00 mL from PIP. 
60. Mix RV1 via Mech/N2 Mix for 5 minutes. 
61. Empty RV1. 
62. Fill RV1 with 15.00 mL from PIP. 
63. Mix RV1 via Mech/N2 Mix for 20 minutes. 
64. Empty RV1. 
65. Blank. 
66. Fill RV1 with 10.00 mL from DMF. 
67. Wash RV1 with 10.00 mL from DMF 4 Times. 
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68. Fill RV1 with 10 mL from DMF. 
69. Delay 5.00 minutes. 
70. Empty RV1. 
71. Blank. 
72. Blank. 
73.** Fmoc-Glutamic acid 3** 
74. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
75. Fill RV1 with 5.20 mL from AA3. 
76. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
77. Empty RV1. 
78. Fill RV1 with 10.00 mL from DMF. 
79. Wash RV1 with 10.00 mL from DMF 4 Times. 
80. Fill RV1 with 10 mL from DMF. 
81. Delay 5.00 minutes. 
82. Empty RV1. 
83. Fill RV1 with 15.00 mL from PIP. 
84. Mix RV1 via Mech/N2 Mix for 5 minutes. 
85. Empty RV1. 
86. Fill RV1 with 15.00 mL from PIP. 
87. Mix RV1 via Mech/N2 Mix for 20 minutes. 
88. Empty RV1. 
89. Blank. 
90. Fill RV1 with 10.00 mL from DMF. 
91. Wash RV1 with 10.00 mL from DMF 4 Times. 
92. Fill RV1 with 10 mL from DMF. 
93. Delay 5.00 minutes. 
94. Empty RV1. 
95. Blank. 
96. Blank. 
97.** Fmoc-Alanine 4** 
98. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
99. Fill RV1 with 5.20 mL from AA4. 
100. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
101. Empty RV1. 
102. Fill RV1 with 10.00 mL from DMF. 
103. Wash RV1 with 10.00 mL from DMF 4 Times. 
104. Fill RV1 with 10 mL from DMF. 
105. Delay 5.00 minutes. 
106. Empty RV1. 
107. Fill RV1 with 15.00 mL from PIP. 
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108. Mix RV1 via Mech/N2 Mix for 5 minutes. 
109. Empty RV1. 
110. Fill RV1 with 15.00 mL from PIP. 
111. Mix RV1 via Mech/N2 Mix for 20 minutes. 
112. Empty RV1. 
113. Blank. 
114. Fill RV1 with 10.00 mL from DMF. 
115. Wash RV1 with 10.00 mL from DMF 4 Times. 
116. Fill RV1 with 10 mL from DMF. 
117. Delay 5.00 minutes. 
118. Empty RV1. 
119. Blank. 
120. Pause. 
 
121. ** Fmoc-Glutamic Acid 5** 
122. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
123. Fill RV1 with 5.20 mL from AA1. 
124. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
125. Empty RV1. 
126. Fill RV1 with 10.00 mL from DMF. 
127. Wash RV1 with 10.00 mL from DMF 4 Times. 
128. Fill RV1 with 10 mL from DMF. 
129. Delay 5.00 minutes. 
130. Empty RV1. 
131. Fill RV1 with 15.00 mL from PIP. 
132. Mix RV1 via Mech/N2 Mix for 5 minutes. 
133. Empty RV1. 
134. Fill RV1 with 15.00 mL from PIP. 
135. Mix RV1 via Mech/N2 Mix for 20 minutes. 
136. Empty RV1. 
137. Blank. 
138. Fill RV1 with 10.00 mL from DMF. 
139. Wash RV1 with 10.00 mL from DMF 4 Times. 
140. Fill RV1 with 10 mL from DMF. 
141. Delay 5.00 minutes. 
142. Empty RV1. 
143. Blank. 
144. Blank. 
145. ** Fmoc-Alanine 6** 
146. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
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147. Fill RV1 with 5.20 mL from AA2. 
148. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
149. Empty RV1. 
150. Fill RV1 with 10.00 mL from DMF. 
151. Wash RV1 with 10.00 mL from DMF 4 Times. 
152. Fill RV1 with 10 mL from DMF. 
153. Delay 5.00 minutes. 
154. Empty RV1. 
155. Fill RV1 with 15.00 mL from PIP. 
156. Mix RV1 via Mech/N2 Mix for 5 minutes. 
157. Empty RV1. 
158. Fill RV1 with 15.00 mL from PIP. 
159. Mix RV1 via Mech/N2 Mix for 20 minutes. 
160. Empty RV1. 
161. Blank. 
162. Fill RV1 with 10.00 mL from DMF. 
163. Wash RV1 with 10.00 mL from DMF 4 Times. 
164. Fill RV1 with 10 mL from DMF. 
165. Delay 5.00 minutes. 
166. Empty RV1. 
167. Blank. 
168. Blank. 
169.** Fmoc-Glutamic acid 7** 
170. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
171. Fill RV1 with 5.20 mL from AA3. 
172. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
173. Empty RV1. 
174. Fill RV1 with 10.00 mL from DMF. 
175. Wash RV1 with 10.00 mL from DMF 4 Times. 
176. Fill RV1 with 10 mL from DMF. 
177. Delay 5.00 minutes. 
178. Empty RV1. 
179. Fill RV1 with 15.00 mL from PIP. 
180. Mix RV1 via Mech/N2 Mix for 5 minutes. 
181. Empty RV1. 
182. Fill RV1 with 15.00 mL from PIP. 
183. Mix RV1 via Mech/N2 Mix for 20 minutes. 
184. Empty RV1. 
185. Blank. 
186. Fill RV1 with 10.00 mL from DMF. 
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187. Wash RV1 with 10.00 mL from DMF 4 Times. 
188. Fill RV1 with 10 mL from DMF. 
189. Delay 5.00 minutes. 
190. Empty RV1. 
191. Blank. 
192. Blank. 
193.** Fmoc-Alanine 8** 
194. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
195. Fill RV1 with 5.20 mL from AA4. 
196. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
197. Empty RV1. 
198. Fill RV1 with 10.00 mL from DMF. 
199. Wash RV1 with 10.00 mL from DMF 4 Times. 
200. Fill RV1 with 10 mL from DMF. 
201. Delay 5.00 minutes. 
202. Empty RV1. 
203. Fill RV1 with 15.00 mL from PIP. 
204. Mix RV1 via Mech/N2 Mix for 5 minutes. 
205. Empty RV1. 
206. Fill RV1 with 15.00 mL from PIP. 
207. Mix RV1 via Mech/N2 Mix for 20 minutes. 
208. Empty RV1. 
209. Blank. 
210. Fill RV1 with 10.00 mL from DMF. 
211. Wash RV1 with 10.00 mL from DMF 4 Times. 
212. Fill RV1 with 10 mL from DMF. 
213. Delay 5.00 minutes. 
214. Empty RV1. 
215. Blank. 
216. Pause. 
217** Fmoc-Threonine 9** 
218. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
219. Fill RV1 with 5.20 mL from AA1. 
220. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
221. Empty RV1. 
222. Fill RV1 with 10.00 mL from DMF. 
223. Wash RV1 with 10.00 mL from DMF 4 Times. 
224. Fill RV1 with 10 mL from DMF. 
225. Delay 5.00 minutes. 
226. Empty RV1. 
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227. Fill RV1 with 15.00 mL from PIP. 
228. Mix RV1 via Mech/N2 Mix for 5 minutes. 
229. Empty RV1. 
230. Fill RV1 with 15.00 mL from PIP. 
231. Mix RV1 via Mech/N2 Mix for 20 minutes. 
232. Empty RV1. 
233. Blank. 
234. Fill RV1 with 10.00 mL from DMF. 
235. Wash RV1 with 10.00 mL from DMF 4 Times. 
236. Fill RV1 with 10 mL from DMF. 
237. Delay 5.00 minutes. 
238. Empty RV1. 
239. Blank. 
240. Blank. 
241. ** Fmoc-Threonine 10** 
242. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
243. Fill RV1 with 5.20 mL from AA2. 
244. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
245. Empty RV1. 
246. Fill RV1 with 10.00 mL from DMF. 
247. Wash RV1 with 10.00 mL from DMF 4 Times. 
248. Fill RV1 with 10 mL from DMF. 
249. Delay 5.00 minutes. 
250. Empty RV1. 
251. Fill RV1 with 15.00 mL from PIP. 
252. Mix RV1 via Mech/N2 Mix for 5 minutes. 
253. Empty RV1. 
254. Fill RV1 with 15.00 mL from PIP. 
255. Mix RV1 via Mech/N2 Mix for 20 minutes. 
256. Empty RV1. 
257. Blank. 
258. Fill RV1 with 10.00 mL from DMF. 
259. Wash RV1 with 10.00 mL from DMF 4 Times. 
260. Fill RV1 with 10 mL from DMF. 
261. Delay 5.00 minutes. 
262. Empty RV1. 
263. Blank. 
264. Blank. 
265.** Fmoc-Threonine 11** 
266. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
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267. Fill RV1 with 5.20 mL from AA3. 
268. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
269. Empty RV1. 
270. Fill RV1 with 10.00 mL from DMF. 
270. Wash RV1 with 10.00 mL from DMF 4 Times. 
272. Fill RV1 with 10 mL from DMF. 
273. Delay 5.00 minutes. 
274. Empty RV1. 
275. Fill RV1 with 15.00 mL from PIP. 
276. Mix RV1 via Mech/N2 Mix for 5 minutes. 
277. Empty RV1. 
278. Fill RV1 with 15.00 mL from PIP. 
279. Mix RV1 via Mech/N2 Mix for 20 minutes. 
280. Empty RV1. 
281. Blank. 
282. Fill RV1 with 10.00 mL from DMF. 
283. Wash RV1 with 10.00 mL from DMF 4 Times. 
284. Fill RV1 with 10 mL from DMF. 
285. Delay 5.00 minutes. 
286. Empty RV1. 
287. Blank. 
288. Blank. 
289.** Fmoc-Threonine 12** 
290. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
291. Fill RV1 with 5.20 mL from AA4. 
292. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
293. Empty RV1. 
294. Fill RV1 with 10.00 mL from DMF. 
295. Wash RV1 with 10.00 mL from DMF 4 Times. 
296. Fill RV1 with 10 mL from DMF. 
297. Delay 5.00 minutes. 
298. Empty RV1. 
299. Fill RV1 with 15.00 mL from PIP. 
300. Mix RV1 via Mech/N2 Mix for 5 minutes. 
301. Empty RV1. 
302. Fill RV1 with 15.00 mL from PIP. 
303. Mix RV1 via Mech/N2 Mix for 20 minutes. 
304. Empty RV1. 
305. Blank. 
306. Fill RV1 with 10.00 mL from DMF. 
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307. Wash RV1 with 10.00 mL from DMF 4 Times. 
308. Fill RV1 with 10 mL from DMF. 
309. Delay 5.00 minutes. 
310. Empty RV1. 
311. Blank. 
312. Blank. 
 
313.** Solvent switch & Storage** 
314. Fill RV1 with 10.00 mL from DCM. 
315. Wash RV1 with 10.00 mL from DCM 4 Times. 
316. Fill RV1 with 10.00 mL from DCM. 
317. Delay for 5.00 minutes. 
318. Empty RV1. 
319. Blank. 
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Peptide 2:  TTTT-AKAKAKAK 
 
T= Threonine, A= Alanine, K=Lysine (Positive charge between pH 4.4~10) 
 
Use Endeavor 90 peptide synthesizer (AAPPTec LLC) to synthesize peptide 2. It is 
conducted on a 0.65 mmol/g Rink Fmoc-amide resin (0.65 mmol amide groups).  
Aminno acid is made in 4× excess to Rink Fmoc-amide resin (4×0.65 mmol amino acid 
in 5.2 mL of 0.9 M DIPEA/DMF solution for coupling each amino acid). 
 
Synthesizing Program: 
 
1. ** swelling & deprotection** 
2. Wash RV1 with 10.00 mL from DMF 2 times. 
3. Fill RV1 with 25.00 mL from DMF. 
4. Blank. 
5. Mix RV1 via Mechanical Mix for 45 minutes. 
6. Empty RV1. 
7. Fill RV1 with 15.00 mL from PIP. 
8. Mix RV1 via Mech/N2 Mix for 5.00 minutes. 
9. Empty RV1. 
10. Blank. 
11. Fill RV1 with 15.00 mL from PIP. 
12. Mix RV1 via Mech/N2 Mix for 20 minutes. 
13. Empty RV1. 
14. Blank. 
15. ** clean PIP from the fluid lines** 
16. Clean lines with 50.00 mL from DMF. 
17. Blank. 
18. ** wash Rink resin** 
19. Wash RV1 with 10 mL from DMF 4 Times. 
20. Fill RV1 with 10 mL from DMF. 
21. Delay 5.00 minutes. 
22. Empty RV1. 
23. Blank. 
24. Blank. 
25. ** Fmoc-Lysine 1** 
26. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
27. Fill RV1 with 5.20 mL from AA1. 
28. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
29. Empty RV1. 
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30. Fill RV1 with 10.00 mL from DMF. 
31. Wash RV1 with 10.00 mL from DMF 4 Times. 
32. Fill RV1 with 10 mL from DMF. 
33. Delay 5.00 minutes. 
34. Empty RV1. 
35. Fill RV1 with 15.00 mL from PIP. 
36. Mix RV1 via Mech/N2 Mix for 5 minutes. 
37. Empty RV1. 
38. Fill RV1 with 15.00 mL from PIP. 
39. Mix RV1 via Mech/N2 Mix for 20 minutes. 
40. Empty RV1. 
41. Blank. 
42. Fill RV1 with 10.00 mL from DMF. 
43. Wash RV1 with 10.00 mL from DMF 4 Times. 
44. Fill RV1 with 10 mL from DMF. 
45. Delay 5.00 minutes. 
46. Empty RV1. 
47. Blank. 
48. Blank. 
49. ** Fmoc-Alanine 2** 
50. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
51. Fill RV1 with 5.20 mL from AA2. 
52. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
53. Empty RV1. 
54. Fill RV1 with 10.00 mL from DMF. 
55. Wash RV1 with 10.00 mL from DMF 4 Times. 
56. Fill RV1 with 10 mL from DMF. 
57. Delay 5.00 minutes. 
58. Empty RV1. 
59. Fill RV1 with 15.00 mL from PIP. 
60. Mix RV1 via Mech/N2 Mix for 5 minutes. 
61. Empty RV1. 
62. Fill RV1 with 15.00 mL from PIP. 
63. Mix RV1 via Mech/N2 Mix for 20 minutes. 
64. Empty RV1. 
65. Blank. 
66. Fill RV1 with 10.00 mL from DMF. 
67. Wash RV1 with 10.00 mL from DMF 4 Times. 
68. Fill RV1 with 10 mL from DMF. 
69. Delay 5.00 minutes. 
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70. Empty RV1. 
71. Blank. 
72. Blank. 
73.** Fmoc-Lysine 3** 
74. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
75. Fill RV1 with 5.20 mL from AA3. 
76. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
77. Empty RV1. 
78. Fill RV1 with 10.00 mL from DMF. 
79. Wash RV1 with 10.00 mL from DMF 4 Times. 
80. Fill RV1 with 10 mL from DMF. 
81. Delay 5.00 minutes. 
82. Empty RV1. 
83. Fill RV1 with 15.00 mL from PIP. 
84. Mix RV1 via Mech/N2 Mix for 5 minutes. 
85. Empty RV1. 
86. Fill RV1 with 15.00 mL from PIP. 
87. Mix RV1 via Mech/N2 Mix for 20 minutes. 
88. Empty RV1. 
89. Blank. 
90. Fill RV1 with 10.00 mL from DMF. 
91. Wash RV1 with 10.00 mL from DMF 4 Times. 
92. Fill RV1 with 10 mL from DMF. 
93. Delay 5.00 minutes. 
94. Empty RV1. 
95. Blank. 
96. Blank. 
97.** Fmoc-Alanine 4** 
98. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
99. Fill RV1 with 5.20 mL from AA4. 
100. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
101. Empty RV1. 
102. Fill RV1 with 10.00 mL from DMF. 
103. Wash RV1 with 10.00 mL from DMF 4 Times. 
104. Fill RV1 with 10 mL from DMF. 
105. Delay 5.00 minutes. 
106. Empty RV1. 
107. Fill RV1 with 15.00 mL from PIP. 
108. Mix RV1 via Mech/N2 Mix for 5 minutes. 
109. Empty RV1. 
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110. Fill RV1 with 15.00 mL from PIP. 
111. Mix RV1 via Mech/N2 Mix for 20 minutes. 
112. Empty RV1. 
113. Blank. 
114. Fill RV1 with 10.00 mL from DMF. 
115. Wash RV1 with 10.00 mL from DMF 4 Times. 
116. Fill RV1 with 10 mL from DMF. 
117. Delay 5.00 minutes. 
118. Empty RV1. 
119. Blank. 
120. Pause. 
 
121. ** Fmoc-Lysine 5** 
122. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
123. Fill RV1 with 5.20 mL from AA1. 
124. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
125. Empty RV1. 
126. Fill RV1 with 10.00 mL from DMF. 
127. Wash RV1 with 10.00 mL from DMF 4 Times. 
128. Fill RV1 with 10 mL from DMF. 
129. Delay 5.00 minutes. 
130. Empty RV1. 
131. Fill RV1 with 15.00 mL from PIP. 
132. Mix RV1 via Mech/N2 Mix for 5 minutes. 
133. Empty RV1. 
134. Fill RV1 with 15.00 mL from PIP. 
135. Mix RV1 via Mech/N2 Mix for 20 minutes. 
136. Empty RV1. 
137. Blank. 
138. Fill RV1 with 10.00 mL from DMF. 
139. Wash RV1 with 10.00 mL from DMF 4 Times. 
140. Fill RV1 with 10 mL from DMF. 
141. Delay 5.00 minutes. 
142. Empty RV1. 
143. Blank. 
144. Blank. 
145. ** Fmoc-Alanine 6** 
146. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
147. Fill RV1 with 5.20 mL from AA2. 
148. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
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149. Empty RV1. 
150. Fill RV1 with 10.00 mL from DMF. 
151. Wash RV1 with 10.00 mL from DMF 4 Times. 
152. Fill RV1 with 10 mL from DMF. 
153. Delay 5.00 minutes. 
154. Empty RV1. 
155. Fill RV1 with 15.00 mL from PIP. 
156. Mix RV1 via Mech/N2 Mix for 5 minutes. 
157. Empty RV1. 
158. Fill RV1 with 15.00 mL from PIP. 
159. Mix RV1 via Mech/N2 Mix for 20 minutes. 
160. Empty RV1. 
161. Blank. 
162. Fill RV1 with 10.00 mL from DMF. 
163. Wash RV1 with 10.00 mL from DMF 4 Times. 
164. Fill RV1 with 10 mL from DMF. 
165. Delay 5.00 minutes. 
166. Empty RV1. 
167. Blank. 
168. Blank. 
169.** Fmoc-Lysine 7** 
170. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
171. Fill RV1 with 5.20 mL from AA3. 
172. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
173. Empty RV1. 
174. Fill RV1 with 10.00 mL from DMF. 
175. Wash RV1 with 10.00 mL from DMF 4 Times. 
176. Fill RV1 with 10 mL from DMF. 
177. Delay 5.00 minutes. 
178. Empty RV1. 
179. Fill RV1 with 15.00 mL from PIP. 
180. Mix RV1 via Mech/N2 Mix for 5 minutes. 
181. Empty RV1. 
182. Fill RV1 with 15.00 mL from PIP. 
183. Mix RV1 via Mech/N2 Mix for 20 minutes. 
184. Empty RV1. 
185. Blank. 
186. Fill RV1 with 10.00 mL from DMF. 
187. Wash RV1 with 10.00 mL from DMF 4 Times. 
188. Fill RV1 with 10 mL from DMF. 
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189. Delay 5.00 minutes. 
190. Empty RV1. 
191. Blank. 
192. Blank. 
193.** Fmoc-Alanine 8** 
194. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
195. Fill RV1 with 5.20 mL from AA4. 
196. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
197. Empty RV1. 
198. Fill RV1 with 10.00 mL from DMF. 
199. Wash RV1 with 10.00 mL from DMF 4 Times. 
200. Fill RV1 with 10 mL from DMF. 
201. Delay 5.00 minutes. 
202. Empty RV1. 
203. Fill RV1 with 15.00 mL from PIP. 
204. Mix RV1 via Mech/N2 Mix for 5 minutes. 
205. Empty RV1. 
206. Fill RV1 with 15.00 mL from PIP. 
207. Mix RV1 via Mech/N2 Mix for 20 minutes. 
208. Empty RV1. 
209. Blank. 
210. Fill RV1 with 10.00 mL from DMF. 
211. Wash RV1 with 10.00 mL from DMF 4 Times. 
212. Fill RV1 with 10 mL from DMF. 
213. Delay 5.00 minutes. 
214. Empty RV1. 
215. Blank. 
216. Pause. 
217** Fmoc-Threonine 9** 
218. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes. 
219. Fill RV1 with 5.20 mL from AA1. 
220. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
221. Empty RV1. 
222. Fill RV1 with 10.00 mL from DMF. 
223. Wash RV1 with 10.00 mL from DMF 4 Times. 
224. Fill RV1 with 10 mL from DMF. 
225. Delay 5.00 minutes. 
226. Empty RV1. 
227. Fill RV1 with 15.00 mL from PIP. 
228. Mix RV1 via Mech/N2 Mix for 5 minutes. 
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229. Empty RV1. 
230. Fill RV1 with 15.00 mL from PIP. 
231. Mix RV1 via Mech/N2 Mix for 20 minutes. 
232. Empty RV1. 
233. Blank. 
234. Fill RV1 with 10.00 mL from DMF. 
235. Wash RV1 with 10.00 mL from DMF 4 Times. 
236. Fill RV1 with 10 mL from DMF. 
237. Delay 5.00 minutes. 
238. Empty RV1. 
239. Blank. 
240. Blank. 
241. ** Fmoc-Threonine 10** 
242. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes. 
243. Fill RV1 with 5.20 mL from AA2. 
244. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
245. Empty RV1. 
246. Fill RV1 with 10.00 mL from DMF. 
247. Wash RV1 with 10.00 mL from DMF 4 Times. 
248. Fill RV1 with 10 mL from DMF. 
249. Delay 5.00 minutes. 
250. Empty RV1. 
251. Fill RV1 with 15.00 mL from PIP. 
252. Mix RV1 via Mech/N2 Mix for 5 minutes. 
253. Empty RV1. 
254. Fill RV1 with 15.00 mL from PIP. 
255. Mix RV1 via Mech/N2 Mix for 20 minutes. 
256. Empty RV1. 
257. Blank. 
258. Fill RV1 with 10.00 mL from DMF. 
259. Wash RV1 with 10.00 mL from DMF 4 Times. 
260. Fill RV1 with 10 mL from DMF. 
261. Delay 5.00 minutes. 
262. Empty RV1. 
263. Blank. 
264. Blank. 
265.** Fmoc-Threonine 11** 
266. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes. 
267. Fill RV1 with 5.20 mL from AA3. 
268. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
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269. Empty RV1. 
270. Fill RV1 with 10.00 mL from DMF. 
270. Wash RV1 with 10.00 mL from DMF 4 Times. 
272. Fill RV1 with 10 mL from DMF. 
273. Delay 5.00 minutes. 
274. Empty RV1. 
275. Fill RV1 with 15.00 mL from PIP. 
276. Mix RV1 via Mech/N2 Mix for 5 minutes. 
277. Empty RV1. 
278. Fill RV1 with 15.00 mL from PIP. 
279. Mix RV1 via Mech/N2 Mix for 20 minutes. 
280. Empty RV1. 
281. Blank. 
282. Fill RV1 with 10.00 mL from DMF. 
283. Wash RV1 with 10.00 mL from DMF 4 Times. 
284. Fill RV1 with 10 mL from DMF. 
285. Delay 5.00 minutes. 
286. Empty RV1. 
287. Blank. 
288. Blank. 
289.** Fmoc-Threonine 12** 
290. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes. 
291. Fill RV1 with 5.20 mL from AA4. 
292. Mix RV1 via Mech/N2 Mix for 30.00 minutes. 
293. Empty RV1. 
294. Fill RV1 with 10.00 mL from DMF. 
295. Wash RV1 with 10.00 mL from DMF 4 Times. 
296. Fill RV1 with 10 mL from DMF. 
297. Delay 5.00 minutes. 
298. Empty RV1. 
299. Fill RV1 with 15.00 mL from PIP. 
300. Mix RV1 via Mech/N2 Mix for 5 minutes. 
301. Empty RV1. 
302. Fill RV1 with 15.00 mL from PIP. 
303. Mix RV1 via Mech/N2 Mix for 20 minutes. 
304. Empty RV1. 
305. Blank. 
306. Fill RV1 with 10.00 mL from DMF. 
307. Wash RV1 with 10.00 mL from DMF 4 Times. 
308. Fill RV1 with 10 mL from DMF. 
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309. Delay 5.00 minutes. 
310. Empty RV1. 
311. Blank. 
312. Blank. 
 
313.** Solvent switch & Storage** 
314. Fill RV1 with 10.00 mL from DCM. 
315. Wash RV1 with 10.00 mL from DCM 4 Times. 
316. Fill RV1 with 10.00 mL from DCM. 
317. Delay for 5.00 minutes. 
318. Empty RV1. 
319. Blank. 
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Appendix D 
Permission License Number for Chapter 4 
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Appendix E 
Permission License Number for Chapter 5 
 
 
